Publications
S Russell, A Wrobel, D Skvarc, B Kavanagh, M Ashton, O Dean, M Berk, A Turner
(2023), Vol. 26, pp. 61-69, The international journal of neuropsychopharmacology, C1
Metformin is Protective Against the Development of Mood Disorders
J Lake, C Bortolasci, A Stuart, J Pasco, S Kidnapillai, B Spolding, T Truong, B Panizzutti, Z Liu, O Dean, T Crowley, M Richardson, J Kim, M Berk, L Williams, K Walder
(2023), Vol. 56, pp. 25-31, Pharmacopsychiatry, Germany, C1
E Ringin, D Dunstan, R McIntyre, M Berk, N Owen, S Rossell, T Van Rheenen
(2023), Vol. 48, pp. 362-370, Neuropsychopharmacology, England, C1
G Roebuck, M Lotfaliany, B Agustini, M Forbes, M Mohebbi, J McNeil, R Woods, C Reid, M Nelson, R Shah, J Ryan, A Newman, A Owen, R Freak-Poli, N Stocks, M Berk
(2023), Vol. 147, pp. 92-104, Acta Psychiatrica Scandinavica, United States, C1
G Carter, M Spittal, L Glowacki, D Gerostamoulos, P Dietze, B Sinclair, S Arunogiri, M Berk, D Lubman, V Manning, P Higgs, B Quinn, A Baker, O Dean, A Turner, R McKetin
(2023), Vol. 118, pp. 470-479, Addiction, England, C1
L Stangler, E Nicolai, F Mivalt, S Chang, I Kim, A Kouzani, K Bennet, M Berk, S Uthamaraj, T Burns, G Worrell, C Howe
(2023), Vol. 20, pp. 016010-016010, Journal of neural engineering, England, C1
In vivo white matter microstructure in adolescents with early-onset psychosis: a multi-site mega-analysis
C Barth, S Kelly, S Nerland, N Jahanshad, C Alloza, S Ambrogi, O Andreassen, D Andreou, C Arango, I Baeza, N Banaj, C Bearden, M Berk, H Bohman, J Castro-Fornieles, Y Chye, B Crespo-Facorro, E de la Serna, C Díaz-Caneja, T Gurholt, C Hegarty, A James, J Janssen, C Johannessen, E Jönsson, K Karlsgodt, P Kochunov, N Lois, M Lundberg, A Myhre, S Pascual-Diaz, F Piras, R Smelror, G Spalletta, T Stokkan, G Sugranyes, C Suo, S Thomopoulos, D Tordesillas-Gutiérrez, D Vecchio, K Wedervang-Resell, L Wortinger, P Thompson, I Agartz
(2023), Vol. 28, pp. 1159-1169, Molecular Psychiatry, Berlin, Germany, C1
A Walker, M Mohebbi, M Maes, M Berk, K Walder, C Bortolasci, Z Liu, C Ng, M Ashton, L Berk, A Singh, G Malhi, O Dean
(2023), Vol. 27, pp. 100581-100581, Brain, Behavior, and Immunity - Health, United States, C1
M Solmi, T Thompson, A Estradé, A Agorastos, J Radua, S Cortese, E Dragioti, F Leisch, D Vancampfort, L Thygesen, H Aschauer, M Schlögelhofer, E Aschauer, A Schneeberger, C Huber, G Hasler, P Conus, K Do Cuénod, R von Känel, G Arrondo, P Fusar-Poli, P Gorwood, P Llorca, M Krebs, E Scanferla, T Kishimoto, G Rabbani, K Skonieczna-Żydecka, P Brambilla, A Favaro, A Takamiya, L Zoccante, M Colizzi, J Bourgin, K Kamiński, M Moghadasin, S Seedat, E Matthews, J Wells, E Vassilopoulou, A Gadelha, K Su, J Kwon, M Kim, T Lee, O Papsuev, D Manková, A Boscutti, C Gerunda, D Saccon, E Righi, F Monaco, G Croatto, G Cereda, J Demurtas, N Brondino, N Veronese, P Enrico, P Politi, V Ciappolino, A Pfennig, A Bechdolf, A Meyer-Lindenberg, K Kahl, K Domschke, M Bauer, N Koutsouleris, S Winter, S Borgwardt, I Bitter, J Balazs, P Czobor, Z Unoka, D Mavridis, K Tsamakis, V Bozikas, C Tunvirachaisakul, M Maes, T Rungnirundorn, T Supasitthumrong, A Haque, A Brunoni, C Costardi, F Schuch, G Polanczyk, J Luiz, L Fonseca, L Aparicio, S Valvassori, M Nordentoft, P Vendsborg, S Hoffmann, J Sehli, N Sartorius, S Heuss, D Guinart, J Hamilton, J Kane, J Rubio, M Sand
(2023), Vol. 326, pp. 249-261, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Jessica Green, Amelia McGuinness, Michael Berk, David Castle, Eugene Athan, Christopher Hair, Philip Strandwitz, Amy Loughman, Andrew Nierenberg, John Cryan, Mohammadreza Mohebbi, Felice Jacka
(2023), Vol. 9, pp. 1-14, Pilot and Feasibility Studies, London, Eng., C1
C Moller, P Badcock, S Hetrick, S Rice, M Berk, K Witt, A Chanen, O Dean, C Gao, S Cotton, C Davey
(2023), pp. 000486742211442-000486742211442, Australian and New Zealand Journal of Psychiatry, England, C1
T Van Rheenen, E Ringin, J Karantonis, L Furlong, K Bozaoglu, S Rossell, M Berk, V Balanzá-Martínez
(2023), Vol. 320, pp. 115013-115013, Psychiatry Research, Ireland, C1
A Ratheesh, D Hett, J Ramain, E Wong, L Berk, P Conus, M Fristad, T Goldstein, M Hillegers, S Jauhar, L Kessing, D Miklowitz, G Murray, J Scott, M Tohen, L Yatham, A Young, M Berk, S Marwaha
(2023), Vol. 11, International Journal of Bipolar Disorders, Germany, C1-1
E Frost, J Donlon, A Mitwally, G Magnani, S Tomlin, M Berk, M Koola
(2023), Vol. 211, pp. 1-4, Journal of Bone and Joint Surgery, United States, C1
T Van Rheenen, S Cotton, O Dandash, R Cooper, E Ringin, R Daglas-Georgiou, K Allott, Y Chye, C Suo, C Macneil, M Hasty, K Hallam, P McGorry, A Fornito, M Yücel, C Pantelis, M Berk
(2023), Vol. 122, pp. 1-9, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1
Jessica Green, Michael Berk, Mohammadreza Mohebbi, Amy Loughman, Amelia McGuinness, David Castle, Mary Chatterton, Joahna Perez, Philip Strandwitz, Eugene Athan, Christopher Hair, Andrew Nierenberg, John Cryan, Felice Jacka
(2023), pp. 1-12, The Canadian Journal of Psychiatry, London, Eng., C1
Childhood trauma and depressive symptoms in bipolar disorder: a network analysis
Anna Wrobel, Sue Cotton, Anuradhi Jayasinghe, Claudia Diaz‐Byrd, Anastasia Yocum, Alyna Turner, Olivia Dean, Samantha Russell, Elizabeth Duval, Tobin Ehrlich, David Marshall, Michael Berk, Melvin McInnis
(2023), Vol. 147, pp. 286-300, Acta Psychiatrica Scandinavica, London, Eng., C1
Surf therapy for improving child and adolescent mental health: A pilot randomised control trial
L Olive, M Dober, C Mazza, A Turner, M Mohebbi, M Berk, R Telford
(2023), Vol. 65, pp. 102349-102349, Psychology of Sport and Exercise, C1
E Dragioti, J Radua, M Solmi, C Gosling, D Oliver, F Lascialfari, M Ahmed, S Cortese, A Estradé, G Arrondo, M Gouva, M Fornaro, A Batiridou, K Dimou, D Tsartsalis, A Carvalho, J Shin, M Berk, S Stringhini, C Correll, P Fusar-Poli
(2023), Vol. 22, pp. 86-104, World Psychiatry, Italy, C1
Effect of vitamin D supplementation on depression in older Australian adults
S Rahman, M Waterhouse, B Romero, C Baxter, D English, O Almeida, M Berk, P Ebeling, B Armstrong, D McLeod, G Hartel, R O’Connell, H Pham, J Scott, J van der Pols, A Venn, P Webb, D Whiteman, R Neale
(2023), Vol. 38, pp. e5847-, International Journal of Geriatric Psychiatry, England, C1
Correlates of Meal Skipping in Community Dwelling Older Adults: A Cross-Sectional Study
H Wild, D Gasevic, R Woods, J Ryan, M Berk, R Wolfe, J McNeil, A Owen
(2023), Vol. 27, pp. 159-165, Journal of Nutrition, Health and Aging, France, C1
Jason Yuen, Abhinav Goyal, Aaron Rusheen, Abbas Kouzani, Michael Berk, Jee Kim, Susannah Tye, Charles Blaha, Kevin Bennet, Kendall Lee, Hojin Shin, Yoonbae Oh
(2023), Vol. 17, pp. 1061578-, Frontiers in Neuroscience, Switzerland, C1
Treating addiction with deep brain stimulation: Ethical and legal considerations
C Lo, M Mane, J Kim, M Berk, R Sharp, K Lee, J Yuen
(2023), Vol. 113, pp. 103964-103964, International Journal of Drug Policy, Netherlands, C1
Samantha Russell, David Skvarc, Mohammadreza Mohebbi, David Camfield, Linda Byrne, Alyna Turner, Melanie Ashton, Michael Berk, Seetal Dodd, Gin Malhi, Sue Cotton, Ashley Bush, Olivia Dean
(2023), Vol. 21, pp. 320-331, Clinical Psychopharmacology and Neuroscience, Seoul, Korea, C1-1
Daniel Dietch, Jess Kerr-Gaffney, Meghan Hockey, Wolfgang Marx, Anu Ruusunen, Allan Young, Michael Berk, Valeria Mondelli
(2023), Vol. 9, pp. 1-15, BJPsych Open, Cambridge, Eng., C1
C Ching, D Hibar, T Gurholt, A Nunes, S Thomopoulos, C Abé, I Agartz, R Brouwer, D Cannon, S de Zwarte, L Eyler, P Favre, T Hajek, U Haukvik, J Houenou, M Landén, T Lett, C McDonald, L Nabulsi, Y Patel, M Pauling, T Paus, J Radua, M Soeiro-de-Souza, G Tronchin, N van Haren, E Vieta, H Walter, L Zeng, M Alda, J Almeida, D Alnæs, S Alonso-Lana, C Altimus, M Bauer, B Baune, C Bearden, M Bellani, F Benedetti, M Berk, A Bilderbeck, H Blumberg, E Bøen, I Bollettini, C del Mar Bonnin, P Brambilla, E Canales-Rodríguez, X Caseras, O Dandash, U Dannlowski, G Delvecchio, A Díaz-Zuluaga, D Dima, É Duchesnay, T Elvsåshagen, S Fears, S Frangou, J Fullerton, D Glahn, J Goikolea, M Green, D Grotegerd, O Gruber, B Haarman, C Henry, F Howells, V Ives-Deliperi, A Jansen, T Kircher, C Knöchel, B Kramer, B Lafer, C López-Jaramillo, R Machado-Vieira, B MacIntosh, E Melloni, P Mitchell, I Nenadic, F Nery, A Nugent, V Oertel, R Ophoff, M Ota, B Overs, D Pham, M Phillips, J Pineda-Zapata, S Poletti, M Polosan, E Pomarol-Clotet, A Pouchon, Y Quidé, M Rive, G Roberts, H Ruhe, R Salvador, S Sarró, T Satterthwaite, A Schene, K Sim
(2022), Vol. 43, pp. 56-82, Human Brain Mapping, United States, C1
T Gurholt, V Lonning, S Nerland, K Jørgensen, U Haukvik, C Alloza, C Arango, C Barth, C Bearden, M Berk, H Bohman, O Dandash, C Díaz-Caneja, C Edbom, T van Erp, A Fett, S Frangou, B Goldstein, A Grigorian, N Jahanshad, A James, J Janssen, C Johannessen, K Karlsgodt, M Kempton, P Kochunov, L Krabbendam, M Kyriakopoulos, M Lundberg, B MacIntosh, B Rund, R Smelror, A Sultan, C Tamnes, S Thomopoulos, A Vajdi, K Wedervang-Resell, A Myhre, O Andreassen, P Thompson, I Agartz
(2022), Vol. 43, pp. 373-384, Human Brain Mapping, United States, C1
U Haukvik, T Gurholt, S Nerland, T Elvsåshagen, T Akudjedu, M Alda, D Alnæs, S Alonso-Lana, J Bauer, B Baune, F Benedetti, M Berk, F Bettella, E Bøen, C Bonnín, P Brambilla, E Canales-Rodríguez, D Cannon, X Caseras, O Dandash, U Dannlowski, G Delvecchio, A Díaz-Zuluaga, T van Erp, M Fatjó-Vilas, S Foley, K Förster, J Fullerton, J Goikolea, D Grotegerd, O Gruber, B Haarman, B Haatveit, T Hajek, B Hallahan, M Harris, E Hawkins, F Howells, C Hülsmann, N Jahanshad, K Jørgensen, T Kircher, B Krämer, A Krug, R Kuplicki, T Lagerberg, T Lancaster, R Lenroot, V Lonning, C López-Jaramillo, U Malt, C McDonald, A McIntosh, G McPhilemy, D van der Meer, I Melle, E Melloni, P Mitchell, L Nabulsi, I Nenadić, V Oertel, L Oldani, N Opel, M Otaduy, B Overs, J Pineda-Zapata, E Pomarol-Clotet, J Radua, L Rauer, R Redlich, J Repple, M Rive, G Roberts, H Ruhe, L Salminen, R Salvador, S Sarró, J Savitz, A Schene, K Sim, M Soeiro-de-Souza, M Stäblein, D Stein, F Stein, C Tamnes, H Temmingh, S Thomopoulos, D Veltman, E Vieta, L Waltemate, L Westlye, H Whalley, P Sämann, P Thompson, C Ching, O Andreassen, I Agartz
(2022), Vol. 43, pp. 385-398, Human Brain Mapping, United States, C1
V Khosravani, M Berk, S Samimi Ardestani, F Sharifi Bastan
(2022), Vol. 26, pp. 85-91, International Journal of Psychiatry in Clinical Practice, England, C1
R Zazula, S Dodd, O Dean, M Berk, C Bortolasci, W Verri, H Vargas, S Nunes
(2022), Vol. 23, pp. 67-77, World Journal of Biological Psychiatry, England, C1
F Abdul, N Sreenivas, J Kommu, M Banerjee, M Berk, M Maes, M Leboyer, M Debnath
(2022), Vol. 33, pp. 93-109, Reviews in the Neurosciences, Germany, C1
Biomarkers for Deep Brain Stimulation in Animal Models of Depression
J Yuen, A Rusheen, J Price, A Barath, H Shin, A Kouzani, M Berk, C Blaha, K Lee, Y Oh
(2022), Vol. 25, pp. 161-170, Neuromodulation, United States, C1
R Freak-Poli, J Ryan, T Tran, A Owen, J McHugh Power, M Berk, N Stocks, D Gonzalez-Chica, J Lowthian, J Fisher, J Byles
(2022), Vol. 26, pp. 1335-1344, Aging and Mental Health, England, C1
R Zazula, M Mohebbi, S Dodd, O Dean, M Berk, H Vargas, S Nunes
(2022), Vol. 37, pp. 376-389, Archives of Clinical Neuropsychology, United States, C1
S Gomes-da-Costa, W Marx, F Corponi, G Anmella, A Murru, M Pons-Cabrera, A Giménez-Palomo, F Gutiérrez-Arango, C Llach, G Fico, G Kotzalidis, N Verdolini, M Valentí, M Berk, E Vieta, I Pacchiarotti
(2022), Vol. 134, pp. 104266-104266, Neuroscience and Biobehavioral Reviews, United States, C1
S Cotton, K Filia, M Lambert, M Berk, A Ratheesh, B Schimmelmann, C Macneil, M Hasty, P McGorry, P Conus
(2022), Vol. 16, pp. 609-617, Early Intervention in Psychiatry, Australia, C1
S Cotton, K Filia, A Watson, A Mackinnon, L Hides, J Gleeson, M Berk, P Conus, M Lambert, B Schimmelmann, H Herrman, V Rayner, A Ratheesh, P McGorry
(2022), Vol. 16, pp. 715-723, Early Intervention in Psychiatry, Australia, C1
A Wrobel, A Jayasinghe, S Russell, W Marx, L Alameda, O Dean, S Cotton, M Berk, A Turner
(2022), Vol. 296, pp. 350-362, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Inflammation and depression in young people: a systematic review and proposed inflammatory pathways
Y Toenders, L Laskaris, C Davey, M Berk, Y Milaneschi, F Lamers, B Penninx, L Schmaal
(2022), Vol. 27, pp. 315-327, Molecular Psychiatry, England, C1
Results of the COVID-19 mental health international for the general population (COMET-G) study
K Fountoulakis, G Karakatsoulis, S Abraham, K Adorjan, H Ahmed, R Alarcón, K Arai, S Auwal, M Berk, S Bjedov, J Bobes, T Bobes-Bascaran, J Bourgin-Duchesnay, C Bredicean, L Bukelskis, A Burkadze, I Abud, R Castilla-Puentes, M Cetkovich, H Colon-Rivera, R Corral, C Cortez-Vergara, P Crepin, D De Berardis, S Zamora Delgado, D De Lucena, A De Sousa, R Stefano, S Dodd, L Elek, A Elissa, B Erdelyi-Hamza, G Erzin, M Etchevers, P Falkai, A Farcas, I Fedotov, V Filatova, N Fountoulakis, I Frankova, F Franza, P Frias, T Galako, C Garay, L Garcia-Álvarez, M García-Portilla, X Gonda, T Gondek, D González, H Gould, P Grandinetti, A Grau, V Groudeva, M Hagin, T Harada, T Hasan, N Hashim, J Hilbig, S Hossain, R Iakimova, M Ibrahim, F Iftene, Y Ignatenko, M Irarrazaval, Z Ismail, J Ismayilova, A Jakobs, M Jakovljević, N Jakšić, A Javed, H Kafali, S Karia, O Kazakova, D Khalifa, O Khaustova, S Koh, S Kopishinskaia, K Kosenko, S Koupidis, I Kovacs, B Kulig, A Lalljee, J Liewig, A Majid, E Malashonkova, K Malik, N Malik, G Mammadzada, B Mandalia, D Marazziti, D Marčinko, S Martinez, E Matiekus, G Mejia, R Memon, X Martínez, D Mickevičiūtė, R Milev, M Mohammed, A Molina-López
(2022), Vol. 54, pp. 21-40, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1
B Mitchell, A Campos, D Whiteman, C Olsen, S Gordon, A Walker, O Dean, M Berk, I Hickie, S Medland, N Wray, N Martin, E Byrne
(2022), Vol. 92, pp. 227-235, Biological Psychiatry, United States, C1
F Gomes, R Cerqueira, Y Lee, R Mansur, F Kapczinski, R McIntyre, L Yatham, M Berk, R Milev, E Brietzke
(2022), Vol. 298, pp. 565-576, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review
A Giménez-Palomo, S Gomes-da-Costa, S Dodd, I Pachiarotti, N Verdolini, E Vieta, M Berk
(2022), Vol. 132, pp. 142-153, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1
G Morris, K Walder, M Berk, A Carvalho, W Marx, C Bortolasci, A Yung, B Puri, M Maes
(2022), Vol. 114, pp. 1-17, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis
M Fornaro, A Carvalho, M De Prisco, A Mondin, M Billeci, P Selby, F Iasevoli, M Berk, D Castle, A de Bartolomeis
(2022), Vol. 132, pp. 289-303, Neuroscience and Biobehavioral Reviews, Amsterfam, The Netherlands, C1
C Abé, C Ching, B Liberg, A Lebedev, I Agartz, T Akudjedu, M Alda, D Alnæs, S Alonso-Lana, F Benedetti, M Berk, E Bøen, C Bonnin, F Breuer, K Brosch, R Brouwer, E Canales-Rodríguez, D Cannon, Y Chye, A Dahl, O Dandash, U Dannlowski, K Dohm, T Elvsåshagen, L Fisch, J Fullerton, J Goikolea, D Grotegerd, B Haatveit, T Hahn, T Hajek, W Heindel, M Ingvar, K Sim, T Kircher, R Lenroot, U Malt, C McDonald, S McWhinney, I Melle, T Meller, E Melloni, P Mitchell, L Nabulsi, I Nenadić, N Opel, B Overs, F Panicalli, J Pfarr, S Poletti, E Pomarol-Clotet, J Radua, J Repple, K Ringwald, G Roberts, E Rodriguez-Cano, R Salvador, K Sarink, S Sarró, S Schmitt, F Stein, C Suo, S Thomopoulos, G Tronchin, E Vieta, L Westlye, A White, L Yatham, N Zak, P Thompson, O Andreassen, M Landén
(2022), Vol. 91, pp. 582-592, Biological Psychiatry, Amsterdam. The Netherlands, C1
Neurofilament light protein as a biomarker in depression and cognitive function
N Travica, M Berk, W Marx
(2022), Vol. 35, pp. 30-37, Current Opinion in Psychiatry, Philadelphia, Pa., C1
P Navalón, R Sahuquillo-Leal, A Moreno-Giménez, L Salmerón, P Benavent, P Sierra, Y Cañada, A Cañada-Martínez, M Berk, A García-Blanco
(2022), Vol. 239, pp. 142-150, Schizophrenia Research, Amsterdam, The Netherlands, C1
M Solmi, A Estradé, T Thompson, A Agorastos, J Radua, S Cortese, E Dragioti, F Leisch, D Vancampfort, L Thygesen, H Aschauer, M Schloegelhofer, E Akimova, A Schneeberger, C Huber, G Hasler, P Conus, K Cuénod, R von Känel, G Arrondo, P Fusar-Poli, P Gorwood, P Llorca, M Krebs, E Scanferla, T Kishimoto, G Rabbani, K Skonieczna-Żydecka, P Brambilla, A Favaro, A Takamiya, L Zoccante, M Colizzi, J Bourgin, K Kamiński, M Moghadasin, S Seedat, E Matthews, J Wells, E Vassilopoulou, A Gadelha, K Su, J Kwon, M Kim, T Lee, O Papsuev, D Manková, A Boscutti, C Gerunda, D Saccon, E Righi, F Monaco, G Croatto, G Cereda, J Demurtas, N Brondino, N Veronese, P Enrico, P Politi, V Ciappolino, A Pfennig, A Bechdolf, A Meyer-Lindenberg, K Kahl, K Domschke, M Bauer, N Koutsouleris, S Winter, S Borgwardt, I Bitter, J Balazs, P Czobor, Z Unoka, D Mavridis, K Tsamakis, V Bozikas, C Tunvirachaisakul, M Maes, T Rungnirundorn, T Supasitthumrong, A Haque, A Brunoni, C Costardi, F Schuch, G Polanczyk, J Luiz, L Fonseca, L Aparicio, S Valvassori, M Nordentoft, P Vendsborg, S Hoffmann, J Sehli, N Sartorius, S Heuss, D Guinart, J Hamilton, J Kane, J Rubio, M Sand, Wolf Marx
(2022), Vol. 299, pp. 367-376, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
S Herniman, S Wood, S Cotton, K Allott, C Davey, M Berk, L Phillips, E Liemburg, S Castelein, W Veling, R Bruggeman, H Knegtering
(2022), Vol. 240, pp. 52-60, Schizophrenia Research, Amsterdam, The Netherlands, C1
M Solmi, A Estradé, T Thompson, A Agorastos, J Radua, S Cortese, E Dragioti, F Leisch, D Vancampfort, L Thygesen, H Aschauer, M Schloegelhofer, E Akimova, A Schneeberger, C Huber, G Hasler, P Conus, K Cuénod, R von Känel, G Arrondo, P Fusar-Poli, P Gorwood, P Llorca, M Krebs, E Scanferla, T Kishimoto, G Rabbani, K Skonieczna-Żydecka, P Brambilla, A Favaro, A Takamiya, L Zoccante, M Colizzi, J Bourgin, K Kamiński, M Moghadasin, S Seedat, E Matthews, J Wells, E Vassilopoulou, A Gadelha, K Su, J Kwon, M Kim, T Lee, O Papsuev, D Manková, A Boscutti, C Gerunda, D Saccon, E Righi, F Monaco, G Croatto, G Cereda, J Demurtas, N Brondino, N Veronese, P Enrico, P Politi, V Ciappolino, A Pfennig, A Bechdolf, A Meyer-Lindenberg, K Kahl, K Domschke, M Bauer, N Koutsouleris, S Winter, S Borgwardt, I Bitter, J Balazs, P Czobor, Z Unoka, D Mavridis, K Tsamakis, V Bozikas, C Tunvirachaisakul, M Maes, T Rungnirundorn, T Supasitthumrong, A Haque, A Brunoni, C Costardi, F Schuch, G Polanczyk, J Luiz, L Fonseca, L Aparicio, S Valvassori, M Nordentoft, P Vendsborg, S Hoffmann, J Sehli, N Sartorius, S Heuss, D Guinart, J Hamilton, J Kane, J Rubio, M Sand, Michael Berk
(2022), Vol. 299, pp. 393-407, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Cocaine increases stimulation-evoked serotonin efflux in the nucleus accumbens
J Yuen, A Goyal, A Rusheen, A Kouzani, M Berk, J Kim, S Tye, C Blaha, K Bennet, K Lee, Y Oh, H Shin
(2022), Vol. 127, pp. 714-724, Journal of neurophysiology, United States, C1
Biomarkers for Deep Brain Stimulation in Animal Models of Depression.
Jason Yuen, Aaron Rusheen, Joshua Price, Abhijeet Barath, Hojin Shin, Abbas Kouzani, Michael Berk, Charles Blaha, Kendall Lee, Yoonbae Oh
(2022), Vol. 25, pp. 161-170, Neuromodulation, London, Eng., C1
Seetal Dodd, David Skvarc, Olivia Dean, Anna Anderson, Mark Kotowicz, Michael Berk
(2022), Vol. 25, pp. 387-398, International Journal of Neuropsychopharmacology, Oxford, Eng., C1
A McGuinness, J Davis, S Dawson, A Loughman, F Collier, M O’Hely, C Simpson, J Green, W Marx, C Hair, G Guest, M Mohebbi, M Berk, D Stupart, D Watters, F Jacka
(2022), Vol. 27, pp. 1920-1935, Molecular Psychiatry, Berlin, Germany, C1
Time for united action on depression: a Lancet-World Psychiatric Association Commission
H Herrman, V Patel, C Kieling, M Berk, C Buchweitz, P Cuijpers, T Furukawa, R Kessler, B Kohrt, M Maj, P McGorry, C Reynolds, M Weissman, D Chibanda, C Dowrick, L Howard, C Hoven, M Knapp, H Mayberg, B Penninx, S Xiao, M Trivedi, R Uher, L Vijayakumar, M Wolpert
(2022), Vol. 399, pp. 957-1022, The Lancet, Amsterdam, The Netherlands, C1
L Olive, E Sciberras, T Berkowitz, E Hoare, R Telford, A O'Neil, A Mikocka-Walus, S Evans, D Hutchinson, J McGillivray, M Berk, S Teague, A Wood, C Olsson, E Westrupp
(2022), Vol. 12, pp. 1-13, Frontiers in Psychiatry, Lausanne, Switzerland, C1
A Wrobel, O Köhler‐Forsberg, L Sylvia, S Russell, O Dean, S Cotton, M Thase, J Calabrese, T Deckersbach, M Tohen, C Bowden, M McInnis, J Kocsis, E Friedman, T Ketter, R Shelton, M Ostacher, D Iosifescu, M Berk, A Turner, A Nierenberg
(2022), Vol. 145, pp. 615-627, Acta Psychiatrica Scandinavica, London, England, C1
Anna Wrobel, Samantha Russell, Anuradhi Jayasinghe, Mojtaba Lotfaliany, Alyna Turner, Olivia Dean, Sue Cotton, Claudia Diaz‐Byrd, Anastasia Yocum, Elizabeth Duval, Tobin Ehrlich, David Marshall, Michael Berk, Melvin McInnis
(2022), Vol. 145, pp. 591-603, Acta Psychiatrica Scandinavica, London, Eng., C1
Licia Luna, Joaquim Radua, Lydia Fortea, Gisela Sugranyes, Adriana Fortea, Paolo Fusar-Poli, Lee Smith, Joseph Firth, Jae Shin, Andre Brunoni, Muhammad Husain, Muhammad Husian, Haris Sair, Walber Mendes, Luiz Uchoa, Michael Berk, Michael Maes, Zafiris Daskalakis, Sophia Frangou, Michele Fornaro, Eduard Vieta, Brendon Stubbs, Marco Solmi, Andre Carvalho
(2022), Vol. 117, pp. 1-8, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1
Claire Young, Tetyana Rocks, Rachelle Opie, Michael Berk, Adrienne O'Neil
(2022), Vol. 52, pp. 62-66, Psychiatric Annals, Thorofore, N.J., C1
Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder
M McInnis, O Andreassen, A Andreazza, U Alon, M Berk, T Brister, K Burdick, D Cui, M Frye, M Leboyer, P Mitchell, K Merikangas, A Nierenberg, J Nurnberger, D Pham, E Vieta, L Yatham, A Young
(2022), pp. 1-10, Bipolar Disorders, London, Eng., C1
David Angeler, Harris Eyre, Michael Berk, Craig Allen, William Hynes, Igor Linkov
(2022), pp. 1-4, International Journal of Health Policy and Management, Kerman, Iran, C1
J Sarris, G Byrne, D Castle, C Bousman, G Oliver, L Cribb, S Blair-West, V Brakoulias, D Camfield, C Ee, S Chamoli, M Boschen, O Dean, N Dowling, R Menon, J Murphy, N Metri, T Nguyen, A Wong, R Jordan, D Karamacoska, S Rossell, M Berk, C Ng
(2022), Vol. 117, pp. 1-9, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
R Bradlow, M Berk, P Kalivas, S Back, R Kanaan
(2022), Vol. 36, pp. 451-482, CNS Drugs, Berlin, Germany, C1
Melissa O'Shea, Hannah Capon, David Skvarc, Subhadra Evans, Shane McIver, Jill Harris, Emma Houston, Michael Berk
(2022), Vol. 307, pp. 1-10, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
J Sarris, A Ravindran, L Yatham, W Marx, J Rucklidge, R McIntyre, S Akhondzadeh, F Benedetti, C Caneo, H Cramer, L Cribb, M de Manincor, O Dean, A Deslandes, M Freeman, B Gangadhar, B Harvey, S Kasper, J Lake, A Lopresti, L Lu, N Metri, D Mischoulon, C Ng, D Nishi, R Rahimi, S Seedat, J Sinclair, K Su, Z Zhang, M Berk
(2022), pp. 1-32, World Journal of Biological Psychiatry, London, Eng., C1
K Burdick, C Millett, A Yocum, C Altimus, O Andreassen, V Aubin, R Belzeaux, M Berk, J Biernacka, H Blumberg, A Cleare, C Diaz‐Byrd, C Dubertret, B Etain, L Eyler, B Forester, J Fullerton, M Frye, S Gard, O Godin, E Haffen, F Klaus, T Lagerberg, M Leboyer, A Martinez‐Aran, S McElroy, P Mitchell, E Olie, P Olorunfemi, C Passerieux, A Peters, D Pham, M Polosan, J Potter, M Sajatovic, L Samalin, R Schwan, M Shanahan, B Solé, R Strawbridge, A Stuart, I Torres, T Ueland, E Vieta, L Williams, A Wrobel, L Yatham, A Young, A Nierenberg, M McInnis
(2022), pp. 1-11, Bipolar Disorders, London, Eng., C1
Lauren Young, Steve Moylan, Tayla John, Megan Turner, Rachelle Opie, Meghan Hockey, Dean Saunders, Courtney Bruscella, Felice Jacka, Megan Teychenne, Simon Rosenbaum, Khyati Banker, Sophie Mahoney, Monica Tembo, Jerry Lai, Niamh Mundell, Grace McKeon, Murat Yucel, Jane Speight, Pilvikki Absetz, Vincent Versace, Mary Chatterton, Michael Berk, Sam Manger, Mohammadreza Mohebbi, Mark Morgan, Anna Chapman, Craig Bennett, Melissa O’Shea, Tetyana Rocks, Sarah Leach, Adrienne O’Neil
(2022), Vol. 22, pp. 1-13, BMC Psychiatry, Berlin, Germany, C1
G Morris, L Sominsky, K Walder, M Berk, W Marx, A Carvalho, C Bortolasci, M Maes, B Puri
(2022), Vol. 59, pp. 3485-3503, Molecular Neurobiology, Berlin, Germany, C1
Common effects of bipolar disorder medications on expression quantitative trait loci genes
T Truong, C Bortolasci, S Kidnapillai, B Spolding, B Panizzutti, Z Liu, B Watmuff, J Kim, O Dean, M Richardson, M Berk, K Walder
(2022), Vol. 150, pp. 105-112, Journal of Psychiatric Research, Amsterdam, The Netherlands, C1
What Injured Workers With Complex Claims Look For in Online Communities: Netnographic Analysis
M Hutson, S Hosking, S Mantalvanos, M Berk, J Pasco, T Dunning
(2022), Vol. 24, Journal of Medical Internet Research, Canada, C1
Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Zoe Liu, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Craig Smith, Olivia Dean, Jee Kim, Michael Berk, Ken Walder
(2022), Vol. 13, pp. 1-12, Frontiers in Pharmacology, Lausanne, Switzerland, C1
Bipolar disorder and bone health: A case-control study
L Williams, A Stuart, M Berk, S Brennan-Olsen, J Hodge, S Quirk, H Koivumaa-Honkanen, R Honkanen, J Heikkinen, V Chandrasekaran, J Cleminson, J Pasco
(2022), Vol. 308, pp. 39-43, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Deep Brain Stimulation for Addictive Disorders-Where Are We Now?
J Yuen, A Kouzani, M Berk, S Tye, A Rusheen, C Blaha, K Bennet, K Lee, H Shin, J Kim, Y Oh
(2022), pp. 1-23, Neurotherapeutics, Berlin, Germany, C1
Trajectories of depressive symptoms in older adults and associated health outcomes
B Agustini, M Lotfaliany, M Mohebbi, R Woods, J McNeil, M Nelson, R Shah, A Murray, C Reid, A Tonkin, J Ryan, L Williams, M Forbes, M Berk
(2022), Vol. 2, pp. 295-302, Nature Aging, Berlin, Germany, C1
C Okechukwu, M Griffiths, M Carta, E Nwobodo, S Shariful Islam, M Forbes, M Berk, M Potenza, M Banach, O Amamihechineke Grace, N Nwobodo, G La Torre
(2022), Vol. 57, pp. 67-79, Rivista di psichiatria, Rome, Italy, C1
Samantha Russell, Anna Wrobel, Olivia Dean, Michael Berk, Seetal Dodd, Chee Ng, Gin Malhi, Susan Cotton, Jerome Sarris, Alyna Turner
(2022), Vol. 20, pp. 300-310, Clinical psychopharmacology and neuroscience, Seoul, Korea (South), C1
Nutrition and bipolar disorder: a systematic review
F Gabriel, M Oliveira, B Martella, M Berk, E Brietzke, F Jacka, B Lafer
(2022), Nutritional Neuroscience, England, C1
M Similon, C Paasche, F Krol, B Lerer, G Goodwin, M Berk, A Meyer-Lindenberg, T Ketter, L Yatham, J Goldberg, G Malhi, R El-Mallakh, R Licht, A Young, F Kapczinski, M Swartz, M Hagin, C Torrent, A Serretti, A Yildiz, A Martínez-Arán, S Strejilevich, J Rybakowski, G Sani, H Grunze, G Vázquez, A Pinto, J Azorin, W Nolen, O Sentissi, C López-Jaramillo, B Frey, A Nierenberg, G Parker, D Bond, A Cohen, A Tortorella, G Perugi, E Vieta, D Popovic
(2022), Vol. 60, pp. 91-99, European Neuropsychopharmacology, Netherlands, C1
Listening to the silent struggles of bipolar disorder through sonification of iMoodJournal data
D Angeler, H Eyre, M Berk
(2022), Vol. 24, pp. 689-692, Bipolar Disorders, Denmark, C1-1
L Saxon, S Bromfield, S Leow-Taylor, C Vega, M Berk, A LaMontagne, A Martin, M Mohebbi, K Nielsen, N Reavley, A Walker, A Conway, A de Silva, K Memish, A Rossetto, G Tanewski, A Noblet
(2022), Vol. 22, pp. 1-12, BMC Psychiatry, London, Eng., C1
Investing in Late-Life Brain Capital
W Dawson, E Smith, L Booi, M Mosse, H Lavretsky, C Reynolds, J Cummings, P Brannally, W Hynes, E Lenze, F Manes, R Ayadi, L Frank, S Chapman, I Robertson, L Rubenstein, J Jraissati, A Ibáñez, H Fillit, D Jeste, A Rao, M Berk, E Storch, A Santuccione Chadha, H Eyre
(2022), Vol. 6, Innovation in Aging, England, C1
Risk factors for depression in Pacific adolescents in New Zealand: A network analysis
L Gossage, A Narayanan, J Dipnall, L Iusitini, A Sumich, M Berk, W Wrapson, E Tautolo, R Siegert
(2022), Vol. 311, pp. 373-382, Journal of Affective Disorders, Netherlands, C1
Effects of psychotropic drugs on ribosomal genes and protein synthesis
Zoe Liu, Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Courtney Swinton, Jee Kim, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Olivia Dean, Sean McGee, Michael Berk, Ken Walder
(2022), Vol. 23, pp. 7180-7180, International Journal of Molecular Sciences, Basel, Switzerland, C1
N Travica, H Aslam, A O'Neil, M Lane, M Berk, E Gamage, K Walder, Z Liu, T Segasby, W Marx
(2022), Vol. 193, pp. 107656-107656, Neurobiology of Learning and Memory, United States, C1
Integrative analyses of transcriptomes to explore common molecular effects of antipsychotic drugs
Trang Truong, Chiara Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Bruna Panizzutti, Zoe Liu, Jee Kim, Olivia Dean, Mark Richardson, Michael Berk, Ken Walder
(2022), Vol. 23, pp. 7508-7508, International Journal of Molecular Sciences, Basel, Switzerland, C1
K Fountoulakis, G Karakatsoulis, S Abraham, K Adorjan, H Ahmed, R Alarcón, K Arai, S Auwal, M Berk, S Bjedov, J Bobes, T Bobes-Bascaran, J Bourgin-Duchesnay, C Bredicean, L Bukelskis, A Burkadze, I Abud, R Castilla-Puentes, M Cetkovich, H Colon-Rivera, R Corral, C Cortez-Vergara, P Crepin, D De Berardis, S Delgado, D De Lucena, A De Sousa, R Stefano, S Dodd, L Elek, A Elissa, B Erdelyi-Hamza, G Erzin, M Etchevers, P Falkai, A Farcas, I Fedotov, V Filatova, N Fountoulakis, I Frankova, F Franza, P Frias, T Galako, C Garay, L Garcia-Álvarez, M García-Portilla, X Gonda, T Gondek, D González, H Gould, P Grandinetti, A Grau, V Groudeva, M Hagin, T Harada, T Hasan, N Hashim, J Hilbig, S Hossain, R Iakimova, M Ibrahim, F Iftene, Y Ignatenko, M Irarrazaval, Z Ismail, J Ismayilova, A Jacobs, M Jakovljević, N Jakšić, A Javed, H Kafali, S Karia, O Kazakova, D Khalifa, O Khaustova, S Koh, S Kopishinskaia, K Kosenko, S Koupidis, I Kovacs, B Kulig, A Lalljee, J Liewig, A Majid, E Malashonkova, K Malik, N Malik, G Mammadzada, B Mandalia, D Marazziti, D Marčinko, S Martinez, E Matiekus, G Mejia, R Memon, X Martínez, D Mickevičiūtė, R Milev, M Mohammed, A Molina-López
(2022), Vol. 315, Psychiatry Research, Ireland, C1
Prediction of disability-free survival in healthy older people
J Neumann, L Thao, A Murray, E Callander, P Carr, M Nelson, R Wolfe, R Woods, C Reid, R Shah, A Newman, J Williamson, A Tonkin, J McNeil, J McNeil, A Murray, L Beilin, A Chan, J Demons, M Ernst, S Espinoza, M Goetz, C Johnston, B Kirpach, D Liew, K Margolis, F Meyskens, M Nelson, C Reid, R Shah, E Storey, A Tonkin, R Woods, J Zalcberg, M Nelson, D Ives, M Berk, W Bernstein, D Brauer, C Burns, T Chong, G Cloud, G Donnan, C Eaton, P Fitzgerald, P Gibbs, A Haydon, M Jelinek, F Macrae, S Mahady, M Malik, K Margolis, C McLean, A Murray, A Newman, L Rodriguez, S Satterfield, R Shah, E Storey, J Tie, A Tonkin, G van Londen, S Ward, J Williamson, E Wood, J Zalcberg, J Mohr, G Anderson, S Connolly, L Friedman, J Manson, M Sano, S Morrison, E Ohman, J McNeil, R Woods, W Abhayaratna, L Beilin, G Donnan, P Gibbs, C Johnston, D Liew, T Lockett, M Nelson, C Reid, N Stocks, E Storey, A Tonkin, J Zalcberg, A Murray, C Reid, W Abhayaratna, M Ernst, C Johnston, B Lewis, D Liew, K Margolis, J McNeil, M Nelson
(2022), Vol. 44, pp. 1641-1655, GeroScience, Switzerland, C1-1
Psilocybin in Neuropsychiatry: A review of its pharmacology, safety and efficacy
S Dodd, T Norman, H Eyre, S Stahl, A Phillips, A Carvalho, M Berk
(2022), CNS Spectrums, United States, C1
I Bojanić, O Bjerkeset, L Williams, M Berk, E Sund, H Sletvold
(2022), Vol. 9, pp. 503-516, Drugs - Real World Outcomes, Berlin, Germany, C1
Erica Neill, Susan Rossell, Caitlin Yolland, Denny Meyer, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael Berk, Kiymet Bozaoglu, Frances Dark, Olivia Dean, Paul Francis, Dennis Liu, Andrea Phillipou, Jerome Sarris, David Castle
(2022), pp. 1-10, Schizophrenia Bulletin, Oxford, Eng., C1
V Van Den Eynde, W Abdelmoemin, M Abraham, J Amsterdam, I Anderson, C Andrade, G Baker, A Beekman, M Berk, T Birkenhäger, B Blackwell, P Blier, M Blom, J Bodkin, C Cattaneo, B Dantz, J Davidson, B Dunlop, R Estévez, S Feinberg, J Finberg, L Fochtmann, D Gotlib, A Holt, T Insel, J Larsen, R Mago, D Menkes, J Meyer, D Nutt, G Parker, M Rego, E Richelson, H Ruhé, J Sáiz-Ruiz, S Stahl, T Steele, M Thase, S Ulrich, A Van Balkom, E Vieta, I Whyte, A Young, P Gillman
(2022), pp. 1-14, CNS Spectrums, United States, C1
A Wrobel, S Russell, A Jayasinghe, B Kavanagh, M Lotfaliany, A Turner, O Dean, S Cotton, C Diaz-Byrd, A Yocum, E Duval, T Ehrlich, D Marshall, M Berk, M McInnis
(2022), Australian and New Zealand Journal of Psychiatry, England, C1
Association between polarity of first episode and solar insolation in bipolar I disorder
M Bauer, T Glenn, E Achtyes, M Alda, E Agaoglu, K Altınbaş, O Andreassen, E Angelopoulos, R Ardau, M Aydin, Y Ayhan, C Baethge, R Bauer, B Baune, C Balaban, C Becerra-Palars, A Behere, P Behere, H Belete, T Belete, G Belizario, F Bellivier, R Belmaker, F Benedetti, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, C Brady, J Cabrera, M Cappucciati, A Paredes Castro, W Chen, E Cheung, S Chiesa, M Crowe, A Cuomo, S Dallaspezia, M Del Zompo, P Desai, S Dodd, B Etain, A Fagiolini, F Fellendorf, E Ferensztajn-Rochowiak, J Fiedorowicz, K Fountoulakis, M Frye, P Geoffroy, A Gonzalez-Pinto, J Gottlieb, P Grof, B Haarman, H Harima, M Hasse-Sousa, C Henry, L Høffding, J Houenou, M Imbesi, E Isometsä, M Ivkovic, S Janno, S Johnsen, F Kapczinski, G Karakatsoulis, M Kardell, L Kessing, S Kim, B König, T Kot, M Koval, M Kunz, B Lafer, M Landén, E Larsen, M Lenger, U Lewitzka, R Licht, C Lopez-Jaramillo, A MacKenzie, H Madsen, S Madsen, J Mahadevan, A Mahardika, M Manchia, W Marsh, M Martinez-Cengotitabengoa, K Martiny, Y Mashima, D McLoughlin, Y Meesters, I Melle, F Meza-Urzúa, Y Mok, S Monteith, M Moorthy, G Morken, E Mosca, A Mozzhegorov
(2022), Vol. 160, pp. 1-10, Journal of Psychosomatic Research, Amsterdam, The Netherlands, C1
Neuropsychiatric Consequences of COVID-19 Pandemic: A Synthetic Review from a Global Perspective
Seithikurippu Pandi-Perumal, Nevin Zaki, Mohammad Qasim, Nesreen Morsy, Md Manzar, Ahmed BaHammam, Haitham Jahrami, Chellamuthu Ramasubramanian, Ramanujam Karthikeyan, Thitiporn Supasitthumrong, Adam Moscovitch, Ilya Trakht, Ravi Gupta, Meera Narasimhan, Timo Partonen, Russel Reiter, Gerwyn Morris, Michael Berk, Sidney Kennedy, Dan Stein, Stephen Stahl, Dennis Charney, Mary Seeman
(2022), Vol. 23, pp. 144-154, ALPHA PSYCHIATRY, Turkey, C1
Open Innovation: The Key to Advancing Brain Health
H Eyre, J Searfoss, M Hopwood, M Berk, S Chen, J Cummings, F Veron, V Zikopolous, A Ibanez, K Kelly, J Soares, E Smith, B Gilbert
(2022), CNS Spectrums, United States, C1
M Chatterton, Y Lee, L Berk, M Mohebbi, M Berk, T Suppes, S Lauder, C Mihalopoulos
(2022), Vol. 9, JMIR Mental Health, Canada, C1
S Cowdery, O Bjerkeset, E Sund, M Mohebbi, J Pasco, M Berk, L Williams
(2022), Vol. 316, pp. 1-9, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Depression, anxiety and worry in young Pacific adults in New Zealand during the COVID-19 pandemic
R Siegert, A Narayanan, J Dipnall, L Gossage, W Wrapson, A Sumich, F Merien, M Berk, J Paterson, E Tautolo
(2022), pp. 1-12, Australian and New Zealand Journal of Psychiatry, London, Eng., C1
A Teixeira, L Martins, M Berk, M Bauer
(2022), Vol. 136, pp. 1257-1280, Clinical Science, London, Eng., C1
R McIntyre, M Alda, R Baldessarini, M Bauer, M Berk, C Correll, A Fagiolini, K Fountoulakis, M Frye, H Grunze, L Kessing, D Miklowitz, G Parker, R Post, A Swann, T Suppes, E Vieta, A Young, M Maj
(2022), Vol. 21, pp. 364-387, World Psychiatry, Italy, C1-1
A Jayasinghe, A Wrobel, K Filia, L Byrne, G Melvin, L Berk, M Berk, S Cotton
(2022), Australian and New Zealand Journal of Psychiatry, London, Eng., C1
M Galbally, K Eggleston, K Northwood, D Siskind, M Berk, S Suetani, N Gill, N O’Connor, S Harvey, S Every-Palmer
(2022), Australian and New Zealand Journal of Psychiatry, England, C1
Falls in community-dwelling women with bipolar disorder: a case-control study
A Stuart, J Pasco, M Berk, S Quirk, H Koivumaa-Honkanen, R Honkanen, M Mohebbi, L Williams
(2022), Vol. 22, BMC Psychiatry, England, C1
C Moller, P Badcock, S Hetrick, S Rice, M Berk, O Dean, A Chanen, C Gao, C Davey, S Cotton
(2022), Omega (United States), United States, C1
The role of metformin as a treatment for neuropsychiatric illness
S Dodd, L Sominsky, D Siskind, C Bortolasci, A Carvalho, M Maes, A Walker, K Walder, A Yung, L Williams, H Myles, T Watson, M Berk
(2022), Vol. 64, pp. 32-43, European Neuropsychopharmacology, Netherlands, C1
B O'Donoghue, K Allott, S Harrigan, F Scalzo, J Ward, S Mallawaarachchi, S Whitson, L Baldwin, J Graham, E Mullen, C MacNeil, D Alexander, S Wood, M Berk, M Alvarez-Jimenez, A Thompson, A Fornito, H Yuen, B Nelson, S Francey, P McGorry
(2022), pp. 1-11, Early Intervention in Psychiatry, London, Eng., C1-1
L Gustad, A Holand, T Hynnekleiv, O Bjerkeset, M Berk, S Romundstad
(2022), Vol. 17, pp. e0274271-e0274271, PLoS ONE, United States, C1
W Marx, S Manger, M Blencowe, G Murray, F Ho, S Lawn, J Blumenthal, F Schuch, B Stubbs, A Ruusunen, H Desyibelew, T Dinan, F Jacka, A Ravindran, M Berk, A O’Neil
(2022), World Journal of Biological Psychiatry, England, C1
B Kavanagh, J O’Donohue, M Ashton, M Lotfaliany, M McCallum, A Wrobel, S Croce, M Berk, L Saunders, J Lai, L Berk
(2022), Vol. 13, Frontiers in Psychiatry, Switzerland, C1
L Gustad, T Myklebust, O Bjerkeset, L Williams, L Laugsand, H Dalen, M Berk, S Romundstad
(2022), Vol. 22, pp. 1-11, BMC Cardiovascular Disorders, London, Eng., C1
E Koning, A McDonald, A Bambokian, F Gomes, J Vorstman, M Berk, J Fabe, R McIntyre, R Milev, R Mansur, E Brietzke
(2022), pp. 1-10, CNS Spectrums, United States, C1
Brain health-directed policymaking : A new concept to strengthen democracy
Ryan Abbott, David Angeler, Rym Ayadi, Virginia Bennett, Michael Berk, Robert Bilder, Andrew Carlo, Shuo Chen, Lynne Corner, Mark D'Esposito, Walter Dawson, Frederic Destrebecq, Harris Eyre, Michael Freeman, Carol Graham, James Hackett, William Hynes, Agustin Ibanez, Dilip Jeste, Jorge Jraissati, Facundo Manes, Michael Matthews, Chee Ng, Wolfgang Oertel, Ian Robertson, Karen Rommelfanger, Antonella Santuccione Chadha, Zoltan Sarnyai, Erin Smith, Jair Soares, Eric Storch, Sebastian Winter, Christine Moutier
(2022), Washington, D.C., A6
K Fountoulakis, E Dragioti, A Theofilidis, T Wiklund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadaǧ, A De Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M De Hert
(2021), Vol. 26, pp. 290-298, CNS Spectrums, United States, C1
Effects of psychoactive drugs on cellular bioenergetic pathways
C Bortolasci, B Spolding, S Kidnapillai, M Richardson, N Vasilijevic, S Martin, L Gray, S McGee, M Berk, K Walder
(2021), Vol. 22, pp. 79-93, World Journal of Biological Psychiatry, England, C1
M Solmi, A Miola, G Croatto, G Pigato, A Favaro, M Fornaro, M Berk, L Smith, J Quevedo, M Maes, C Correll, A Carvalho
(2021), Vol. 43, pp. 189-202, Brazilian Journal of Psychiatry, Brazil, C1
Y Quidé, C Bortolasci, B Spolding, S Kidnapillai, O Watkeys, S Cohen-Woods, V Carr, M Berk, K Walder, M Green
(2021), Vol. 105, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1
A novel way to quantify schizophrenia symptoms in clinical trials
O Medvedev, M Berk, O Dean, E Brown, M Sandham, J Dipnall, R McNamara, A Sumich, C Krägeloh, A Narayanan, R Siegert
(2021), Vol. 51, European Journal of Clinical Investigation, England, C1
P Sunder, M Chia, K Filia, C Macneil, M Hasty, C Davey, P McGorry, M Berk, S Cotton, A Ratheesh
(2021), Vol. 278, pp. 23-32, Journal of affective disorders, Amsterdam, The Netherlands, C1
Mood disorder and cancer onset: Evidence from a population-based sample of australian women
S Cowdery, A Stuart, J Pasco, M Berk, D Campbell, O Bjerkeset, L Williams
(2021), Vol. 43, pp. 355-361, Brazilian Journal of Psychiatry, Brazil, C1
A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder
M Ashton, B Kavanagh, W Marx, M Berk, J Sarris, C Ng, M Hopwood, L Williams, O Dean
(2021), Vol. 66, pp. 262-273, Canadian Journal of Psychiatry, United States, C1
T Van Rheenen, R McIntyre, V Balanzá-Martínez, M Berk, S Rossell
(2021), Vol. 278, pp. 556-562, Journal of Affective Disorders, Netherlands, C1
R McKETIN, B Quinn, P Higgs, M Berk, O Dean, A Turner, P Kelly, D Lubman, G Carter, A Baker, V Manning, T Thomas, R Bathish, D Raftery, L Saunders, A Wrobel, A Meehan, B Sinclair, D Reid, S Arunogiri, H Hill, F Cordaro, P Dietze
(2021), Vol. 40, pp. 1249-1255, Drug and Alcohol Review, Australia, C1
Trace amine-associated receptor 1 (TAAR1): a new drug target for psychiatry?
S Dodd, A Carvalho, B Puri, M Maes, C Bortolasci, G Morris, M Berk
(2021), Vol. 120, pp. 537-541, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
Preventing the development of severe COVID-19 by modifying immunothrombosis
G Morris, C Bortolasci, B Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk
(2021), Vol. 264, Life Sciences, Netherlands, C1
R Zazula, M Husain, M Mohebbi, A Walker, I Chaudhry, A Khoso, M Ashton, B Agustini, N Husain, J Deakin, A Young, M Berk, B Kanchanatawan, C Ng, M Maes, L Berk, A Singh, G Malhi, O Dean
(2021), Vol. 55, pp. 784-798, Australian and New Zealand Journal of Psychiatry, England, C1
Diet and depression: exploring the biological mechanisms of action
W Marx, M Lane, M Hockey, H Aslam, M Berk, K Walder, A Borsini, J Firth, C Pariante, K Berding, J Cryan, G Clarke, J Craig, K Su, D Mischoulon, F Gomez-Pinilla, J Foster, P Cani, S Thuret, H Staudacher, A Sánchez-Villegas, H Arshad, T Akbaraly, A O’Neil, T Segasby, F Jacka
(2021), Vol. 26, pp. 134-150, Molecular Psychiatry, England, C1
M Lane, J Davis, S Beattie, C Gómez-Donoso, A Loughman, A O'Neil, F Jacka, M Berk, R Page, W Marx, T Rocks
(2021), Vol. 22, Obesity Reviews, England, C1
B Kavanagh, M Ashton, S Cowdery, O Dean, A Turner, M Berk, S Gwini, S Brennan-Olsen, H Koivumaa-Honkanen, A Chanen, L Williams
(2021), Vol. 279, pp. 711-721, Journal of affective disorders, Amsterdam, The Netherlands, C1
Y Cañada, A Sabater, P Sierra, V Balanzá-Martínez, M Berk, S Dodd, P Navalón, L Livianos, A García-Blanco
(2021), Vol. 55, pp. 1005-1016, Australian and New Zealand Journal of Psychiatry, England, C1
Design of a brief psychological intervention for youth who self-harm: A formative study in India
S Aggarwal, G Patton, M Berk, V Patel
(2021), Vol. 24, pp. E2-, Evidence-Based Mental Health, England, C1
W Marx, A McGuinness, T Rocks, A Ruusunen, J Cleminson, A Walker, S Gomes-da-Costa, M Lane, M Sanches, A Diaz, P Tseng, P Lin, M Berk, G Clarke, A O’Neil, F Jacka, B Stubbs, A Carvalho, J Quevedo, J Soares, B Fernandes
(2021), Vol. 26, pp. 4158-4178, Molecular Psychiatry, England, C1
C Moller, S Cotton, P Badcock, S Hetrick, M Berk, O Dean, A Chanen, C Davey
(2021), Vol. 281, pp. 714-720, Journal of Affective Disorders, Netherlands, C1
A Guerin, E Nestler, M Berk, A Lawrence, S Rossell, J Kim
(2021), Vol. 120, pp. 48-74, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
M Fornaro, F Daray, F Hunter, A Anastasia, B Stubbs, D De Berardis, J Shin, M Husain, E Dragioti, P Fusar-Poli, M Solmi, M Berk, E Vieta, A Carvalho
(2021), Vol. 280, pp. 409-431, Journal of Affective Disorders, Netherlands, C1
S Dodd, M Bauer, A Carvalho, H Eyre, M Fava, S Kasper, S Kennedy, J Khoo, C Lopez Jaramillo, G Malhi, R McIntyre, P Mitchell, A Castro, A Ratheesh, E Severus, T Suppes, M Trivedi, M Thase, L Yatham, A Young, M Berk
(2021), Vol. 22, pp. 483-494, World Journal of Biological Psychiatry, England, C1
Measuring fatigue: a meta-review
M Machado, N Kang, F Tai, R Sambhi, M Berk, A Carvalho, L Chada, J Merola, V Piguet, A Alavi
(2021), Vol. 60, pp. 1053-1069, International Journal of Dermatology, England, C1
A Turner, A Baker, O Dean, A Walker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk
(2021), Vol. 66, pp. 354-366, Canadian Journal of Psychiatry, United States, C1
Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
G Morris, A Walker, K Walder, M Berk, W Marx, A Carvalho, M Maes, B Puri
(2021), Vol. 58, pp. 2158-2182, Molecular Neurobiology, United States, C1
G Raghu, M Berk, P Campochiaro, H Jaeschke, G Marenzi, L Richeldi, F Wen, F Nicoletti, P Calverley
(2021), Vol. 19, pp. 1202-1224, Current neuropharmacology, United Arab Emirates, C1
S Aggarwal, G Patton, M Berk, V Patel
(2021), Vol. 56, pp. 1729-1750, Social Psychiatry and Psychiatric Epidemiology, Germany, C1
The mental health and lifestyle impacts of COVID-19 on bipolar disorder
James Karantonis, Susan Rossell, Michael Berk, Tamsyn Van Rheenen
(2021), Vol. 282, pp. 442-447, Journal of Affective Disorders, Aamsterdam, The Netherlands, C1
T Purton, L Staskova, M Lane, S Dawson, M West, J Firth, G Clarke, J Cryan, M Berk, A O'Neil, O Dean, A Hadi, C Honan, W Marx
(2021), Vol. 123, pp. 1-13, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
Nutrition-based interventions for mood disorders
L Martins, J Braga Tibães, M Sanches, F Jacka, M Berk, A Teixeira
(2021), Vol. 21, pp. 303-315, Expert Review of Neurotherapeutics, England, C1
M Gałecka, K Bliźniewska-Kowalska, A Orzechowska, J Szemraj, M Maes, M Berk, K Su, P Gałecki
(2021), Vol. 11, pp. 1-14, Journal of Personalized Medicine, Switzerland, C1
M Berk, B Agustini, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, S Dodd, A Murray, N Stocks, P Fitzgerald, C Mazza, J McNeil
(2021), Vol. 26, pp. 5161-5170, Molecular Psychiatry, England, C1
C Young, M Mohebbi, H Staudacher, F Kay-Lambkin, M Berk, F Jacka, A O'Neil
(2021), Vol. 8, JMIR Mental Health, Canada, C1
Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors
R Méndez, V Balanzá-Martínez, S Luperdi, I Estrada, A Latorre, P González-Jiménez, L Feced, L Bouzas, K Yépez, A Ferrando, D Hervás, E Zaldívar, S Reyes, M Berk, R Menéndez
(2021), Vol. 290, pp. 621-631, Journal of Internal Medicine, England, C1
Vahid Khosravani, Michael Berk, Farangis Sharifi Bastan, Seyed Samimi Ardestani, Anna Wrobel
(2021), Vol. 25, pp. 90-102, International journal of psychiatry in clinical practice, Abingdon, Eng., C1
V Chandrasekaran, J Pasco, A Stuart, S Brennan-Olsen, M Berk, J Hodge, R Samarasinghe, L Williams
(2021), Vol. 22, BMC Musculoskeletal Disorders, England, C1
J Sarris, W Marx, M Ashton, C Ng, N Galvao-Coelho, Z Ayati, Z Zhang, S Kasper, A Ravindran, B Harvey, A Lopresti, D Mischoulon, J Amsterdam, L Yatham, M Berk
(2021), Vol. 66, pp. 849-862, Canadian Journal of Psychiatry, United States, C1
Cognitive ability and metabolic physical health in first-episode psychosis
S Whitson, B O'Donoghue, R Hester, L Baldwin, S Harrigan, S Francey, J Graham, B Nelson, A Ratheesh, M Alvarez-Jimenez, A Fornito, C Pantelis, H Yuen, A Thompson, M Kerr, M Berk, S Wood, P McGorry, K Allott
(2021), Vol. 24, Schizophrenia Research: Cognition, United States, C1
T Cartmill, D Skvarc, R Bittar, J McGillivray, M Berk, L Byrne
(2021), Vol. 31, pp. 385-401, Neuropsychology Review, United States, C1
Gerwyn Morris, B Puri, C Bortolasci, Andre Carvalho, M Berk, K Walder, E Moreira, M Maes
(2021), Vol. 125, pp. 244-263, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
L Arancini, R Borland, M Le Grande, M Mohebbi, S Dodd, O Dean, M Berk, A McNeill, G Fong, K Cummings
(2021), Vol. 116, pp. 2509-2520, Addiction, England, C1
J Chen, L Yin, H Xu, S Zhang, W Huang, H Li, B Li, K Yang, Q Li, M Berk, Y Su
(2021), Vol. 17, pp. 787-795, Neuropsychiatric Disease and Treatment, New Zealand, C1
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm
D Perkins, J Sarris, S Rossell, Y Bonomo, D Forbes, C Davey, D Hoyer, C Loo, G Murray, S Hood, V Schubert, N Galvão-Coelho, M O’Donnell, O Carter, P Liknaitzky, M Williams, D Siskind, D Penington, M Berk, D Castle
(2021), Vol. 55, pp. 1127-1133, Australian and New Zealand Journal of Psychiatry, England, C1
K Witt, T Madsen, M Berk, O Dean, A Chanen, P McGorry, S Cotton, C Davey, S Hetrick
(2021), Vol. 55, pp. 506-516, Australian and New Zealand Journal of Psychiatry, England, C1
R McIntyre, J Rosenblat, C Nemeroff, G Sanacora, J Murrough, M Berk, E Brietzke, S Dodd, P Gorwood, R Ho, D Iosifescu, C Jaramillo, S Kasper, K Kratiuk, J Lee, Y Lee, L Lui, R Mansur, G Papakostas, M Subramaniapillai, M Thase, E Vieta, A Young, C Zarate, S Stahl
(2021), Vol. 178, pp. 383-399, American Journal of Psychiatry, Washington, D.C., C1
G Anmella, G Fico, M Lotfaliany, D Hidalgo-Mazzei, Ó Soto-Angona, A Giménez-Palomo, S Amoretti, A Murru, J Radua, A Solanes, I Pacchiarotti, N Verdolini, S Cowdery, S Dodd, L Williams, M Mohebbi, A Carvalho, L Kessing, E Vieta, M Berk
(2021), Vol. 126, pp. 529-541, Neuroscience and Biobehavioral Reviews, United States, C1
Bianca Kavanagh, Stella Gwini, Julie Pasco, Amanda Stuart, Shae Quirk, James Gaston, Kara Holloway-Kew, Alyna Turner, Michael Berk, Olivia Dean, Andrew Chanen, Heli Koivumaa-Honkanen, Paul Moran, Rohan Borschmann, Lana Williams
(2021), Vol. 2, pp. 1-8, Frontiers in Global Women's Health, Lausanne, Switzerland, C1
Miniature FSCV Devices: A Review
D Corva, S Adams, K Bennet, M Berk, A Kouzani
(2021), Vol. 21, pp. 13006-13018, IEEE Sensors Journal, C1
Associations between dairy consumption and constipation in adults: A cross-sectional study
H Aslam, M Mohebbi, A Ruusunen, S Dawson, L Williams, M Berk, K Holloway-Kew, F Collier, A Loughman, J Pasco, F Jacka
(2021), pp. 1-9, Nutrition and Health, London, Eng., C1
W Marx, N Veronese, J Kelly, L Smith, M Hockey, S Collins, G Trakman, E Hoare, S Teasdale, A Wade, M Lane, H Aslam, J Davis, A O'neil, N Shivappa, J Hebert, L Blekkenhorst, M Berk, T Segasby, F Jacka
(2021), Vol. 12, pp. 1681-1690, Advances in Nutrition, United States, C1
M Forbes, A O'Neil, M Lane, B Agustini, N Myles, M Berk
(2021), Vol. 38, pp. 451-467, Drugs and aging, Cham, Switzerland, C1
A Wrobel, S Russell, O Dean, S Cotton, M Berk, A Turner
(2021), Vol. 11, pp. 1-8, BMJ open, London, Eng., C1
H Eyre, R Ayadi, W Ellsworth, G Aragam, E Smith, W Dawson, A Ibanez, C Altimus, M Berk, H Manji, E Storch, M Leboyer, N Kawaguchi, M Freeman, P Brannelly, F Manes, S Chapman, J Cummings, C Graham, B Miller, Z Sarnyai, R Meyer, W Hynes
(2021), Vol. 109, pp. 1430-1432, Neuron, Amsterdam, The Netherlands, C1
M Debnath, M Berk, M Maes
(2021), Vol. 111, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1
K Blizniewska-Kowalska, A Halaris, S Wang, K Su, M Maes, M Berk, P Galecki
(2021), Vol. 27, Medical Science Monitor, United States, C1
C Young, M Mohebbi, H Staudacher, M Berk, F Jacka, A O’Neil
(2021), Vol. 33, pp. 266-279, International Review of Psychiatry, London, Eng., C1
Preventive psychiatry: a blueprint for improving the mental health of young people
P Fusar-Poli, C Correll, C Arango, M Berk, V Patel, J Ioannidis
(2021), Vol. 20, pp. 200-221, World psychiatry, Chichester, Eng., C1
G Morris, E Gamage, N Travica, M Berk, F Jacka, A O'Neil, B Puri, A Carvalho, C Bortolasci, K Walder, W Marx
(2021), Vol. 172, pp. 101-122, Free radical biology and medicine, Amsterdam, The Netherlands, C1
G Morris, C Bortolasci, B Puri, W Marx, A O'Neil, E Athan, K Walder, M Berk, L Olive, A Carvalho, M Maes
(2021), Vol. 144, Cytokine, England, C1
Hospital-in-the-Home as a Model for Mental Health Care Delivery: A Narrative Review
M Towicz, W Yang, S Moylan, R Tindall, M Berk
(2021), Vol. 72, pp. 1415-1427, Psychiatric services (Washington, D.C.), United States, C1
The lipid paradox in neuroprogressive disorders: causes and consequences
Gerwyn Morris, M Berk, K Walder, A O'Neil, M Maes, B Puri
(2021), Vol. 128, pp. 35-57, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
G Morris, K Walder, S Kloiber, P Amminger, M Berk, C Bortolasci, M Maes, B Puri, A Carvalho
(2021), Vol. 170, Pharmacological Research, Netherlands, C1
R Kupka, A Duffy, J Scott, J Almeida, V Balanzá-Martínez, B Birmaher, D Bond, E Brietzke, I Chendo, B Frey, I Grande, D Hafeman, T Hajek, M Hillegers, M Kauer-Sant’Anna, R Mansur, A van der Markt, R Post, M Tohen, H Tremain, G Vazquez, E Vieta, L Yatham, M Berk, M Alda, F Kapczinski
(2021), Vol. 23, pp. 659-678, Bipolar Disorders, Denmark, C1
W Marx, D Skvarc, M Mohebbi, A Walker, A Meehan, A Turner, A Baker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk, O Dean
(2021), Vol. 12, Frontiers in Psychiatry, Switzerland, C1
J Sarris, G Byrne, G Oliver, L Cribb, S Blair-West, D Castle, O Dean, D Camfield, V Brakoulias, C Bousman, N Dowling, C Ee, J Murphy, R Menon, M Berk, S Chamoli, M Boschen, C Ng
(2021), CNS Spectrums, United States, C1
B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, G Morris, L Gray, J Kim, O Dean, M Berk, K Walder
(2021), Vol. 22, International Journal of Molecular Sciences, Switzerland, C1
Statins: Neurobiological underpinnings and mechanisms in mood disorders
A Walker, Y Kim, I Borissiouk, R Rehder, S Dodd, G Morris, A Nierenberg, M Maes, B Fernandes, O Dean, L Williams, H Eyre, S Kim, S Zoungas, A Carvalho, M Berk
(2021), Vol. 128, pp. 693-708, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1
J Yuen, A Goyal, A Rusheen, A Kouzani, M Berk, J Kim, S Tye, C Blaha, K Bennet, D Jang, K Lee, H Shin, Y Oh
(2021), Vol. 12, Frontiers in Pharmacology, Switzerland, C1
P Talukdar, F Abdul, M Maes, M Berk, G Venkatasubramanian, B Kutty, M Debnath
(2021), Vol. 52, pp. 48-61, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1
The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment
A Giménez-Palomo, S Dodd, G Anmella, A Carvalho, G Scaini, J Quevedo, I Pacchiarotti, E Vieta, M Berk
(2021), Vol. 12, Frontiers in Psychiatry, Switzerland, C1
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial
R McKetin, O Dean, A Turner, P Kelly, B Quinn, D Lubman, P Dietze, G Carter, P Higgs, B Sinclair, D Reid, A Baker, V Manning, N Pas, T Thomas, R Bathish, D Raftery, A Wrobel, L Saunders, S Arunogiri, F Cordaro, H Hill, S Hall, P Clare, M Mohebbi, M Berk
(2021), Vol. 38, eClinicalMedicine, England, C1
M Solmi, M Suresh Sharma, E Osimo, M Fornaro, B Bortolato, G Croatto, A Miola, E Vieta, C Pariante, L Smith, P Fusar-Poli, J Shin, M Berk, A Carvalho
(2021), Vol. 97, pp. 193-203, Brain, Behavior, and Immunity, Netherlands, C1
Diabetes and mood disorders: shared mechanisms and therapeutic opportunities
L Martins, J Braga Tibães, M Berk, A Teixeira
(2021), pp. 1-13, International Journal of Psychiatry in Clinical Practice, London, Eng., C1
R Kale, T Nguyen, J Price, N Yates, K Walder, M Berk, R Sillitoe, A Kouzani, S Tye
(2021), Vol. 15, Frontiers in Human Neuroscience, Switzerland, C1
C Bortolasci, A Turner, M Mohebbi, Z Liu, M Ashton, L Gray, W Marx, A Walker, G Kowalski, F Jacka, M Berk, O Dean, K Walder
(2021), Vol. 142, pp. 376-383, Journal of Psychiatric Research, England, C1
An Investigation Into Miniaturised Closed-Loop DBS Devices
Dean Corva, Scott Adams, Kevin Bennet, Parastoo Hashemi, Michael Berk, Abbas Kouzani
(2021), Vol. 3, pp. 671-680, IEEE Transactions on Medical Robotics and Bionics, Piscataway, N.J., C1
Anticonvulsant use and fracture: A case-control study
V Chandrasekaran, A Stuart, J Pasco, S Brennan-Olsen, M Berk, J Hodge, R Samarasinghe, L Williams
(2021), Vol. 21, pp. 422-428, Journal of Musculoskeletal Neuronal Interactions, Kifissia, Greece, C1
K Fountoulakis, E Dragioti, A Theofilidis, T Wiklund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadağ, A de Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M de Hert
(2021), CNS Spectrums, United States, C1
M Bauer, T Glenn, E Achtyes, M Alda, E Agaoglu, K Altınbaş, O Andreassen, E Angelopoulos, R Ardau, E Vares, M Aydin, Y Ayhan, C Baethge, R Bauer, B Baune, C Balaban, C Becerra-Palars, A Behere, P Behere, H Belete, T Belete, G Belizario, F Bellivier, R Belmaker, F Benedetti, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, C Brady, J Cabrera, M Cappucciati, A Castro, W Chen, E Cheung, S Chiesa, M Crowe, A Cuomo, S Dallaspezia, M Del Zompo, P Desai, S Dodd, M Donix, B Etain, A Fagiolini, F Fellendorf, E Ferensztajn-Rochowiak, J Fiedorowicz, K Fountoulakis, M Frye, P Geoffroy, A Gonzalez-Pinto, J Gottlieb, P Grof, B Haarman, H Harima, M Hasse-Sousa, C Henry, L Høffding, J Houenou, M Imbesi, E Isometsä, M Ivkovic, S Janno, S Johnsen, F Kapczinski, G Karakatsoulis, M Kardell, L Kessing, S Kim, B König, T Kot, M Koval, M Kunz, B Lafer, M Landén, E Larsen, M Lenger, U Lewitzka, R Licht, C Lopez-Jaramillo, A MacKenzie, H Madsen, S Madsen, J Mahadevan, A Mahardika, M Manchia, W Marsh, M Martinez-Cengotitabengoa, K Martiny, Y Mashima, D McLoughlin, Y Meesters, I Melle, F Meza-Urzúa, M Ming, S Monteith, M Moorthy, G Morken
(2021), Vol. 9, International Journal of Bipolar Disorders, Germany, C1
Biological mechanism(S) underpinning the association between antipsychotic drugs and weight gain
B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, L Gray, J Kim, O Dean, M Berk, K Walder
(2021), Vol. 10, Journal of Clinical Medicine, Switzerland, C1
Implications of the COVID-19 pandemic for people with bipolar disorders: A scoping review
M Fornaro, M De Prisco, M Billeci, E Ermini, A Young, B Lafer, J Soares, E Vieta, J Quevedo, A de Bartolomeis, K Sim, L Yatham, M Bauer, D Stein, M Solmi, M Berk, A Carvalho
(2021), Vol. 295, pp. 740-751, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
A Loughman, J Hedley, C Olsson, M Berk, S Moylan, R Saffery, P Sly, M Tang, A Ponsonby, P Vuillermin
(2021), Vol. 73, pp. 578-585, Australian Journal of Psychology, London, England, C1
L Yatham, T Chakrabarty, D Bond, A Schaffer, S Beaulieu, S Parikh, R McIntyre, R Milev, M Alda, G Vazquez, A Ravindran, B Frey, V Sharma, B Goldstein, S Rej, C O’Donovan, V Tourjman, J Kozicky, M Kauer-Sant’Anna, G Malhi, T Suppes, E Vieta, F Kapczinski, S Kanba, R Lam, S Kennedy, J Calabrese, M Berk, R Post
(2021), Vol. 23, pp. 767-788, Bipolar Disorders, Denmark, C1
L Arancini, M Mohebbi, M Berk, O Dean, C Bortolasci, B Spolding, R Zazula, S Dodd
(2021), Vol. 53, pp. 120-126, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1
M Khodatars, A Shoeibi, D Sadeghi, N Ghaasemi, M Jafari, P Moridian, A Khadem, R Alizadehsani, A Zare, Y Kong, A Khosravi, S Nahavandi, S Hussain, U Acharya, M Berk
(2021), Vol. 139, Computers in Biology and Medicine, United States, C1
Universal depression prevention: An umbrella review of meta-analyses
E Hoare, S Collins, W Marx, E Callaly, R Moxham-Smith, P Cuijpers, A Holte, A Nierenberg, N Reavley, H Christensen, C Reynolds, A Carvalho, F Jacka, M Berk
(2021), Vol. 144, pp. 483-493, Journal of Psychiatric Research, Amsterdam, The Netherlands, C1
Dietary quality and nutrient intake in adults with obsessive-compulsive disorder
T Nguyen, L Cribb, C Ng, G Byrne, D Castle, V Brakoulias, S Blair-West, G Oliver, C Ee, O Dean, D Camfield, C Bousman, N Dowling, R Roy, M Berk, J Sarris
(2021), Vol. 7, BJPsych Open, C1
G Murray, N Thomas, E Michalak, S Jones, S Lapsley, S Bowe, F Foley, K Fletcher, T Perich, S Johnson, S Cotton, L Berk, C Mihalopoulos, M Kyrios, M Berk
(2021), Vol. 89, pp. 830-844, Journal of Consulting and Clinical Psychology, Washington, D.C., C1
Microdialysis and microperfusion electrodes in neurologic disease monitoring
L Stangler, A Kouzani, K Bennet, L Dumee, M Berk, G Worrell, S Steele, T Burns, C Howe
(2021), Vol. 18, Fluids and Barriers of the CNS, England, C1
K Hasebe, M Mohebbi, L Gray, A Walker, C Bortolasci, A Turner, M Berk, K Walder, M Maes, B Kanchanatawan, M Ashton, L Berk, C Ng, G Malhi, A Singh, O Dean
(2021), Vol. 34, Acta Neuropsychiatrica, England, C1
R Freak-Poli, J Ryan, J Neumann, A Tonkin, C Reid, R Woods, M Nelson, N Stocks, M Berk, J McNeil, C Britt, A Owen
(2021), Vol. 21, BMC Geriatrics, England, C1
F Gaughran, D Stringer, G Wojewodka, S Landau, S Smith, P Gardner-Sood, D Taylor, H Jordan, E Whiskey, A Krivoy, S Ciufolini, B Stubbs, C Casetta, J Williams, S Moore, L Allen, S Rathod, A Boardman, R Khalifa, M Firdosi, P McGuire, M Berk, J McGrath
(2021), Vol. 4, JAMA Network Open, United States, C1
The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder
S Kidnapillai, C Bortolasci, M Udawela, B Panizzutti, B Spolding, T Connor, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, E Scarr, M Leboyer, B Dean, M Berk, K Walder
(2020), Vol. 21, pp. 775-783, World Journal of Biological Psychiatry, England, C1
H Aslam, J Green, F Jacka, F Collier, M Berk, J Pasco, S Dawson
(2020), Vol. 23, pp. 659-671, Nutritional Neuroscience, England, C1
Bianca Kavanagh, Lana Williams, Michael Berk, Alyna Turner, Henry Jackson, Mohammadreza Mohebbi, Buranee Kanchanatawan, Melanie Ashton, Chee Ng, Michael Maes, Lesley Berk, Gin Malhi, Nathan Dowling, Ajeet Singh, Olivia Dean
(2020), Vol. 42, pp. 14-21, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1
Unravelled facets of milk derived opioid peptides: a focus on gut physiology, fractures and obesity
Hajara Aslam, Anu Ruusunen, Michael Berk, Amy Loughman, Leni Rivera, Julie Pasco, Felice Jacka
(2020), Vol. 71, pp. 36-49, International journal of food sciences and nutrition, Abingdon, Eng., C1
N Ottesen, I Meluken, R Frikke-Schmidt, P Plomgaard, T Scheike, B Fernandes, M Berk, H Poulsen, L Kessing, K Miskowiak, M Vinberg
(2020), pp. 1-10, Psychological Medicine, Cambridge, Eng., C1
EPA and DHA as markers of nutraceutical treatment response in major depressive disorder
K van der Burg, L Cribb, J Firth, D Karmacoska, D Mischoulon, G Byrne, C Bousman, C Stough, J Murphy, G Oliver, M Berk, C Ng, J Sarris
(2020), Vol. 59, pp. 2439-2447, European Journal of Nutrition, Germany, C1
M Subbanna, V Shivakumar, D Venugopal, J Narayanaswamy, M Berk, S Varambally, G Venkatasubramanian, M Debnath
(2020), Vol. 74, pp. 64-69, Psychiatry and clinical neurosciences, Chichester, Eng., C1
Opportunities in the Australian national education initiative for promoting mental health in schools
E Hoare, A Thorp, N Bartholomeusz-Raymond, A McCoy, M Berk
(2020), Vol. 4, pp. 11-13, The Lancet Child and Adolescent Health, England, C1
M Ashton, O Dean, W Marx, M Mohebbi, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, K Faye-Chauhan, Y Kim, S Dash, F Jacka, N Shivappa, J Hebert, A Turner
(2020), Vol. 54, pp. 159-172, Australian and New Zealand journal of psychiatry, London, Eng., C1
W Marx, M Hockey, A McGuinness, M Lane, J Christodoulou, I van der Mei, M Berk, O Dean, B Taylor, S Broadley, J Lechner-Scott, F Jacka, R Lucas, A Ponsonby
(2020), Vol. 37, Multiple Sclerosis and Related Disorders, Netherlands, C1
Differences in the immune-inflammatory profiles of unipolar and bipolar depression
A Brunoni, T Supasitthumrong, A Teixeira, E Vieira, W Gattaz, I Benseñor, P Lotufo, B Lafer, M Berk, A Carvalho, M Maes
(2020), Vol. 262, pp. 8-15, Journal of Affective Disorders, Netherlands, C1
J Sarris, J Murphy, C Stough, D Mischoulon, C Bousman, P MacDonald, L Adams, S Nazareth, G Oliver, L Cribb, K Savage, R Menon, S Chamoli, M Berk, C Ng, G Byrne
(2020), Vol. 237, pp. 209-218, Psychopharmacology, Berlin, Germany, C1
Depression, stress and vascular function from childhood to adolescence: a longitudinal investigation
L Olive, W Abhayaratna, D Byrne, R Telford, M Berk, R Telford
(2020), Vol. 62, pp. 6-12, General hospital psychiatry, Amsterdam, The Netherlands, C1
Depression in the medically ill
J Rosenblat, P Kurdyak, F Cosci, M Berk, M Maes, A Brunoni, M Li, G Rodin, R McIntyre, A Carvalho
(2020), Vol. 54, pp. 346-366, Australian and New Zealand Journal of Psychiatry, London, Eng., C1
M Ashton, M Mohebbi, A Turner, W Marx, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, B Stubbs, O Dean
(2020), Vol. 65, pp. 306-318, Canadian journal of psychiatry, London, Eng., C1
C Yolland, D Hanratty, E Neill, S Rossell, M Berk, O Dean, D Castle, E Tan, A Phillipou, A Harris, A Barreiros, A Hansen, D Siskind
(2020), Vol. 54, pp. 453-466, Australian and New Zealand journal of psychiatry, London, Eng., C1
F Gaughran, D Stringer, M Berk, S Smith, D Taylor, E Whiskey, S Landau, R Murray, P McGuire, P Gardner-Sood, G Wojewodka, S Ciufolini, H Jordan, J Clarke, L Allen, A Krivoy, B Stubbs, P Lowe, M Arbuthnott, S Rathod, A Boardman, M Firdosi, J McGrath
(2020), Vol. 21, Trials, England, C1
S Kidnapillai, B Wade, C Bortolasci, B Panizzutti, B Spolding, T Connor, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder
(2020), Vol. 34, pp. 370-379, Journal of Psychopharmacology, United States, C1
G Morris, B Puri, M Maes, L Olive, M Berk, A Carvalho
(2020), Vol. 99, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1
M Berk, M Mohebbi, O Dean, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Weller, A MacKinnon, F Giorlando, S Baird, L Incerti, R Brodie, N Ferguson, S Rice, M Schäfer, E Mullen, S Hetrick, M Kerr, S Harrigan, A Quinn, C Mazza, P McGorry, C Davey
(2020), Vol. 18, BMC Medicine, England, C1
S Adams, E Doeven, S Tye, K Bennet, M Berk, A Kouzani
(2020), Vol. 28, pp. 133-142, IEEE Transactions on Neural Systems and Rehabilitation Engineering, Piscataway, N.J., C1
J Velosa, A Delgado, E Finger, M Berk, F Kapczinski, T de Azevedo Cardoso
(2020), Vol. 141, pp. 510-521, Acta Psychiatrica Scandinavica, United States, C1
M Costa, M Kunz, A Nierenberg, T Deckersbach, M Berk, P Magalhaes
(2020), Vol. 65, pp. 245-252, Canadian Journal of Psychiatry, United States, C1
D Stein, P Szatmari, W Gaebel, M Berk, E Vieta, M Maj, Y De Vries, A Roest, P De Jonge, A Maercker, C Brewin, K Pike, C Grilo, N Fineberg, P Briken, P Cohen-Kettenis, G Reed
(2020), Vol. 18, BMC Medicine, England, C1
T Guu, D Mischoulon, J Sarris, J Hibbeln, R McNamara, K Hamazaki, M Freeman, M Maes, Y Matsuoka, R Belmaker, W Marx, C Pariante, M Berk, F Jacka, K Su
(2020), Vol. 265, pp. 233-238, Journal of affective disorders, Amsterdam, The Netherlands, C1
B Agustini, M Mohebbi, R Woods, J McNeil, M Nelson, R Shah, A Murray, M Ernst, C Reid, A Tonkin, J Lockery, M Berk
(2020), Vol. 34, pp. 787-794, Journal of Human Hypertension, England, C1
O Köhler-Forsberg, L Petersen, M Berk, C Gasse, S Østergaard
(2020), Vol. 32, pp. 120-130, European Neuropsychopharmacology, Netherlands, C1
Neurodevelopmental pathways in bipolar disorder
S Kloiber, J Rosenblat, M Husain, A Ortiz, M Berk, J Quevedo, E Vieta, M Maes, B Birmaher, J Soares, A Carvalho
(2020), Vol. 112, pp. 213-226, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1
Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?
G Morris, B Puri, A Carvalho, M Maes, M Berk, A Ruusunen, L Olive
(2020), Vol. 23, pp. 366-384, International Journal of Neuropsychopharmacology, England, C1
Bone health in bipolar disorder: A study protocol for a case-control study in Australia
L Williams, A Stuart, M Berk, S Brennan-Olsen, J Hodge, S Cowdery, V Chandrasekaran, J Pasco
(2020), Vol. 10, BMJ Open, England, C1
G Morris, M Maes, M Berk, A Carvalho, B Puri
(2020), Vol. 63, European Psychiatry, England, C1
C Bortolasci, W Marx, A Walker, K Hasebe, B Kavanagh, M Morris, M Mohebbi, A Turner, L Gray, L Berk, K Walder, M Berk, O Dean
(2020), Vol. 10, pp. e035080-, BMJ open, England, C1
Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression
Y Milaneschi, F Lamers, M Berk, B Penninx
(2020), Vol. 88, pp. 369-380, Biological Psychiatry, New York, N.Y., C1
J Lotter, M Möller, O Dean, M Berk, B Harvey
(2020), Vol. 11, Frontiers in Psychiatry, Switzerland, C1
Y Toenders, L Schmaal, B Harrison, R Dinga, M Berk, C Davey
(2020), Vol. 10, Translational Psychiatry, United States, C1
Patterns of Association between Depressive Symptoms and Chronic Medical Morbidities in Older Adults
B Agustini, M Lotfaliany, R Woods, J McNeil, M Nelson, R Shah, A Murray, M Ernst, C Reid, A Tonkin, J Lockery, L Williams, M Berk, M Mohebbi
(2020), Vol. 68, pp. 1834-1841, Journal of the American Geriatrics Society, Chichester, Eng., C1
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
A Carvalho, M Solmi, M Sanches, M Machado, B Stubbs, O Ajnakina, C Sherman, Y Sun, C Liu, A Brunoni, G Pigato, B Fernandes, B Bortolato, M Husain, E Dragioti, J Firth, T Cosco, M Maes, M Berk, K Lanctôt, E Vieta, D Pizzagalli, L Smith, P Fusar-Poli, P Kurdyak, M Fornaro, J Rehm, N Herrmann
(2020), Vol. 10, Translational Psychiatry, United States, C1
B Fernandes, C Karmakar, R Tamouza, T Tran, J Yearwood, N Hamdani, H Laouamri, J Richard, R Yolken, M Berk, S Venkatesh, M Leboyer
(2020), Vol. 10, Translational Psychiatry, United States, C1
M Berk, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, S Dodd, A Murray, N Stocks, P Fitzgerald, C Mazza, B Agustini, J McNeil
(2020), Vol. 77, pp. 1012-1020, JAMA psychiatry, Chicago, Ill., C1
Lithium therapy and its interactions
G Malhi, E Bell, T Outhred, M Berk
(2020), Vol. 43, pp. 91-93, Australian Prescriber, Deakin West, A.C.T., C1
Genetic gateways to COVID-19 infection: implications for risk, severity, and outcomes
M Debnath, M Banerjee, M Berk
(2020), Vol. 34, pp. 8787-8795, FASEB journal, Chichester, Eng., C1
C Lin, Y Huang, K Huang, S Wu, Y Chang, H Yeh, C Chang, I Lin, H Huang, F Sun, M Berk, S Liu
(2020), Vol. 290, Psychiatry Research, Ireland, C1
C Bortolasci, C Voigt, A Turner, M Mohebbi, L Gray, S Dodd, K Walder, M Berk, S Cotton, G Malhi, C Ng, N Dowling, J Sarris, O Dean
(2020), Vol. 32, pp. 313-320, Acta Neuropsychiatrica, England, C1
H Tremain, K Fletcher, J Scott, C McEnery, M Berk, G Murray
(2020), Vol. 22, pp. 666-692, Bipolar disorders, Chichester, Eng., C1
Explanatory style in youth self-harm: an Indian qualitative study to inform intervention design
S Aggarwal, G Patton, D Bahl, N Shah, M Berk, V Patel
(2020), Vol. 23, pp. 100-106, Evidence-based mental health, London, Eng., C1
Personality disorder increases risk of low quality of life among women with mental state disorders
B Kavanagh, A Stuart, M Berk, A Turner, O Dean, J Pasco, H Jackson, H Koivumaa-Honkanen, A Chanen, L Williams
(2020), Vol. 102, Comprehensive Psychiatry, United States, C1
The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
G Morris, C Bortolasci, B Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk
(2020), Vol. 258, Life Sciences, Netherlands, C1
A Maier, A Dharan, G Oliver, M Berk, S Redston, S Back, P Kalivas, C Ng, R Kanaan
(2020), Vol. 20, BMC Psychiatry, England, C1
S Cowdery, A Stuart, J Pasco, M Berk, D Campbell, L Williams
(2020), Vol. 68, Cancer Epidemiology, Netherlands, C1
M Fornaro, A Carvalho, A Fusco, A Anastasia, M Solmi, M Berk, K Sim, E Vieta, A de Bartolomeis
(2020), Vol. 276, pp. 970-983, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Promoting tech transfer between space and global mental health
D Chang, E Storch, L Black, M Berk, N Pellis, H Lavretsky, J Sutton, K Ternes, M Shepanek, E Smith, R Abbott, H Eyre
(2020), Vol. 91, pp. 737-745, Aerospace Medicine and Human Performance, United States, C1
Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study
L Kessing, H Rytgaard, C Ekstrøm, C Torp-Pedersen, M Berk, T Gerds
(2020), Vol. 76, pp. 1263-1279, Hypertension, United States, C1
Wolfgang Marx, Andrew Scholey, Joseph Firth, Nathan D’Cunha, Melissa Lane, Meghan Hockey, Melanie Ashton, John Cryan, A O'Neil, Nenad Naumovski, Michael Berk, Olivia Dean, Felice Jacka
(2020), Vol. 118, pp. 472-484, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1
Antidiabetes agents and incident depression: A nationwide population-based study
L Kessing, H Rytgaard, C Ekstrøm, F Knop, M Berk, T Gerds
(2020), Vol. 43, pp. 3050-3060, Diabetes Care, United States, C1
Ó Soto-Angona, G Anmella, M Valdés-Florido, N De Uribe-Viloria, A Carvalho, B Penninx, M Berk
(2020), Vol. 18, BMC Medicine, England, C1
H Aslam, F Jacka, W Marx, K Karatzi, C Mavrogianni, E Karaglani, M Mohebbi, J Pasco, A O’neil, M Berk, T Nomikos, S Kanellakis, O Androutsos, Y Manios, G Moschonis
(2020), Vol. 12, pp. 1-15, Nutrients, Switzerland, C1
Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
G Morris, E Athan, K Walder, C Bortolasci, A O'Neil, W Marx, M Berk, A Carvalho, M Maes, B Puri
(2020), Vol. 262, Life Sciences, Netherlands, C1
Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments
G Morris, B Puri, L Olive, A Carvalho, M Berk, K Walder, L Gustad, M Maes
(2020), Vol. 18, BMC Medicine, England, C1
Dietary tryptophan and bone health: a cross-sectional, population-based study
J Cleminson, A Stuart, J Pasco, J Hodge, M Berk, R Samarasinghe, L Williams
(2020), Vol. 15, Archives of Osteoporosis, England, C1
Transcriptional effects of psychoactive drugs on genes involved in neurogenesis
C Bortolasci, B Spolding, S Kidnapillai, T Connor, T Truong, Z Liu, B Panizzutti, M Richardson, L Gray, M Berk, O Dean, K Walder
(2020), Vol. 21, pp. 1-19, International Journal of Molecular Sciences, Switzerland, C1
J Scott, A Baker, C Lim, S Foley, F Dark, A Gordon, D Ward, D Richardson, G Bruxner, K Beckmann, S Hatherill, S Stathis, K Dixon, A Ryan, B McWhinney, J Ungerer, M Berk, O Dean, S Saha, J McGrath
(2020), Vol. 3, pp. e2024335-, JAMA network open, United States, C1
R McIntyre, M Berk, E Brietzke, B Goldstein, C López-Jaramillo, L Kessing, G Malhi, A Nierenberg, J Rosenblat, A Majeed, E Vieta, M Vinberg, A Young, R Mansur
(2020), Vol. 396, pp. 1841-1856, The Lancet, England, C1
G Malhi, E Bell, P Boyce, D Bassett, M Berk, R Bryant, M Gitlin, A Hamilton, P Hazell, M Hopwood, B Lyndon, R McIntyre, G Morris, R Mulder, R Porter, A Singh, L Yatham, A Young, G Murray
(2020), Vol. 22, pp. 805-821, Bipolar Disorders, London, Eng., C1
B Azimi Manavi, A Stuart, J Pasco, J Hodge, K Corney, M Berk, L Williams
(2020), Vol. 10, BMJ Open, England, C1
G Malhi, E Bell, A Singh, D Bassett, M Berk, P Boyce, R Bryant, M Gitlin, A Hamilton, P Hazell, M Hopwood, B Lyndon, R McIntyre, G Morris, R Mulder, R Porter, L Yatham, A Young, G Murray
(2020), Vol. 22, pp. 788-804, Bipolar Disorders, London, Eng., C1
J Green, J Davis, M Berk, C Hair, A Loughman, D Castle, E Athan, A Nierenberg, J Cryan, F Jacka, W Marx
(2020), Vol. 12, pp. 1-25, Gut Microbes, United States, C1
Personality Disorder and Physical Health Comorbidities: A Link With Bone Health?
L Williams, S Quirk, H Koivumaa-Honkanen, R Honkanen, J Pasco, A Stuart, B Kavanagh, J Heikkinen, M Berk
(2020), Vol. 11, Frontiers in Psychiatry, Switzerland, C1
Shona Francey, Brian O’Donoghue, Barnaby Nelson, Jessica Graham, Lara Baldwin, Hok Yuen, Melissa Kerr, Aswin Ratheesh, Kelly Allott, Mario Alvarez-Jimenez, Alex Fornito, Susy Harrigan, Andrew Thompson, Stephen Wood, Michael Berk, Patrick McGorry
(2020), Vol. 1, pp. 1-11, Schizophrenia Bulletin Open, Oxford, Eng., C1
Exploring A-Acetylcysteine in Psychiatry
A Gimenez-Palomo, S Dodd, O Dean, C Bortolasci, M Berk
(2020), Vol. 37, pp. 48-51, Psychiatric Times, Santa Ana, Calif., C1-1
The role of depression pharmacogenetic decision support tools in shared decision making
K Arandjelovic, H Eyre, E Lenze, A Singh, M Berk, C Bousman
(2019), Vol. 126, pp. 87-94, Journal of Neural Transmission, Austria, C1
E Gliddon, V Cosgrove, L Berk, S Lauder, M Mohebbi, D Grimm, S Dodd, C Coulson, K Raju, T Suppes, M Berk
(2019), Vol. 21, pp. 28-39, Bipolar Disorders, London, Eng., C1
Could Alzheimer's Disease Originate in the Periphery and If So How So?
G Morris, M Berk, M Maes, B Puri
(2019), Vol. 56, pp. 406-434, Molecular Neurobiology, United States, C1
O Dean, K Gray, S Dodd, K Villagonzalo, E Brown, B Tonge, M Berk, L Byrne
(2019), Vol. 44, pp. 474-480, Journal of Intellectual and Developmental Disability, C1
B O'Donoghue, S Francey, B Nelson, A Ratheesh, K Allott, J Graham, L Baldwin, M Alvarez-Jimenez, A Thompson, A Fornito, A Polari, M Berk, C Macneil, K Crisp, C Pantelis, H Yuen, S Harrigan, P McGorry
(2019), Vol. 13, pp. 953-960, Early Intervention in Psychiatry, Australia, C1
Association of depression with mortality in an elderly treated hypertensive population
E Chowdhury, M Berk, M Nelson, L Wing, C Reid
(2019), Vol. 31, pp. 371-381, International Psychogeriatrics, England, C1
New drug candidates for depression - a nationwide population-based study
L Kessing, H Rytgaard, T Gerds, M Berk, C Ekstrøm, P Andersen
(2019), Vol. 139, pp. 68-77, Acta Psychiatrica Scandinavica, United States, C1
Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice Jacka, Susan Cotton, Jon-Paul Khoo, Mary Chatterton, Bianca Kavanagh, Sarah Nadjidai, Samantha Lo Monaco, Brian Harvey, Jerome Sarris, Gin Malhi, Nathan Dowling, Olivia Dean
(2019), Vol. 41, pp. 245-253, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1
M Fornaro, A Anastasia, S Novello, A Fusco, R Pariano, D De Berardis, M Solmi, N Veronese, B Stubbs, E Vieta, M Berk, A de Bartolomeis, A Carvalho
(2019), Vol. 139, pp. 494-502, Pharmacological Research, Netherlands, C1
J Sarris, G Byrne, C Stough, C Bousman, D Mischoulon, J Murphy, P Macdonald, L Adams, S Nazareth, G Oliver, L Cribb, K Savage, R Menon, S Chamoli, M Berk, C Ng
(2019), Vol. 245, pp. 1007-1015, Journal of Affective Disorders, Netherlands, C1
D Hidalgo-Mazzei, M Berk, A Cipriani, A Cleare, A Florio, D Dietch, J Geddes, G Goodwin, H Grunze, J Hayes, I Jones, S Kasper, K Macritchie, R McAllister-Williams, R Morriss, S Nayrouz, S Pappa, J Soares, D Smith, T Suppes, P Talbot, E Vieta, S Watson, L Yatham, A Young, P Stokes
(2019), Vol. 214, pp. 27-35, British Journal of Psychiatry, England, C1
WFSBP guidelines on how to grade treatment evidence for clinical guideline development
A Hasan, B Bandelow, L Yatham, M Berk, P Falkai, H Möller, S Kasper
(2019), Vol. 20, pp. 2-16, World Journal of Biological Psychiatry, England, C1
Y Quidé, C Bortolasci, B Spolding, S Kidnapillai, O Watkeys, S Cohen-Woods, M Berk, V Carr, K Walder, M Green
(2019), Vol. 49, pp. 2736-2744, Psychological Medicine, England, C1
P Ellegaard, R Licht, R Nielsen, O Dean, M Berk, H Poulsen, M Mohebbi, C Nielsen
(2019), Vol. 245, pp. 1043-1051, Journal of Affective Disorders, Netherlands, C1
M Berk, A Turner, G Malhi, C Ng, S Cotton, S Dodd, Y Samuni, M Tanious, C McAulay, N Dowling, J Sarris, L Owen, A Waterdrinker, D Smith, O Dean
(2019), Vol. 17, BMC Medicine, England, C1
The impact of urbanization on mood disorders: an update of recent evidence
Erin Hoare, Felice Jacka, Michael Berk
(2019), Vol. 32, pp. 198-203, Current opinion in psychiatry, Philadelphia, Pa., C1
G Morris, M Berk, M Maes, A Carvalho, B Puri
(2019), Vol. 56, pp. 5866-5890, Molecular Neurobiology, United States, C1
Putative neuroprotective pharmacotherapies to target the staged progression of mental illness
O Robertson, N Coronado, R Sethi, M Berk, S Dodd
(2019), Vol. 13, pp. 1032-1049, Early Intervention in Psychiatry, Australia, C1
S Cotton, M Berk, H Jackson, G Murray, K Filia, M Hasty, A Chanen, C Davey, B Nelson, A Ratheesh, C MacNeil
(2019), Vol. 13, pp. 1470-1479, Early Intervention in Psychiatry, Australia, C1
Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?
Gerwyn Morris, Michael Maes, Michael Berk, Basant Puri
(2019), Vol. 34, pp. 385-415, Metabolic brain disease, New York, N.Y., C1
Bipolar disorder and bone health: a systematic review
Vinoomika Chandrasekaran, Sharon Brennan-Olsen, Amanda Stuart, Julie Pasco, Michael Berk, Jason Hodge, Lana Williams
(2019), Vol. 249, pp. 262-269, Journal of affective disorders, Amsterdam, The Netherlands, C1
Development of a miniature device for emerging deep brain stimulation paradigms
S Adams, K Bennet, S Tye, M Berk, A Kouzani
(2019), Vol. 14, PLoS ONE, United States, C1
Buffering against maladaptive perfectionism in bipolar disorder: the role of self-compassion
Kathryn Fletcher, Yan Yang, Sheri Johnson, Michael Berk, Tania Perich, Sue Cotton, Steven Jones, Sara Lapsley, Erin Michalak, Greg Murray
(2019), Vol. 250, pp. 132-139, Journal of affective disorders, Amsterdam, The Netherlands, C1
Association between solar insolation and a history of suicide attempts in bipolar I disorder
M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, Y Ayhan, C Baethge, R Bauer, B Baune, C Becerra-Palars, F Bellivier, R Belmaker, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, J Cabrera, E Wo Cheung, M Del Zompo, S Dodd, M Donix, B Etain, A Fagiolini, K Fountoulakis, M Frye, A Gonzalez-Pinto, J Gottlieb, P Grof, H Harima, C Henry, E Isometsä, S Janno, F Kapczinski, M Kardell, S Khaldi, S Kliwicki, B König, T Kot, R Krogh, M Kunz, B Lafer, M Landén, E Larsen, U Lewitzka, R Licht, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, F Meza-Urzúa, M Ming, S Monteith, G Morken, E Mosca, A Mozzhegorov, R Munoz, S Mythri, F Nacef, R Nadella, F Nery, R Nielsen, C O'Donovan, A Omrani, Y Osher, H Sørensen, U Ouali, Y Ruiz, M Pilhatsch, M Pinna, F da Ponte, D Quiroz, R Ramesar, N Rasgon, M Reddy, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Raghuraman, Â Scippa, E Severus, C Simhandl, P Stackhouse, D Stein, S Strejilevich, M Subramaniam, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, L Tondo, C Torrent, A Vaaler, E Vares, J Veeh, E Vieta
(2019), Vol. 113, pp. 1-9, Journal of Psychiatric Research, England, C1
Statins and inflammation: New therapeutic opportunities in psychiatry
S Kim, H Kang, M Jhon, J Kim, J Lee, A Walker, B Agustini, J Kim, M Berk
(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1
New drug candidates for bipolar disorder-A nation-wide population-based study
L Kessing, H Rytgaard, T Gerds, M Berk, C Ekstrøm, P Andersen
(2019), Vol. 21, pp. 410-418, Bipolar Disorders, Denmark, C1
M Ashton, O Dean, A Walker, C Bortolasci, C Ng, M Hopwood, B Harvey, M Möller, J McGrath, W Marx, A Turner, S Dodd, J Scott, J Khoo, K Walder, J Sarris, M Berk
(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1
Alyna Turner, John McGrath, Olivia Dean, Seetal Dodd, Andrea Baker, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Adam Walker, Ellie Brown, Michael Berk
(2019), Vol. 17, pp. 297-307, Clinical psychopharmacology and neuroscience, Seoul, South Korea, C1
M Ashton, M Berk, C Ng, M Hopwood, B Kavanagh, L Williams, J Sarris, O Dean
(2019), Vol. 9, BMJ Open, England, C1
C Lim, A Baker, S Saha, S Foley, A Gordon, D Ward, B Burgher, F Dark, M Beckmann, S Stathis, G Bruxner, A Ryan, D Richardson, S Hatherill, M Berk, O Dean, J McGrath, J Chapman, S Patterson, S Singh, B Mowry, L Tracy, M Duhig, A Machin, E Troman, S Suetani, T Dinala, L Burton, P Cosgrove, C Gamble, J Scott
(2019), Vol. 20, Trials, England, C1
Childbirth and prevention of bipolar disorder: an opportunity for change
V Sharma, V Bergink, M Berk, P Chandra, T Munk-Olsen, A Viguera, L Yatham
(2019), Vol. 6, pp. 786-792, The Lancet Psychiatry, England, C1
M Mohebbi, B Agustini, R Woods, J McNeil, M Nelson, R Shah, V Nguyen, E Storey, A Murray, C Reid, B Kirpach, R Wolfe, J Lockery, M Berk
(2019), Vol. 34, pp. 1208-1216, International Journal of Geriatric Psychiatry, England, C1
Supporting engagement, adherence, and behavior change in online dietary interventions
Claire Young, Sara Campolonghi, Stephanie Ponsonby, Samantha Dawson, Adrienne O'Neil, Frances Kay-Lambkin, Sarah McNaughton, Michael Berk, Felice Jacka
(2019), Vol. 51, pp. 719-739, Journal of nutrition education and behavior, Amsterdam, The Netherlands, C1
B Kavanagh, S Brennan-Olsen, A Turner, O Dean, M Berk, M Ashton, H Koivumaa-Honkanen, L Williams
(2019), Vol. 9, BMJ Open, England, C1
Mojtaba Lotfaliany, Bruno Agustini, Paul Kowal, Michael Berk, Mohammadreza Mohebbi
(2019), Vol. 31, pp. 95-105, Annals of clinical psychiatry, Montvale, N.J., C1
B Agustini, M Mohebbi, R Woods, J McNeil, M Nelson, R Shah, A Murray, M Ernst, C Reid, A Tonkin, J Lockery, M Berk
(2019), Vol. 33, pp. 685-694, CNS Drugs, New Zealand, C1
Supporting Self-Management in Bipolar Disorder: Mixed-Methods Knowledge Translation Study
Erin Michalak, Emma Morton, Steven Barnes, Rachelle Hole, Greg Murray
(2019), Vol. 6, JMIR MENTAL HEALTH, Canada, C1
Wolfgang Marx, Melissa Lane, Tetyana Rocks, Anu Ruusunen, Amy Loughman, Adrian Lopresti, Skye Marshall, Michael Berk, Felice Jacka, Olivia Dean
(2019), Vol. 77, pp. 557-571, Nutrition reviews, Oxford, Eng., C1
The potential of carnosine in brain-related disorders: A comprehensive review of current evidence
M Schön, A Mousa, M Berk, W Chia, J Ukropec, A Majid, B Ukropcová, B De Courten
(2019), Vol. 11, Nutrients, Switzerland, C1
H Tremain, K Fletcher, J Scott, C McEnery, M Berk, G Murray
(2019), Vol. 8, Systematic Reviews, England, C1
R McKetin, O Dean, A Turner, P Kelly, B Quinn, D Lubman, P Dietze, G Carter, P Higgs, A Baker, B Sinclair, D Reid, V Manning, N Te Pas, W Liang, T Thomas, R Bathish, M Kent, D Raftery, S Arunogiri, F Cordaro, H Hill, M Berk
(2019), Vol. 20, Trials, England, C1
E Hoare, I Thorisdóttir, A Kristjansson, I Sigfusdóttir, J Hayward, S Allender, C Strugnell, N Reavley, G Patton, M Berk, F Jacka
(2019), Vol. 15, pp. 1-4, Mental health and prevention, Amsterdam, The Netherlands, C1
A Stuart, J Pasco, S Brennan-Olsen, M Berk, A Betson, K Bennett, E Timney, L Williams
(2019), Vol. 8, pp. 50-55, Journal of Public Health Research, United States, C1
A Neuroethics Framework for the Australian Brain Initiative
J Kennett, A Carter, J Bourne, W Hall, N Levy, J Mattingley, A Lawrence, C Forlini, L Malcolm, N Vincent, L Richards, G Egan, M Breakspear, K Cornish, G Halliday, L Poole-Warren, S Sriram, T Soulis, B Fitzgibbon, I Kiral-Kornek, D Badcock, B Balleine, J Bekkers, M Berk, A Bradley, A Brichta, O Carter, A Castles, J Clements, J Cornish, G de Zubicaray, P Enticott, A Fornito, L Griffiths, J Gullifer, A Hannan, S Harrer, A Harvey, I Hickie, L Jazwinska, M Kiernan, T Kilpatrick, R Leventer, J Licinio, N Lovell, G Mackellar, S Medland, P Michie, J Nithianantharajah, J Parker, J Payne, S Rossell, P Sah, Z Sarnyai, P Schofield, D Shum, T Silk, M Slee, G Stuart, J Tapson, A van Schaik, B Vissel, A Waters, D Apthorp, S Cohen-Woods, S Conn, M Korgaonkar, A Mason, M Azghadi, O Shimoni, A Smith, M Thompson
(2019), Vol. 101, pp. 365-369, Neuron, United States, C1
The case for improved care and provision of treatment for people with first-episode mania
S Jauhar, A Ratheesh, C Davey, L Yatham, P McGorry, P McGuire, M Berk, A Young
(2019), Vol. 6, pp. 869-876, The Lancet Psychiatry, England, C1
B Agustini, M Bocharova, A Walker, M Berk, A Young, M Juruena
(2019), Vol. 256, pp. 584-593, Journal of affective disorders, Amsterdam, The Netherlands, C1
Beyond evidence-based treatment of bipolar disorder: rational pragmatic approaches to management
R Post, L Yatham, E Vieta, M Berk, A Nierenberg
(2019), Vol. 21, pp. 650-659, Bipolar disorders, Chichester, Eng., C1
The compensatory antioxidant response system with a focus on neuroprogressive disorders
G Morris, B Puri, A Walker, M Berk, K Walder, C Bortolasci, W Marx, A Carvalho, M Maes
(2019), Vol. 95, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1
C Davey, A Chanen, S Hetrick, S Cotton, A Ratheesh, G Amminger, J Koutsogiannis, M Phelan, E Mullen, B Harrison, S Rice, A Parker, O Dean, A Weller, M Kerr, A Quinn, L Catania, N Kazantzis, P McGorry, M Berk
(2019), Vol. 6, pp. 735-744, The Lancet Psychiatry, England, C1
M Chia, S Cotton, K Filia, M Phelan, P Conus, S Jauhar, S Marwaha, P McGorry, C Davey, M Berk, A Ratheesh
(2019), Vol. 257, pp. 669-677, Journal of Affective Disorders, Netherlands, C1
A case of antibiotic-associated mania in a 67-year-old woman
P Navalón, Y Cañada, M Merizalde, P Sierra, A García-Blanco, A Domínguez-Carabantes, M Berk
(2019), Vol. 21, pp. 670-672, Bipolar Disorders, Denmark, C1
G Morris, B Puri, L Olive, A Carvalho, M Berk, M Maes
(2019), Vol. 148, Pharmacological Research, Netherlands, C1
T Guu, D Mischoulon, J Sarris, J Hibbeln, R McNamara, K Hamazaki, M Freeman, M Maes, Y Matsuoka, R Belmaker, F Jacka, C Pariante, M Berk, W Marx, K Su
(2019), Vol. 88, pp. 263-273, Psychotherapy and psychosomatics, Basel, Switzerland, C1
S Cowdery, M Sajjad, K Holloway-Kew, M Mohebbi, L Williams, M Kotowicz, P Livingston, M Khasraw, S Hakkennes, T Dunning, S Brumby, R Page, A Sutherland, S Brennan-Olsen, M Berk, D Campbell, J Pasco
(2019), Vol. 19, BMC Cancer, England, C1
Gianni Faedda, Ross Baldessarini, Ciro Marangoni, Andreas Bechdolf, Michael Berk, Boris Birmaher, Philippe Conus, Melissa DelBello, Anne Duffy, Manon Hillegers, Andrea Pfennig, Robert Post, Martin Preisig, Aswin Ratheesh, Paola Salvatore, Mauricio Tohen, Gustavo Vazquez, Eduard Vieta, Lakshmi Yatham, Eric Youngstrom, Anna Van Meter, Christoph Correll
(2019), Vol. 21, pp. 720-740, Bipolar disorders, Chichester, Eng., C1
L Arancini, C Bortolasci, S Dodd, O Dean, M Berk
(2019), Vol. 20, Trials, England, C1
R Sethi, N Gómez-Coronado, A Walker, O Robertson, B Agustini, M Berk, S Dodd
(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1
G Morris, B Puri, A Walker, M Maes, A Carvalho, K Walder, C Mazza, M Berk
(2019), Vol. 148, Pharmacological Research, Netherlands, C1
J Firth, S Teasdale, K Allott, D Siskind, W Marx, J Cotter, N Veronese, F Schuch, L Smith, M Solmi, A Carvalho, D Vancampfort, M Berk, B Stubbs, J Sarris
(2019), Vol. 18, pp. 308-324, World psychiatry, Chichester, Eng., C1
S Kidnapillai, C Bortolasci, B Panizzutti, B Spolding, T Connor, K Bonifacio, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder
(2019), Vol. 20, pp. 766-777, World Journal of Biological Psychiatry, London, Eng., C1
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
G Morris, B Puri, A Walker, M Maes, A Carvalho, C Bortolasci, K Walder, M Berk
(2019), Vol. 107, pp. 862-882, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
C Reedtz, K van Doesum, G Signorini, C Lauritzen, T van Amelsvoort, F van Santvoort, A Young, P Conus, R Musil, T Schulze, M Berk, A Stringaris, G Piché, G de Girolamo
(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1
Staging of Schizophrenia with the Use of PANSS: An International Multi-Center Study
K Fountoulakis, E Dragioti, A Theofilidis, T Wikilund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Injac Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadaǧ, A De Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M De Hert
(2019), Vol. 22, pp. 681-697, International Journal of Neuropsychopharmacology, Oxford, Eng., C1
M Kowalczyk, J Szemraj, K Bliźniewska, M Maes, M Berk, K Su, P Gałecki
(2019), Vol. 71, pp. 1299-1307, Pharmacological reports, Amsterdam, The Netherlands, C1
S Cotton, M Berk, A Watson, S Wood, K Allott, C Bartholomeusz, C Bortolasci, K Walder, B O'Donoghue, O Dean, A Chanen, G Amminger, P McGorry, A Burnside, J Uren, A Ratheesh, S Dodd
(2019), Vol. 20, Trials, England, C1
Variation in the prevalence of depression and patterns of association, sociodemographic and lifestyle factors in community-dwelling older adults in six low- and middle-income countries
M Lotfaliany, E Hoare, F Jacka, P Kowal, M Berk, M Mohebbi
(2019), Vol. 251, pp. 218-226, Journal of Affective Disorders, Netherlands, C1
S Dodd, A Walker, A Brnabic, N Hong, A Burns, M Berk
(2019), Vol. 21, pp. 142-150, Bipolar Disorders, Denmark, C1
Falls and Depression in Men: A Population-Based Study
A Stuart, J Pasco, F Jacka, M Berk, L Williams
(2018), Vol. 12, pp. 14-18, American Journal of Men's Health, United States, C1
A Quinn, O Dean, C Davey, M Kerr, S Harrigan, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, M Schäfer, E Mullen, S Hetrick, P McGorry, M Berk
(2018), Vol. 12, pp. 45-54, Early Intervention in Psychiatry, Australia, C1
G Morris, M Berk, B Puri
(2018), Vol. 55, pp. 3592-3609, Molecular Neurobiology, United States, C1
The limitations of using randomised controlled trials as a basis for developing treatment guidelines
R Mulder, A Singh, A Hamilton, P Das, T Outhred, G Morris, D Bassett, B Baune, M Berk, P Boyce, B Lyndon, G Parker, G Malhi
(2018), Vol. 21, pp. 4-6, Evidence-Based Mental Health, England, C1
S Kim, H Kang, K Bae, I Shin, Y Hong, Y Ahn, M Jeong, M Berk, J Yoon, J Kim
(2018), Vol. 80, pp. 250-254, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1
D Brownstein, E Salagre, C Köhler, B Stubbs, J Vian, C Pereira, V Chavarria, C Karmakar, A Turner, J Quevedo, A Carvalho, M Berk, B Fernandes
(2018), Vol. 52, pp. 24-38, Australian and New Zealand Journal of Psychiatry, England, C1
Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis
A Ratheesh, S Cotton, C Davey, A Lin, S Wood, H Yuen, A Bechdolf, P McGorry, A Yung, M Berk, B Nelson
(2018), Vol. 192, pp. 345-350, Schizophrenia Research, Netherlands, C1-1
The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases
G Morris, K Walder, A Carvalho, S Tye, K Lucas, M Berk, M Maes
(2018), Vol. 84, pp. 453-469, Neuroscience and Biobehavioral Reviews, United States, C1
Cognition in depression: can we THINC-it better?
B Baune, G Malhi, G Morris, T Outhred, A Hamilton, P Das, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, A Singh
(2018), Vol. 225, pp. 559-562, Journal of affective disorders, Amsterdam, The Netherlands, C1
M Mohebbi, V Nguyen, J McNeil, R Woods, M Nelson, R Shah, E Storey, A Murray, C Reid, B Kirpach, R Wolfe, J Lockery, M Berk
(2018), Vol. 51, pp. 118-125, General Hospital Psychiatry, United States, C1
A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression
C Roomruangwong, G Anderson, M Berk, D Stoyanov, A Carvalho, M Maes
(2018), Vol. 81, pp. 262-274, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1
S Dodd, P Mitchell, M Bauer, L Yatham, A Young, S Kennedy, L Williams, T Suppes, C Lopez Jaramillo, M Trivedi, M Fava, A Rush, R McIntyre, M Thase, R Lam, E Severus, S Kasper, M Berk
(2018), Vol. 19, pp. 330-348, World Journal of Biological Psychiatry, England, C1
Cell death pathways: a novel therapeutic approach for neuroscientists
G Morris, A Walker, M Berk, M Maes, B Puri
(2018), Vol. 55, pp. 5767-5786, Molecular neurobiology, New York, N.Y., C1
I Oberholzer, M Möller, B Holland, O Dean, M Berk, B Harvey
(2018), Vol. 33, pp. 467-480, Metabolic Brain Disease, United States, C1
D Skvarc, M Berk, L Byrne, O Dean, S Dodd, M Lewis, A Marriott, E Moore, G Morris, R Page, L Gray
(2018), Vol. 84, pp. 116-133, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
J Paterson, O Medvedev, A Sumich, E Tautolo, C Krägeloh, R Sisk, R McNamara, M Berk, A Narayanan, R Siegert
(2018), Vol. 227, pp. 698-704, Journal of affective disorders, Amsterdam, The Netherlands, C1
J Firth, R Carney, B Stubbs, S Teasdale, D Vancampfort, P Ward, M Berk, J Sarris
(2018), Vol. 44, pp. 1275-1292, Schizophrenia Bulletin, United States, C1
Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking
N Gómez-Coronado, A Walker, M Berk, S Dodd
(2018), Vol. 38, pp. 235-258, Pharmacotherapy, United States, C1
G Morris, M Berk, A Carvalho, M Maes, A Walker, B Puri
(2018), Vol. 341, pp. 154-175, Behavioural brain research, Amsterdam, The Netherlands, C1
G Morris, E Reiche, A Murru, A Carvalho, M Maes, M Berk, B Puri
(2018), Vol. 55, pp. 6282-6306, Molecular Neurobiology, United States, C1
M Jhon, T Yoo, J Lee, S Kim, J Kim, I Shin, L Williams, M Berk, J Yoon, S Kim
(2018), Vol. 33, Human Psychopharmacology, England, C1
Early intervention in Bipolar Disorder
Eduard Vieta, Estela Salagre, Iria Grande, André Carvalho, Brisa Fernandes, Michael Berk, Boris Birmaher, Mauricio Tohen, Trisha Suppes
(2018), Vol. 175, pp. 411-426, American journal of psychiatry, Arlington, Va., C1
An update on adjunctive treatment options for bipolar disorder
O Dean, E Gliddon, T Van Rheenen, F Giorlando, S Davidson, M Kaur, T Ngo, L Williams
(2018), Vol. 20, pp. 87-96, Bipolar Disorders, Denmark, C1
S Adams, A Kouzani, S Tye, K Bennet, M Berk
(2018), Vol. 15, Journal of NeuroEngineering and Rehabilitation, England, C1
Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men
L Williams, M Berk, J Hodge, M Kotowicz, A Stuart, V Chandrasekaran, J Cleminson, J Pasco
(2018), Vol. 103, pp. 125-130, Calcified Tissue International, United States, C1
Mechanisms underpinning the polypharmacy effects of medications in psychiatry
C Bortolasci, B Spolding, E Callaly, S Martin, B Panizzutti, S Kidnapillai, T Connor, K Hasebe, M Mohebbi, O Dean, S McGee, S Dodd, L Gray, M Berk, K Walder
(2018), Vol. 21, pp. 582-591, International Journal of Neuropsychopharmacology, England, C1
W Zheng, Q Zhang, D Cai, X Yang, Y Qiu, G Ungvari, C Ng, M Berk, Y Ning, Y Xiang
(2018), Vol. 137, pp. 391-400, Acta Psychiatrica Scandinavica, United States, C1
The subjective wellbeing profile of the 'pretiree' demographic: A cross-sectional study
J Pasco, K Holloway, A Stuart, L Williams, S Brennan-Olsen, M Berk
(2018), Vol. 110, pp. 111-117, Maturitas, Ireland, C1
E Vieta, M Berk, T Schulze, A Carvalho, T Suppes, J Calabrese, K Gao, K Miskowiak, I Grande
(2018), Vol. 4, Nature Reviews Disease Primers, England, C1
T Yoo, W Choi, J-H Hong, J-Y Lee, J-M Kim, I-S Shin, S Yang, P Amminger, M Berk, J-S Yoon, S-W Kim
(2018), Vol. 15, pp. 396-401, Psychiatry Investigation, Soeul, South Korea, C1
O Dandash, M Yücel, R Daglas, C Pantelis, P McGorry, M Berk, A Fornito
(2018), Vol. 8, Translational Psychiatry, United States, C1
L Yatham, S Kennedy, S Parikh, A Schaffer, D Bond, B Frey, V Sharma, B Goldstein, S Rej, S Beaulieu, M Alda, G MacQueen, R Milev, A Ravindran, C O'Donovan, D McIntosh, R Lam, G Vazquez, F Kapczinski, R McIntyre, J Kozicky, S Kanba, B Lafer, T Suppes, J Calabrese, E Vieta, G Malhi, R Post, M Berk
(2018), Vol. 20, pp. 97-170, Bipolar Disorders, Denmark, C1
Mitochondrial agents for bipolar disorder
C Pereira, V Chavarria, J Vian, M Ashton, M Berk, W Marx, O Dean
(2018), Vol. 21, pp. 550-569, International Journal of Neuropsychopharmacology, England, C1
G Morris, B Puri, K Walder, M Berk, B Stubbs, M Maes, A Carvalho
(2018), Vol. 55, pp. 8765-8787, Molecular Neurobiology, United States, C1
Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal
J Davis, M Desmond, M Berk
(2018), Vol. 23, pp. 897-903, Nephrology, Australia, C1
P Ellegaard, R Licht, H Poulsen, R Nielsen, M Berk, O Dean, M Mohebbi, C Nielsen
(2018), Vol. 6, International Journal of Bipolar Disorders, Germany, C1
J Price, Carrie Bronars, Sophie Erhardt, Kathyrn Cullen, Lilly Schwieler, Michael Berk, Ken Walder, Sean McGee, Mark Frye, Susannah Tye
(2018), Vol. 90, pp. 212-220, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
G Morris, B Stubbs, C Köhler, K Walder, A Slyepchenko, M Berk, A Carvalho
(2018), Vol. 41, pp. 255-265, Sleep Medicine Reviews, England, C1
Economic evaluation of a dietary intervention for adults with major depression (the "SMILES" trial)
M Chatterton, C Mihalopoulos, A O'Neil, C Itsiopoulos, R Opie, D Castle, S Dash, L Brazionis, M Berk, F Jacka
(2018), Vol. 18, BMC Public Health, England, C1
M Mohebbi, S Dodd, O Dean, M Berk
(2018), Vol. 53, pp. 17-22, European Psychiatry, England, C1
Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?
M Berk, C Loo, C Davey, B Harvey
(2018), Vol. 52, pp. 1026-1029, Australian and New Zealand Journal of Psychiatry, England, C1
A Bruschi, M Mazza, G Camardese, S Calò, C Palumbo, L Mandelli, A Callea, A Gori, M Di Nicola, G Marano, M Berk, G di Sciascio, L Janiri
(2018), Vol. 9, Frontiers in Psychology, Switzerland, C1
B Panizzutti, C Bortolasci, K Hasebe, S Kidnapillai, L Gray, K Walder, M Berk, M Mohebbi, S Dodd, C Gama, P Magalhães, S Cotton, F Kapczinski, A Bush, G Malhi, O Dean
(2018), Vol. 30, pp. 334-341, Acta Neuropsychiatrica, England, C1
K Fletcher, F Foley, N Thomas, E Michalak, L Berk, M Berk, S Bowe, S Cotton, L Engel, S Johnson, S Jones, M Kyrios, S Lapsley, C Mihalopoulos, T Perich, G Murray
(2018), Vol. 18, BMC Psychiatry, England, C1
C Young, K Trapani, S Dawson, A O’Neil, F Kay-Lambkin, M Berk, F Jacka
(2018), Vol. 52, pp. 834-846, Australian and New Zealand Journal of Psychiatry, England, C1
J Sarris, G Byrne, C Bousman, C Stough, J Murphy, P MacDonald, L Adams, S Nazareth, G Oliver, L Cribb, K Savage, R Menon, S Chamoli, M Berk, C Ng, D Mischoulon
(2018), Vol. 28, pp. 1126-1136, European Neuropsychopharmacology, Netherlands, C1
Role of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia
M Subbanna, V Shivakumar, P Talukdar, J Narayanaswamy, D Venugopal, M Berk, S Varambally, G Venkatasubramanian, M Debnath
(2018), Vol. 111, pp. 112-118, Cytokine, England, C1
A review of the neurobiological underpinning of comorbid substance use and mood disorders
N Gómez-Coronado, R Sethi, C Bortolasci, L Arancini, M Berk, S Dodd
(2018), Vol. 241, pp. 388-401, Journal of Affective Disorders, Netherlands, C1
T Martini, L Czepielewski, D Baldez, E Gliddon, C Kieling, L Berk, M Berk, M Kauer-Sant’anna
(2018), Vol. 40, pp. 326-336, Trends in Psychiatry and Psychotherapy, Brazil, C1
Internet use by older adults with bipolar disorder: international survey results
R Bauer, T Glenn, S Strejilevich, J Conell, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, A Castro, E Cheung, C Chillotti, S Choppin, A Cuomo, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, M Fernández Hernandez, J Garnham, J Geddes, J Gildebro, M Gitlin, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, A Lund, V Kapur, G Kunigiri, B Lafer, E Larsen, U Lewitzka, R Licht, B Misiak, P Piotrowski, Â Miranda-Scippa, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O’Donovan, Y Okamura, Y Osher, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, J Veeh, E Vieta, M Vinberg, B Viswanath, M Zetin, P Whybrow, M Bauer
(2018), Vol. 6, International Journal of Bipolar Disorders, Germany, C1
A Gold, A Peters, M Otto, L Sylvia, P Magalhaes, M Berk, D Dougherty, D Miklowitz, E Frank, A Nierenberg, T Deckersbach
(2018), Vol. 52, pp. 847-855, Australian and New Zealand Journal of Psychiatry, England, C1
Leaky brain in neurological and psychiatric disorders: drivers and consequences
Gerwyn Morris, Brisa Fernandes, Basant Puri, Adam Walker, Andre Carvalho, Michael Berk
(2018), Vol. 52, pp. 924-948, Australian and New Zealand journal of psychiatry, London, Eng., C1
Effect of aspirin on all-cause mortality in the healthy elderly
J McNeil, M Nelson, R Woods, J Lockery, R Wolfe, C Reid, B Kirpach, R Shah, D Ives, E Storey, J Ryan, A Tonkin, A Newman, J Williamson, K Margolis, M Ernst, W Abhayaratna, N Stocks, S Fitzgerald, S Orchard, R Trevaks, L Beilin, G Donnan, P Gibbs, C Johnston, B Radziszewska, R Grimm, A Murray
(2018), Vol. 379, pp. 1519-1528, New England Journal of Medicine, United States, C1
Effect of aspirin on disability-free survival in the healthy elderly
J McNeil, R Woods, M Nelson, C Reid, B Kirpach, R Wolfe, E Storey, R Shah, J Lockery, A Tonkin, A Newman, J Williamson, K Margolis, M Ernst, W Abhayaratna, N Stocks, S Fitzgerald, S Orchard, R Trevaks, L Beilin, G Donnan, P Gibbs, C Johnston, J Ryan, B Radziszewska, R Grimm, A Murray
(2018), Vol. 379, pp. 1499-1508, New England Journal of Medicine, United States, C1
Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
John McNeil, Rory Wolfe, Robyn Woods, Andrew Tonkin, Geoffrey Donnan, Mark Nelson, Christopher Reid, Jessica Lockery, Brenda Kirpach, Elsdon Storey, Raj Shah, Jeff Williamson, Karen Margolis, Michael Ernst, Walter Abhayaratna, Nigel Stocks, Sharyn Fitzgerald, Suzanne Orchard, Ruth Trevaks, Lawrence Beilin, Colin Johnston, Joanne Ryan, Barbara Radziszewska, Michael Jelinek, Mobin Malik, Charles Eaton, Donna Brauer, Geoff Cloud, Erica Wood, Suzanne Mahady, Suzanne Satterfield, Richard Grimm, Anne Murray, Michael Berk
(2018), Vol. 379, pp. 1509-1518, New England journal of medicine, Waltham, Mass., C1
G Parker, G Tavella, G Macqueen, M Berk, H Grunze, T Deckersbach, D Dunner, M Sajatovic, J Amsterdam, T Ketter, L Yatham, L Kessing, D Bassett, M Zimmerman, K Fountoulakis, A Duffy, M Alda, C Calkin, V Sharma, A Anand, M Singh, T Hajek, P Boyce, B Frey, D Castle, A Young, E Vieta, J Rybakowski, H Swartz, A Schaffer, G Murray, A Bayes, R Lam, E Bora, R Post, M Ostacher, B Lafer, A Cleare, K Burdick, C O’Donovan, A Ortiz, C Henry, S Kanba, J Rosenblat, S Parikh, D Bond, M Grunebaum, S Frangou, J Goldberg, M Orum, D Osser, M Frye, R McIntyre, A Fagiolini, V Manicavasagar, G Carlson, G Malhi
(2018), Vol. 52, pp. 1173-1182, Australian and New Zealand Journal of Psychiatry, England, C1
J Davis, M Desmond, M Berk
(2018), Vol. 19, BMC Nephrology, England, C1
Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
E Salagre, S Dodd, A Aedo, A Rosa, S Amoretti, J Pinzon, M Reinares, M Berk, F Kapczinski, E Vieta, I Grande
(2018), Vol. 9, Frontiers in Psychiatry, Switzerland, C1
Julie Pasco, K Holloway-Kew, N Hyde, Monica Tembo, Pamela Rufus, Sophia Sui, Michael Berk, Mark Kotowicz
(2018), Vol. 3, pp. 1-12, JCSM Clinical Reports, London, Eng., C1
The MHC/HLA gene complex in major psychiatric disorders: emerging roles and implications
M Debnath, M Berk, M Leboyer, R Tamouza
(2018), Vol. 5, pp. 179-188, Current behavioral neuroscience reports, New York, N.Y.g, C1
Depression and chronic diseases: Co-occurrence and communality of risk factors
M Lotfaliany, S Bowe, P Kowal, L Orellana, M Berk, M Mohebbi
(2018), Vol. 241, pp. 461-468, Journal of Affective Disorders, Netherlands, C1
Ethical considerations in preventive interventions for bipolar disorder
A Ratheesh, S Cotton, C Davey, S Adams, A Bechdolf, C Macneil, M Berk, P McGorry
(2017), Vol. 11, pp. 104-112, Early Intervention in Psychiatry, Australia, C1
A potential role for N-acetylcysteine in the management of methamphetamine dependence
R McKetin, O Dean, A Baker, G Carter, A Turner, P Kelly, M Berk
(2017), Vol. 36, pp. 153-159, Drug and Alcohol Review, Australia, C1
The prevalence, age distribution and comorbidity of personality disorders in Australian women
S Quirk, M Berk, J Pasco, S Brennan-Olsen, A Chanen, H Koivumaa-Honkanen, L Burke, H Jackson, C Hulbert, C A Olsson, P Moran, A Stuart, L Williams
(2017), Vol. 51, pp. 141-150, Australian and New Zealand Journal of Psychiatry, England, C1
O Dean, K Gray, K Villagonzalo, S Dodd, M Mohebbi, T Vick, B Tonge, M Berk
(2017), Vol. 51, pp. 241-249, Australian and New Zealand Journal of Psychiatry, England, C1
G Morris, M Berk, H Klein, K Walder, P Galecki, M Maes
(2017), Vol. 54, pp. 4271-4291, Molecular Neurobiology, United States, C1
G Morris, M Berk, A Carvalho, J Caso, Y Sanz, K Walder, M Maes
(2017), Vol. 54, pp. 4432-4451, Molecular Neurobiology, United States, C1
Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, M Figueira, O Dean
(2017), Vol. 72, pp. 73-86, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1
Do sleep disturbances predict or moderate the response to psychotherapy in bipolar disorder?
L Sylvia, S Salcedo, A Peters, P Da Silva Magalhães, E Frank, D Miklowitz, M Otto, M Berk, A Nierenberg, T Deckersbach
(2017), Vol. 205, pp. 196-202, Journal of Nervous and Mental Disease, United States, C1
N Sands, S Elsom, R Corbett, S Keppich-Arnold, R Prematunga, M Berk, J Considine
(2017), Vol. 26, pp. 226-237, International journal of mental health nursing, Milton, Qld., C1
J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer
(2017), Vol. 39, pp. 40-50, European Psychiatry, England, C1
C Bousman, D Müller, C Ng, K Byron, M Berk, A Singh
(2017), Vol. 27, pp. 1-6, Pharmacogenetics and Genomics, United States, C1
R Veerabhadrappa, A Bhatti, M Berk, S Tye, S Nahavandi
(2017), Vol. 249, pp. 299-313, Neurocomputing, C1
Cognitive effects of adjunctive N-acetyl cysteine in psychosis
M Rapado-Castro, S Dodd, A Bush, G Malhi, D Skvarc, Z On, M Berk, O Dean
(2017), Vol. 47, pp. 866-876, Psychological Medicine, England, C1
Functional implications of the IL-23/IL-17 immune axis in schizophrenia
M Debnath, M Berk
(2017), Vol. 54, pp. 8170-8178, Molecular neurobiology, Berlin, Germany, C1
S de Campos-Carli, M Araújo, A de Oliveira Silveira, V de Rezende, N Rocha, R Ferretjans, R Ribeiro-Santos, A Teixeira-Carvalho, O Martins-Filho, M Berk, J Salgado, A Teixeira
(2017), Vol. 87, pp. 44-52, Journal of Psychiatric Research, England, C1
A Ratheesh, C Davey, S Hetrick, M Alvarez-Jimenez, C Voutier, A Bechdolf, P McGorry, J Scott, M Berk, S Cotton
(2017), Vol. 135, pp. 273-284, Acta psychiatrica Scandinavica, London, Eng., C1
A model of the mitochondrial basis of bipolar disorder
G Morris, K Walder, S McGee, O Dean, S Tye, M Maes, M Berk
(2017), Vol. 74, pp. 1-20, Neuroscience and Biobehavioral Reviews, United States, C1
G Murray, N Leitan, N Thomas, E Michalak, S Johnson, S Jones, T Perich, L Berk, M Berk
(2017), Vol. 52, pp. 148-163, Clinical psychology review, Amsterdam, The Netherlands, C1
M Berk, O Dandash, R Daglas, S Cotton, K Allott, A Fornito, C Suo, P Klauser, B Liberg, L Henry, C Macneil, M Hasty, P McGorry, C Pantelis, M Yöcel
(2017), Vol. 7, Translational Psychiatry, United States, C1
F Jacka, A O'Neil, R Opie, C Itsiopoulos, S Cotton, M Mohebbi, D Castle, S Dash, C Mihalopoulos, M Chatterton, L Brazionis, O Dean, A Hodge, M Berk
(2017), Vol. 15, BMC Medicine, England, C1
A review of the theoretical and biological understanding of the nocebo and placebo phenomena
S Dodd, O Dean, J Vian, M Berk
(2017), Vol. 39, pp. 469-476, Clinical therapeutics, Amsterdam, The Netherlands, C1
C Bousman, M Forbes, M Jayaram, H Eyre, C Reynolds, M Berk, M Hopwood, C Ng
(2017), Vol. 17, BMC Psychiatry, England, C1
J Firth, B Stubbs, J Sarris, S Rosenbaum, S Teasdale, M Berk, A Yung
(2017), Vol. 47, pp. 1515-1527, Psychological medicine, Cambridge, Eng., C1
M Chatterton, E Stockings, M Berk, J Barendregt, R Carter, C Mihalopoulos
(2017), Vol. 210, pp. 333-341, British Journal of Psychiatry, England, C1
The placebo and nocebo phenomena: their clinical management and impact on treatment outcomes
V Chavarria, J Vian, C Pereira, J Data-Franco, B Fernandes, M Berk, S Dodd
(2017), Vol. 39, pp. 477-486, Clinical therapeutics, New York, N.Y., C1
M Berk, R Daglas, O Dandash, M Yücel, L Henry, K Hallam, C Macneil, M Hasty, C Pantelis, B Murphy, L Kader, S Damodaran, M Wong, P Conus, A Ratheesh, P McGorry, S Cotton
(2017), Vol. 210, pp. 413-421, British Journal of Psychiatry, England, C1
S Lauder, V Cosgrove, E Gliddon, D Grimm, S Dodd, L Berk, D Castle, T Suppes, M Berk
(2017), Vol. 56, pp. 18-24, Contemporary clinical trials, Amsterdam, The Netherlands, C1
K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean
(2017), Vol. 29, pp. 337-346, Acta Neuropsychiatrica, England, C1
Do Statins Have Antidepressant Effects?
O Köhler-Forsberg, C Gasse, M Berk, S Østergaard
(2017), Vol. 31, pp. 335-343, CNS Drugs, New Zealand, C1
Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis
E Salagre, A Vizuete, M Leite, D Brownstein, A McGuinness, F Jacka, S Dodd, B Stubbs, C Köhler, E Vieta, A Carvalho, M Berk, B Fernandes
(2017), Vol. 43, pp. 81-91, European Psychiatry, England, C1
A Ryan, A Baker, F Dark, S Foley, A Gordon, S Hatherill, S Stathis, S Saha, G Bruxner, M Beckman, D Richardson, M Berk, O Dean, J McGrath, C Group, J Scott
(2017), Vol. 18, Trials, England, C1
S Aggarwal, G Patton, N Reavley, S Sreenivasan, M Berk
(2017), Vol. 63, pp. 359-375, International journal of social psychiatry, London, Eng., C1
the effect of n-acetylcysteine (nac) on human cognition - a systematic review
D Skvarc, O Dean, L Byrne, L Gray, S Lane, M Lewis, B Fernandes, M Berk, A Marriott
(2017), Vol. 78, pp. 44-56, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1
L Berk, K Hallam, K Venugopal, A Lewis, D Austin, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, M Berk
(2017), Vol. 19, pp. 184-197, Bipolar disorders, Hoboken, N.J., C1
B Bortolato, C Köhler, E Evangelou, J León-Caballero, M Solmi, B Stubbs, L Belbasis, I Pacchiarotti, L Kessing, M Berk, E Vieta, A Carvalho
(2017), Vol. 19, pp. 84-96, Bipolar Disorders, Denmark, C1
G Scaini, G Fries, S Valvassori, C Zeni, G Zunta-Soares, M Berk, J Soares, J Quevedo
(2017), Vol. 7, pp. e1111-, Translational psychiatry, United States, C1
Evaluation of modified patient health questionnaire-9 teen in South African adolescents
S Aggarwal, L Taljard, Z Wilson, M Berk
(2017), Vol. 39, pp. 143-145, Indian Journal of Psychological Medicine, Mumbai, India, C1
Pattern of psychotropic medication use over two decades in Australian women
A Stuart, M Mohebbi, J Pasco, S Quirk, S Brennan-Olsen, M Berk, L Williams
(2017), Vol. 51, pp. 1212-1219, Australian and New Zealand Journal of Psychiatry, England, C1
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial
O Dean, B Kanchanatawan, M Ashton, M Mohebbi, C Ng, M Maes, L Berk, A Sughondhabirom, S Tangwongchai, A Singh, H McKenzie, D Smith, G Malhi, N Dowling, M Berk
(2017), Vol. 51, pp. 829-840, Australian and New Zealand Journal of Psychiatry, England, C1
A Ratheesh, C Davey, R Daglas, C Macneil, M Hasty, K Filia, P McGorry, M Berk, P Conus, S Cotton
(2017), Vol. 219, pp. 133-140, Journal of affective disorders, Amsterdam, The Netherlands, C1
Defining melancholia: A core mood disorder
G Parker, D Bassett, T Outhred, G Morris, A Hamilton, P Das, B Baune, M Berk, P Boyce, B Lyndon, R Mulder, A Singh, G Malhi
(2017), Vol. 19, pp. 235-237, Bipolar Disorders, Denmark, C1
Psychotropic pharmacogenetics - distraction or destiny?
A Singh, B Baune, A Hamilton, P Das, T Outhred, G Morris, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, G Malhi
(2017), Vol. 51, pp. 665-667, Australian & New Zealand journal of psychiatry, London, Eng., C1
International multi-site survey on the use of online support groups in bipolar disorder
R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Zompo, R Dias, S Dodd, A Duffy, B Etain
(2017), Vol. 71, pp. 473-476, Nordic Journal of Psychiatry, Abingdon, Eng, C1
K Landucci Bonifácio, D Sabbatini Barbosa, E Gastaldello Moreira, C de Farias, L Higachi, A Camargo, J Favaro Soares, H Odebrecht Vargas, S Nunes, M Berk, S Dodd, M Maes
(2017), Vol. 222, pp. 185-194, Journal of Affective Disorders, Netherlands, C1
Solar insolation in springtime influences age of onset of bipolar I disorder
M Bauer, T Glenn, M Alda, M Aleksandrovich, O Andreassen, E Angelopoulos, R Ardau, Y Ayhan, C Baethge, S Bharathram, R Bauer, B Baune, C Becerra-Palars, F Bellivier, R Belmaker, M Berk, Y Bersudsky, Bicakci, H Birabwa-Oketcho, T Bjella, L Bossini, J Cabrera, E Cheung, M Del Zompo, S Dodd, M Donix, B Etain, A Fagiolini, K Fountoulakis, M Frye, A Gonzalez-Pinto, J Gottlieb, P Grof, H Harima, C Henry, E Isometsä, S Janno, F Kapczinski, M Kardell, S Khaldi, S Kliwicki, B König, T Kot, R Krogh, M Kunz, B Lafer, M Landén, E Larsen, U Lewitzka, R Licht, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, F Meza-Urzúa, M Yee Ming, S Monteith, G Morken, E Mosca, R Munoz, S Mythri, F Nacef, R Nadella, F Nery, R Nielsen, C O'Donovan, A Omrani, Y Osher, H Østermark Sørensen, U Ouali, Y Pica Ruiz, M Pilhatsch, M Pinna, F da Ponte, D Quiroz, R Ramesar, N Rasgon, M Reddy, A Reif, P Ritter, J Rybakowski, K Sagduyu, M Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, M Subramaniam, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, L Tondo, C Torrent, A Vaaler, J Veeh, E Vieta, B Viswanath
(2017), Vol. 136, pp. 571-582, Acta Psychiatrica Scandinavica, United States, C1
Mixed mood: the not so united states?
G Malhi, M Berk, G Morris, A Hamilton, T Outhred, P Das, D Bassett, B Baune, P Boyce, B Lyndon, R Mulder, G Parker, A Singh
(2017), Vol. 19, pp. 242-245, Bipolar Disorders, Hoboken, N. J., C1
The renin-angiotensin system: A possible new target for depression
J Vian, C Pereira, V Chavarria, C Köhler, B Stubbs, J Quevedo, S Kim, A Carvalho, M Berk, B Fernandes
(2017), Vol. 15, BMC Medicine, England, C1
Online ethics: where will the interface of mental health and the internet lead us?
V Cosgrove, E Gliddon, L Berk, D Grimm, S Lauder, S Dodd, M Berk, T Suppes
(2017), Vol. 5, International Journal of Bipolar Disorders, Germany, C1
Plasma levels of tumor necrosis factor superfamily molecules are increased in bipolar disorder
I Barbosa, G Vaz, N Rocha, R Machado-Vieira, M Ventura, R Huguet, M Bauer, M Berk, A Teixeira
(2017), Vol. 15, pp. 269-275, Clinical Psychopharmacology and Neuroscience, Korea (South), C1
M Berger, S Smesny, S Kim, C Davey, S Rice, Z Sarnyai, M Schlögelhofer, M Schäfer, M Berk, P McGorry, G Amminger
(2017), Vol. 7, pp. 1-6, Translational Psychiatry, United States, C1
J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer
(2017), Vol. 51, pp. 1121-1133, Australian and New Zealand Journal of Psychiatry, England, C1
S Quirk, A Stuart, M Berk, J Pasco, S Brennan Olsen, H Koivumaa-Honkanen, R Honkanen, P Lukkala, A Chanen, M Kotowicz, L Williams
(2017), Vol. 257, pp. 546-549, Psychiatry Research, Ireland, C1
M Duailibi, Q Cordeiro, E Brietzke, M Ribeiro, S LaRowe, M Berk, A Trevizol
(2017), Vol. 26, pp. 660-666, American Journal on Addictions, England, C1
Staging in bipolar disorder: from theoretical framework to clinical utility
M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, A Carvalho, M Ashton, L Berk, S Cotton, P McGorry, B Fernandes, L Yatham, S Dodd
(2017), Vol. 16, pp. 236-244, World psychiatry, Chichester, Eng., C1
A Kouzani, R Kale, P Zarate-Garza, M Berk, K Walder, S Tye
(2017), Vol. 25, pp. 1365-1374, IEEE Transactions on Neural Systems and Rehabilitation Engineering, United States, C1
Nutritional psychiatry: the present state of the evidence
W Marx, G Moseley, M Berk, F Jacka
(2017), Vol. 76, pp. 427-436, Proceedings of the Nutrition Society, Cambridge, Eng., C1
Cognitive functioning following stabilisation from first episode mania
R Daglas, K Allott, M Yücel, L Henry, C Macneil, M Hasty, M Berk, S Cotton
(2017), Vol. 5, International Journal of Bipolar Disorders, Germany, C1
R Menon, L Cribb, J Murphy, M Ashton, G Oliver, N Dowling, A Turner, O Dean, M Berk, C Ng, J Sarris
(2017), Vol. 4, pp. 109-114, Advances in integrative medicine, Amsterdam, The Netherlands, C1
Joan Asarnow, Michele Berk, Lily Zhang, Peter Wang, Lingqi Tang
(2017), Vol. 47, pp. 551-566, SUICIDE AND LIFE-THREATENING BEHAVIOR, England, C1
Cardiovascular efficacy and safety of bococizumab in high-risk patients
P Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, M Flather, R Glynn, J Gregoire, J Jukema, Y Karpov, J Kastelein, W Koenig, A Lorenzatti, P Manga, U Masiukiewicz, M Miller, A Mosterd, J Murin, J Nicolau, S Nissen, P Ponikowski, R Santos, P Schwartz, H Soran, H White, R Wright, M Vrablik, C Yunis, C Shear, J Tardif, D Conde, D Colquhoun, L Missault, J Grégoire, R Gao, M Urina, M Solar, H Jensen, D Grobbee, M Savolainen, F Schiele, G Montalescot, I Edes, G Blake, C Lotan, A Maggioni, S Savonitto, C Lee, J Leiva Pons, G Dan, J Cortada, L Mellbin, T Kahan, S Noble, J Hwang, P Sritara, L Tökgozoğlu, L Tarasenko, J Borer, H Black, R Carmena, K Furie, J McMurray, J Neaton, F Zannad, B O’Neill, F Welty, R McNamara, H Chun, J Abbott, D Jacoby, C McPherson, F Jadbabaie, D Pinto, L McCullough, I Silverman, L Sansing, J Dearborn-Tomazos, J Foody, J Schindler, G Piazza, A Chakrabarti, Y Pride, E Gelfand, D Baultrukonis, S Chaudhuri, R Frederich, M Johnson, K Mridha, C Powell, E Wang, C Wei, P Anderson, M Buonanno, C Epsley, B Evans, M Frolova, M Goetsch, D Hessinger, M Berk
(2017), Vol. 376, pp. 1527-1539, New England journal of medicine, Boston, Mass., C1
Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities
Mohammad Alyamani, Zhenfei Li, Michael Berk, Jianneng Li, Jingjie Tang, Sunil Upadhyay, Richard Auchus, Nima Sharifi
(2017), Vol. 24, pp. 825-+, CELL CHEMICAL BIOLOGY, United States, C1
Jianneng Li, Mohammad Alyamani, Ao Zhang, Kai-Hsiung Chang, Michael Berk, Zhenfei Li, Ziqi Zhu, Marianne Petro, Cristina Magi-Galluzzi, Mary-Ellen Taplin, Jorge Garcia, Kevin Courtney, Eric Klein, Nima Sharifi
(2017), Vol. 6, ELIFE, England, C1
S Rice, I Hickie, A Yung, A Mackinnon, M Berk, C Davey, D Hermens, S Hetrick, A Parker, M Schäfer, P McGorry, G Amminger
(2016), Vol. 10, pp. 290-299, Early Intervention in Psychiatry, Australia, C1
G Morris, M Berk, P Galecki, K Walder, M Maes
(2016), Vol. 53, pp. 1195-1219, Molecular Neurobiology, United States, C1
M Maes, G Nowak, J Caso, J Leza, C Song, M Kubera, H Klein, P Galecki, C Noto, E Glaab, R Balling, M Berk
(2016), Vol. 53, pp. 2927-2935, Molecular Neurobiology, United States, C1
G Morris, M Berk, K Walder, M Maes
(2016), Vol. 53, pp. 2550-2571, Molecular Neurobiology, United States, C1
B Fernandes, J Steiner, H Bernstein, S Dodd, J Pasco, O Dean, P Nardin, C Gonçalves, M Berk
(2016), Vol. 21, pp. 554-564, Molecular Psychiatry, England, C1
G Morris, K Walder, B Puri, M Berk, M Maes
(2016), Vol. 53, pp. 4638-4658, Molecular neurobiology, New York, N.Y., C1
M Martin-Subero, G Anderson, B Kanchanatawan, M Berk, M Maes
(2016), Vol. 21, pp. 184-198, CNS Spectrums, Cambridge, Eng., C1
Citalopram and sertraline exposure compromises embryonic bone development
D Fraher, J Hodge, F Collier, J McMillan, R Kennedy, M Ellis, G Nicholson, K Walder, S Dodd, M Berk, J Pasco, L Williams, Y Gibert
(2016), Vol. 21, pp. 656-664, Molecular Psychiatry, England, C1
I Grande, M Berk, B Birmaher, E Vieta
(2016), Vol. 387, pp. 1561-1572, The Lancet, England, C1
Autobiographical memory dysfunctions in depressive disorders
M Talarowska, M Berk, M Maes, P Gałecki
(2016), Vol. 70, pp. 100-108, Psychiatry and Clinical Neurosciences, Australia, C1
The prevalence and age of onset of psychiatric disorders in Australian men
L Williams, F Jacka, J Pasco, C Coulson, S Quirk, A Stuart, M Berk
(2016), Vol. 50, pp. 678-684, Australian and New Zealand Journal of Psychiatry, England, C1
B Fernandes, J Hodge, J Pasco, M Berk, L Williams
(2016), Vol. 33, pp. 21-25, Drugs and Aging, New Zealand, C1
Theory of mind in major depressive disorder: A meta-analysis
E Bora, M Berk
(2016), Vol. 191, pp. 49-55, Journal of Affective Disorders, Netherlands, C1
R Daglas, S Cotton, K Allott, M Yücel, C Macneil, M Hasty, B Murphy, C Pantelis, K Hallam, L Henry, P Conus, A Ratheesh, L Kader, M Wong, P McGorry, M Berk
(2016), Vol. 31, pp. 20-28, European Psychiatry, England, C1
The trajectory of cognitive functioning following first episode mania: A 12-month follow-up study
R Daglas, K Allott, M Yücel, C Pantelis, C Macneil, M Berk, S Cotton
(2016), Vol. 50, pp. 1186-1197, Australian and New Zealand Journal of Psychiatry, England, C1
Depression as a risk factor for fracture in women: A 10 year longitudinal study
L Williams, J Pasco, H Jackson, L Kiropoulos, A Stuart, F Jacka, M Berk
(2016), Vol. 192, pp. 34-40, Journal of Affective Disorders, Netherlands, C1
DNA methylation and the social gradient of osteoporotic fracture: A conceptual model
S Brennan-Olsen, R Page, M Berk, J Riancho, W Leslie, S Wilson, K Saban, L Janusek, J Pasco, J Hodge, S Quirk, N Hyde, S Hosking, L Williams
(2016), Vol. 84, pp. 204-212, Bone, United States, C1
A Duong, Y Che, D Ceylan, A Pinguelo, A Andreazza, L Trevor Young, M Berk
(2016), Vol. 236, pp. 148-157, Psychiatry Research, Ireland, C1
S Quirk, M Berk, A Chanen, H Koivumaa-Honkanen, S Brennan-Olsen, J Pasco, L Williams
(2016), Vol. 7, pp. 136-146, Personality Disorders: Theory, Research, and Treatment, United States, C1
J Stange, E Kleiman, L Sylvia, P Magalhães, M Berk, A Nierenberg, T Deckersbach
(2016), Vol. 33, pp. 464-472, Depression and Anxiety, United States, C1
Cognitive remission: A novel objective for the treatment of major depression?
B Bortolato, K Miskowiak, C Köhler, M Maes, B Fernandes, M Berk, A Carvalho
(2016), Vol. 14, BMC Medicine, England, C1
Bias in Peripheral Depression Biomarkers
A Carvalho, C Köhler, A Brunoni, K Miskowiak, N Herrmann, K Lanctôt, T Hyphantis, J Quevedo, B Fernandes, M Berk
(2016), Vol. 85, pp. 81-90, Psychotherapy and Psychosomatics, Switzerland, C1
J Stange, L Sylvia, P Da Silva Magalhães, D Miklowitz, M Otto, E Frank, C Yim, M Berk, D Dougherty, A Nierenberg, T Deckersbach
(2016), Vol. 208, pp. 352-358, British Journal of Psychiatry, England, C1
Statin and Aspirin Use and the Risk of Mood Disorders among Men
L Williams, J Pasco, M Mohebbi, F Jacka, A Stuart, K Venugopal, A O'Neil, M Berk
(2016), Vol. 19, pp. 1-4, International Journal of Neuropsychopharmacology, England, C1
Harnessing the potential of community-based participatory research approaches in bipolar disorder
E Michalak, S Jones, F Lobban, G Algorta, S Barnes, L Berk, M Berk, R Hole, S Lapsley, V Maxwell, R Milev, J McManamy, G Murray, M Tohen, S Tse, M Sanchez de Carmona, S Johnson
(2016), Vol. 4, pp. 1-9, International Journal of Bipolar Disorders, Germany, C1
J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer
(2016), Vol. 11, PLoS ONE, United States, C1
Niacin skin sensitivity is increased in adolescents at ultra-high risk for psychosis
G Berger, S Smesny, M Schäfer, B Milleit, K Langbein, U Hipler, C Milleit, C Klier, M Schlögelhofer, M Holub, I Holzer, M Berk, P McGorry, H Sauer, G Amminger
(2016), Vol. 11, PLoS ONE, United States, C1
Trajectory and predictors of quality of life in first episode psychotic mania
M Oldis, G Murray, C Macneil, M Hasty, R Daglas, M Berk, P Conus, S Cotton
(2016), Vol. 195, pp. 148-155, Journal of Affective Disorders, Netherlands, C1
A Slyepchenko, M Maes, C Köhler, G Anderson, J Quevedo, G Alves, M Berk, B Fernandes, A Carvalho
(2016), Vol. 64, pp. 83-100, Neuroscience and Biobehavioral Reviews, United States, C1
The putative use of lithium in alzheimer's disease
G Morris, M Berk
(2016), Vol. 13, pp. 853-861, Current alzheimer research, Bussum, Netherlands, C1
A O'Neil, A Fisher, K Kibbey, F Jacka, M Kotowicz, L Williams, A Stuart, M Berk, P Lewandowski, C Taylor, J Pasco
(2016), Vol. 196, pp. 117-124, Journal of Affective Disorders, Netherlands, C1
A O'Neil, A Fisher, K Kibbey, F Jacka, M Kotowicz, L Williams, A Stuart, M Berk, P Lewandowski, J Atherton, C Taylor, J Pasco
(2016), Vol. 87, pp. 115-120, Preventive Medicine, United States, C1
S Quirk, A Stuart, S Brennan-Olsen, J Pasco, M Berk, A Chanen, H Koivumaa-Honkanen, M Kotowicz, P Lukkala, L Williams
(2016), Vol. 34, pp. 29-35, European Psychiatry, England, C1
Fibromyalgia and bipolar disorder: Emerging epidemiological associations and shared pathophysiology
B Bortolato, M Berk, M Maes, R McIntyre, A Carvalho
(2016), Vol. 16, pp. 119-136, Current Molecular Medicine, Netherlands, C1
S Kim, M Jhon, J Kim, S Smesny, S Rice, M Berk, C Klier, P McGorry, M Schäfer, G Amminger
(2016), Vol. 11, PLoS ONE, United States, C1
J Rosenblat, R Kakar, M Berk, L Kessing, M Vinberg, B Baune, R Mansur, E Brietzke, B Goldstein, R Mcintyre
(2016), Vol. 18, pp. 89-101, Bipolar Disorders, Denmark, C1
Mental health for all Australians
M Berk
(2016), Vol. 50, pp. 301-302, Australian and New Zealand Journal of Psychiatry, England, C1
Leptin in bipolar disorder: A systematic review and meta-analysis
B Fernandes, S Dash, F Jacka, S Dodd, A Carvalho, C Köhler, J Steiner, M da Graça Cantarelli, P Nardin, C Gonçalves, M Berk
(2016), Vol. 35, pp. 1-7, European Psychiatry, England, C1
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
J Davis, H Eyre, F Jacka, S Dodd, O Dean, S McEwen, M Debnath, J McGrath, M Maes, P Amminger, P McGorry, C Pantelis, M Berk
(2016), Vol. 65, pp. 185-194, Neuroscience and Biobehavioral Reviews, United States, C1
D Kwiatkowski, P Czarny, M Toma, N Jurkowska, A Sliwinska, J Drzewoski, A Bachurska, J Szemraj, M Maes, M Berk, K Su, P Galecki, T Sliwinski
(2016), Vol. 41, pp. 152-171, Dementia and Geriatric Cognitive Disorders, Switzerland, C1
Areas of controversy in neuroprogression in bipolar disorder
I Passos, B Mwangi, E Vieta, M Berk, F Kapczinski
(2016), Vol. 134, pp. 91-103, Acta Psychiatrica Scandinavica, United States, C1
Adjunctive nutraceuticals for depression: a systematic review and meta-analyses
J Sarris, J Murphy, D Mischoulon, G Papakostas, M Fava, M Berk, C Ng
(2016), Vol. 173, pp. 575-587, American journal of psychiatry, Arlington, Va., C1
Antioxidant treatments for schizophrenia
P Magalhães, O Dean, A Andreazza, M Berk, F Kapczinski
(2016), Vol. 2016, Cochrane Database of Systematic Reviews, England, C1
N-acetylcysteine in depressive symptoms and functionality: A systematic review and meta-analysis
B Fernandes, O Dean, S Dodd, G Malhi, M Berk
(2016), Vol. 77, pp. e457-e466, Journal of Clinical Psychiatry, United States, C1
Integrating early intervention for borderline personality disorder and mood disorders
A Chanen, M Berk, K Thompson
(2016), Vol. 24, pp. 330-341, Harvard Review of Psychiatry, United States, C1
E Salagre, B Fernandes, S Dodd, D Brownstein, M Berk
(2016), Vol. 200, pp. 235-242, Journal of affective disorders, Amsterdam, The Netherlands, C1
Mental health system development in Asia: Does Australia have a role?
K Arandjelovic, H Eyre, M Forbes, R Bauer, S Aggarwal, A Singh, B Baune, I Everall, M Berk, C Ng
(2016), Vol. 50, pp. 834-841, Australian and New Zealand Journal of Psychiatry, England, C1
Bias in emerging biomarkers for bipolar disorder
A Carvalho, C Köhler, B Fernandes, J Quevedo, K Miskowiak, A Brunoni, R Machado-Vieira, M Maes, E Vieta, M Berk
(2016), Vol. 46, pp. 2287-2297, Psychological Medicine, England, C1
Is there a nexus between mental and bone health?
L Williams, J Pasco, J Hodge, M Berk
(2016), Vol. 50, pp. 829-830, Australian and New Zealand Journal of Psychiatry, England, C1
T Deckersbach, A Peters, L Sylvia, A Gold, P Da Silva Magalhaes, D Henry, E Frank, M Otto, M Berk, D Dougherty, A Nierenberg, D Miklowitz
(2016), Vol. 203, pp. 152-157, Journal of affective disorders, Amsterdam, The Netherlands, C1
Y Kim, S McGee, J Czeczor, A Walker, R Kale, A Kouzani, K Walder, M Berk, S Tye
(2016), Vol. 6, pp. e842-, Translational psychiatry, United States, C1
Unified selective sorting approach to analyse multi-electrode extracellular data
R Veerabhadrappa, C Lim, T Nguyen, M Berk, S Tye, P Monaghan, S Nahavandi, A Bhatti
(2016), Vol. 6, Scientific Reports, England, C1
F Kay-Lambkin, L Thornton, J Lappin, T Hanstock, L Sylvia, F Jacka, A Baker, M Berk, P Mitchell, R Callister, N Rogers, S Webster, S Dennis, C Oldmeadow, A MacKinnon, C Doran, A Turner, S Hunt
(2016), Vol. 5, Systematic Reviews, England, C1
Internet use by patients with bipolar disorder: Results from an international multisite survey
R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, M Hernandez, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O'Donovan, Y Okamura, Y Osher, P Piotrowski, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, Â Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, P Whybrow, M Bauer
(2016), Vol. 242, pp. 388-394, Psychiatry Research, Ireland, C1
G Scaini, G Rezin, A Carvalho, E Streck, M Berk, J Quevedo
(2016), Vol. 68, pp. 694-713, Neuroscience and Biobehavioral Reviews, United States, C1
C Karmakar, W Luo, T Tran, M Berk, S Venkatesh
(2016), Vol. 3, JMIR Mental Health, Canada, C1
Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression
A Peters, L Shesler, L Sylvia, P Da Silva Magalhaes, D Miklowitz, M Otto, E Frank, M Berk, D Dougherty, A Nierenberg, T Deckersbach
(2016), Vol. 50, pp. 667-677, Australian and New Zealand journal of psychiatry, London, Eng., C1
J Kulkarni, E Gavrilidis, S Gwini, R Worsley, J Grigg, A Warren, C Gurvich, H Gilbert, M Berk, S Davis
(2016), Vol. 73, pp. 947-954, JAMA psychiatry, Chicago, Ill., C1
ASPREE-D: Aspirin for the prevention of depression in the elderly
M Berk, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, A Murray, B Kirpach, R Grimm, J McNeil
(2016), Vol. 28, pp. 1741-1748, International Psychogeriatrics, England, C1
D Skvarc, O Dean, L Byrne, L Gray, K Ives, S Lane, M Lewis, C Osborne, R Page, D Stupart, A Turner, M Berk, A Marriott
(2016), Vol. 17, Trials, England, C1
J Conell, R Bauer, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Paredes Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, C Lam, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, P Piotrowski, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O’Donovan, Y Okamura, Y Osher, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, Â Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, I Zorrilla, P Whybrow, M Bauer
(2016), Vol. 4, International Journal of Bipolar Disorders, Germany, C1
The impact of HLA-G 3′ UTR variants and sHLA-G on risk and clinical correlates of schizophrenia
A Rajasekaran, V Shivakumar, S Kalmady, J Narayanaswamy, M Subbana, D Venugopal, A Amaresha, G Venkatasubramanian, M Berk, M Debnath
(2016), Vol. 77, pp. 1166-1171, Human Immunology, United States, C1
S Rossell, P Francis, C Galletly, A Harris, D Siskind, M Berk, K Bozaoglu, F Dark, O Dean, D Liu, D Meyer, E Neill, A Phillipou, J Sarris, D Castle
(2016), Vol. 16, BMC Psychiatry, England, C1
An ISBD perspective on the sociocultural challenges of managing bipolar disorder: A content analysis
C Oedegaard, L Berk, M Berk, S Dilsaver, R Belmaker, K Oedegaard, O Fasmer, I Engebretsen, E Youngstrom
(2016), Vol. 50, pp. 1096-1103, Australian and New Zealand Journal of Psychiatry, England, C1
Shortened telomere length in bipolar disorder: A comparison of the early and late stages of disease
F Barbé-Tuana, M Parisi, B Panizzutti, G Fries, L Grun, F Guma, F Kapczinski, M Berk, C Gama, A Rosa
(2016), Vol. 38, pp. 281-286, Revista Brasileira de Psiquiatria, Brazil, C1
Immuno-psychiatry: An agenda for clinical practice and innovative research
M Leboyer, M Berk, R Yolken, R Tamouza, D Kupfer, L Groc
(2016), Vol. 14, BMC Medicine, England, C1
B Fernandes, J Steiner, M Molendijk, S Dodd, P Nardin, C Gonçalves, F Jacka, C Köhler, C Karmakar, A Carvalho, M Berk
(2016), Vol. 3, pp. 1147-1156, The Lancet Psychiatry, England, C1
A Slyepchenko, M Maes, F Jacka, C Köhler, T Barichello, R McIntyre, M Berk, I Grande, J Foster, E Vieta, A Carvalho
(2016), Vol. 86, pp. 31-46, Psychotherapy and Psychosomatics, Switzerland, C1
P Czarny, D Kwiatkowski, M Toma, P Gałecki, A Orzechowska, K Bobińska, A Bielecka-Kowalska, J Szemraj, M Berk, G Anderson, T Śliwiński
(2016), Vol. 22, pp. 4455-4474, Medical Science Monitor, United States, C1-1
W Luo, D Phung, T Tran, S Gupta, S Rana, C Karmakar, A Shilton, J Yearwood, N Dimitrova, T Ho, S Venkatesh, M Berk
(2016), Vol. 18, Journal of Medical Internet Research, Canada, C1
J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer
(2016), Vol. 11, PLoS ONE, United States, C1
C Köhler, M Maes, A Slyepchenko, M Berk, M Solmi, K Lanctôt, A Carvalho
(2016), Vol. 22, pp. 6152-6166, Current Pharmaceutical Design, United Arab Emirates, C1
A Slyepchenko, M Maes, R Machado-Vieira, G Anderson, M Solmik, Y Sanz, M Berk, C Köhlerp, A Carvalhop
(2016), Vol. 22, pp. 6087-6106, Current Pharmaceutical Design, United Arab Emirates, C1
G Anderson, M Seo, M Berk, A Carvalho, M Maes
(2016), Vol. 22, pp. 6142-6151, Current Pharmaceutical Design, United Arab Emirates, C1
G Morris, M Berk, A Carvalho, J Caso, Y Sanz, M Maes
(2016), Vol. 22, pp. 6058-6075, Current pharmaceutical design, Beijing, China, C1
R Kale, A Kouzani, J Berk, K Walder, M Berk, S Tye
(2016), pp. 1814-1817, EMBC 2016 : Proceedings of the 38th Annual International Conference of the Engineering in Medicine and Biology Society, Orlando, Florida, E1
The use of mixed methods in drug discovery: integrating qualitative methods into clinical trials
M Berk, R Otmar, O Dean, L Berk, E Michalak
(2015), pp. 59-73, Clinical trial design challenges in mood disorders, Amsterdam, The Netherlands, B1
J Kulkarni, E Gavrilidis, Wang, W, R Worsley, P Fitzgerald, C Gurvich, T Van Rheenen, M Berk, H Burger
(2015), Vol. 20, pp. 695-702, Molecular psychiatry, Basingstoke, Eng., C1
M Rapado-Castro, M Berk, K Venugopal, A Bush, S Dodd, O Dean
(2015), Vol. 57, pp. 69-75, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1
S Quirk, R El-Gabalawy, S Brennan, J Bolton, J Sareen, M Berk, A Chanen, J Pasco, L Williams
(2015), Vol. 50, pp. 807-820, Social Psychiatry and Psychiatric Epidemiology, Germany, C1
S Lauder, A Chester, D Castle, S Dodd, E Gliddon, L Berk, J Chamberlain, B Klein, M Gilbert, D Austin, M Berk
(2015), Vol. 171, pp. 13-21, Journal of affective disorders, Amsterdam, The Netherlands, C1
B Fernandes, J Steiner, M Berk, M Molendijk, A Gonzalez-Pinto, C Turck, P Nardin, C Gonçalves
(2015), Vol. 20, pp. 1108-1119, Molecular Psychiatry, London, Eng., C1
J Thompson, M Berk, M O'Donnell, L Stafford, T Nordfjaern
(2015), Vol. 29, pp. 500-508, Clinical rehabilitation, London, Eng., C1
A Hayley, L Williams, K Venugopal, G Kennedy, M Berk, J Pasco
(2015), Vol. 49, pp. 156-170, Australian & New Zealand journal of psychiatry, London, England, C1
Towards a classification of biomarkers of neuropsychiatric disease: From encompass to compass
J Davis, M Maes, A Andreazza, J McGrath, S Tye, M Berk
(2015), Vol. 20, pp. 152-153, Molecular Psychiatry, England, C1
S Nunes, L Piccoli de Melo, M Pizzo de Castro, D Barbosa, H Vargas, M Berk, M Maes
(2015), Vol. 172, pp. 55-62, Journal of affective disorders, Amsterdam, The Netherlands, C1
S Mancuso, V Morgan, P Mitchell, M Berk, A Young, D Castle
(2015), Vol. 172, pp. 30-37, Journal of affective disorders, Amsterdam, The Netherlands, C1
The gut microbiome and diet in psychiatry: focus on depression
S Dash, G Clarke, M Berk, F Jacka
(2015), Vol. 28, pp. 1-6, Current opinion in psychiatry, Philadelphia, Pa., C1
S Aggarwal, S Dodd, M Berk
(2015), Vol. 10, pp. 98-105, Current drug safety, San Francisco, Calif., C1-1
Excessive daytime sleepiness and metabolic syndrome: a cross-sectional study
A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco
(2015), Vol. 64, pp. 244-252, Metabolism, Maryland Heights, MO, C1
STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders.
M Pizzo de Castro, S Vargas Nunes, R Guembarovski, C Ariza, J Oda, H Vargas, L Piccoli de Melo, M Watanabe, M Berk, M Maes
(2015), Vol. 172, pp. 347-354, Journal of Affective Disorders, Amsterdam , Netherlands, C1
Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications.
A Rajasekaran, G Venkatasubramanian, M Berk, M Debnath
(2015), Vol. 48, pp. 10-21, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1
Influence of birth cohort on age of onset cluster analysis in bipolar I disorder
M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsä, F Kapczinski, S Kliwicki, B König, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Hatim Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow
(2015), Vol. 30, pp. 99-105, European psychiatry, Amsterdam, Netherlands, C1
S Aggarwal, M Berk
(2015), Vol. 13, pp. 3-12, Asian journal of psychiatry, Amsterdam, The Netherlands, C1
Fetal programming of schizophrenia: select mechanisms
M Debnath, G Venkatasubramanian, M Berk
(2015), Vol. 49, pp. 90-104, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
G Amminger, A Mechelli, S Rice, S Kim, C Klier, R McNamara, M Berk, P McGorry, M Schäfer
(2015), Vol. 5, pp. e495-e495, Translational Psychiatry, United States, C1
The association between use of antidepressants and bone quality using quantitative heel ultrasound
P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams
(2015), Vol. 49, pp. 437-443, Australian & New Zealand journal of psychiatry, London, Eng., C1
RF rectifiers for EM power harvesting in a deep brain stimulating device
M Hosain, A Kouzani, S Tye, A Kaynak, M Berk
(2015), Vol. 38, pp. 157-172, Australasian physical and engineering sciences in medicine, Berlin, Germany, C1
M Berk, J Tiller, J Zhao, L Yatham, G Malhi, E Weiller
(2015), Vol. 76, pp. 728-734, Journal of clinical psychiatry, Memphis, Tenn., C1
A O'Neil, F Jacka, S Quirk, F Cocker, C Taylor, B Oldenburg, M Berk
(2015), Vol. 15, pp. 15-15, BMC Psychiatry, England, C1
S Moylan, K Gustavson, S Øverland, E Karevold, F Jacka, J Pasco, M Berk
(2015), Vol. 13, pp. 24-24, BMC Medicine, England, C1
S Kim, B Jeong, J Kim, I Shin, M Hwang, G Paul Amminger, B Nelson, M Berk, P McGorry, J Yoon
(2015), Vol. 226, pp. 368-375, Psychiatry research, Shannon, Ireland, C1
N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study
E Prado, M Maes, L Piccoli, M Baracat, D Barbosa, O Franco, S Dodd, M Berk, S Vargas Nunes
(2015), Redox report, Edinburgh, Scotland, C1
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
G Morris, M Berk, K Walder, M Maes
(2015), Vol. 13, pp. 1-23, BMC Medicine, London, Eng., C1
G Murray, N Leitan, M Berk, N Thomas, E Michalak, L Berk, S Johnson, S Jones, T Perich, N Allen, M Kyrios
(2015), Vol. 178, pp. 46-51, Journal of affective disorders, Amsterdam, The Netherlands, C1
J Sarris, C Stough, C Bousman, J Murphy, K Savage, D Smith, R Menon, S Chamoli, G Oliver, M Berk, G Byrne, C Ng, D Mischoulon
(2015), Vol. 2, pp. 49-56, Advances in integrative medicine, Amsterdam, The Netherlands, C1-1
A brief review of exercise, bipolar disorder, and mechanistic pathways.
D Thomson, A Turner, S Lauder, M Gigler, L Berk, A Singh, J Pasco, M Berk, L Sylvia
(2015), Vol. 6, pp. 147-147, Frontiers in Psychology, Switzerland, C1
Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy
E Callaly, K Walder, G Morris, M Maes, M Debnath, M Berk
(2015), Vol. 15, pp. 355-365, Mini-reviews in medicinal chemistry, Amsterdam, The Netherlands, C1
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
G Morris, M Berk
(2015), Vol. 13, pp. 1-25, BMC medicine, London, Eng., C1
C Bortolasci, H Vargas, S Vargas Nunes, L de Melo, M de Castro, E Moreira, S Dodd, D Barbosa, M Berk, M Maes
(2015), Vol. 179, pp. 148-155, Journal of affective disorders, Amsterdam, The Netherlands, C1
Influence of light exposure during early life on the age of onset of bipolar disorder
M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, B Baune, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Wo Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, J Gottlieb, H Harima, S Hassel, C Henry, A Iacovides, E Isometsä, F Kapczinski, S Kliwicki, B König, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, Â Miranda-Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow
(2015), Vol. 64, pp. 1-8, Journal of psychiatric research, Amsterdam, The Netherlands, C1
Instruments that prospectively predict bipolar disorder - a systematic review.
A Ratheesh, M Berk, C Davey, P McGorry, S Cotton
(2015), Vol. 179, pp. 65-73, Journal of affective disorders, Amsterdam, The Netherlands, C1
Psychiatric disorders, psychotropic medication use and falls among women: an observational study
L Williams, J Pasco, A Stuart, F Jacka, S Brennan, A Dobbins, R Honkanen, H Koivumaa-Honkanen, P Rauma, M Berk
(2015), Vol. 15, pp. 1-7, BMC psychiatry, London, Eng., C1
Oxidant/antioxidant imbalance is an inherent feature of depression
M Talarowska, J Szemraj, M Berk, M Maes, P Gałecki
(2015), Vol. 15, pp. 1-7, BMC psychiatry, London, Eng., C1
A Ghanizadeh, A Singh, M Berk, M Torabi-Nami
(2015), Vol. 19, pp. 1-13, Expert opinion on therapeutic targets, Oxford, Eng., C1
R Daglas, M Yücel, S Cotton, K Allott, S Hetrick, M Berk
(2015), Vol. 3, pp. 1-18, International Journal of Bipolar Disorders, Heidelberg, Germany, C1
Tobacco use in bipolar disorder.
D Thomson, M Berk, S Dodd, M Rapado-Castro, S Quirk, P Ellegaard, L Berk, O Dean
(2015), Vol. 13, pp. 1-11, Clinical Psychopharmacology and Neuroscience, Korea (South), C1
G Oliver, O Dean, D Camfield, S Blair-West, C Ng, M Berk, J Sarris
(2015), Vol. 13, pp. 12-24, Clinical psychopharmacology and neuroscience, Korea (South), C1
A Singh, C Bousman, C Ng, K Byron, M Berk
(2015), Vol. 13, pp. 53-61, Clinical psychopharmacology and neuroscience, Korea (South), C1
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
Deepmala, J Slattery, N Kumar, L Delhey, M Berk, O Dean, C Spielholz, R Frye
(2015), Vol. 55, pp. 294-321, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1
N Hyde, S Dodd, K Venugopal, Purdie, M Berk, A O'Neil
(2015), Vol. 10, pp. 125-131, Current drug safety, San Francisco, Calif., C1
B Panizzutti, C Gubert, A Schuh, P Ferrari, G Bristot, G Fries, R Massuda, J Walz, N Rocha, M Berk, A Teixeira, C Gama
(2015), Vol. 182, pp. 64-69, Journal of affective disorders, Amsterdam, The Netherlands, C1
A Ratheesh, S Cotton, J Betts, A Chanen, B Nelson, C Davey, P McGorry, M Berk, A Bechdolf
(2015), Vol. 183, pp. 45-48, Journal of affective disorders, Amsterdam, The Netherlands, C1
P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams
(2015), Vol. 15, pp. 177-185, Journal of Musculoskeletal and Neuronal Interactions, Greece, C1
Mechanisms underlying neurocognitive dysfunctions in recurrent major depression
P Gałecki, M Talarowska, G Anderson, M Berk, M Maes
(2015), Vol. 21, pp. 1535-1547, Medical Science Monitor: international medical journal for clinical and experimental research, Warsaw, Poland, C1
Excessive daytime sleepiness and falls among older men and women: cross-sectional examination of a population-based sample
A Hayley, L Williams, G Kennedy, K Holloway, M Berk, S Brennan-Olsen, J Pasco
(2015), Vol. 15, pp. 74-74, BMC geriatrics, London, Eng., C1
S Dodd, A Schacht, K Kelin, H Dueñas, V Reed, L Williams, F Quirk, G Malhi, M Berk
(2015), Vol. 76, pp. 702-711, Journal of clinical psychology, Weinheim, Germany, C1
Evolution of optogenetic microdevices
R Kale, A Kouzani, K Walder, M Berk, S Tye
(2015), Vol. 2, pp. 1-11, Neurophotonics, Bellingham, W.A., C1
Impact of cannabis use on long-term remission in bipolar I and schizoaffective disorder
S Kim, S Dodd, L Berk, J Kulkarni, A de Castella, P Fitzgerald, J Kim, J Yoon, M Berk
(2015), Vol. 12, pp. 349-355, Psychiatry Investigation, Seoul, Korea (South), C1
Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis
A Carvalho, C Köhler, R McIntyre, C Knöchel, A Brunoni, M Thase, J Quevedo, B Fernandes, M Berk
(2015), Vol. 62, pp. 18-26, Psychoneuroendocrinology, Amsterdam, The Netherlands, C1
J Pasco, L Williams, F Jacka, N Stupka, S Brennan-Olsen, K Holloway, M Berk
(2015), Vol. 13, pp. 351-357, Current Osteoporosis Reports, New York, N.Y., C1
S Smesny, B Milleit, M Schaefer, U Hipler, C Milleit, C Wiegand, J Hesse, C Klier, M Holub, I Holzer, M Berk, P McGorry, H Sauer, G Paul Amminger
(2015), Vol. 101, pp. 15-21, Prostaglandins leukot essent fatty acids, Amsterdam, The Netherlands, C1
M Hosain, A Kouzani, S Tye, M Samad, R Kale, K Bennet, F Manciu, M Berk
(2015), Vol. 37, pp. 1020-1026, Medical engineering and physics, Amsterdam, The Netherlands, C1
J de Souza Gomes, G de Souza, M Berk, L Cavalcante, F de Sousa, J Budni, D de Lucena, J Quevedo, A Carvalho, D Macêdo
(2015), Vol. 25, pp. 2086-2097, European neuropsychopharmacology, Amsterdam, The Netherlands, C1
J Sarris, G Oliver, D Camfield, O Dean, N Dowling, D Smith, J Murphy, R Menon, M Berk, S Blair-West, C Ng
(2015), Vol. 29, pp. 801-809, CNS Drugs, Berlin, Germany, C1
A Hayley, J Skogen, B Sivertsen, B Wold, M Berk, J Pasco, S Øverland
(2015), Vol. 38, pp. 1599-1606, Sleep, Darien, Ill., C1
P Conus, M Berk, S Cotton, L Kader, C Macneil, M Hasty, K Hallam, M Lambert, B Murphy, P McGorry
(2015), Vol. 30, pp. 975-982, European psychiatry, Amsterdam, The Netherlands, C1-1
E Gliddon, S Lauder, L Berk, V Cosgrove, D Grimm, S Dodd, T Suppes, M Berk
(2015), Vol. 15, pp. 1-9, BMC psychiatry, London, Eng., C1
B Fernandes, M Molendijk, C Kohler,, J Soares, C Leite, R Machado-Vieria, T Ribeiro, J Silva, P Sales, J Quevedo, V Oertel-Knochel, E Vieta, A Gonzalez-Pinto, M Berk, A Carvalho
(2015), Vol. 13, pp. 1-22, BMC Medicine, London, Eng., C1
The use of statins for the treatment of depression in patients with acute coronary syndrome
S Kim, K Bae, J Kim, I Shin, Y Hong, Y Ahn, M Jeong, M Berk, J Yoon
(2015), Vol. 5, pp. 1-7, Translational psychiatry, London, Eng., C1-1
Wireless optogenetics: an exploration of portable microdevices for small animal photostimulation
R Kale, A Kouzani, M Berk, K Walder, J Berk, S Tye
(2015), Vol. 20, pp. 225-230, Procedia technology, Amsterdam, The Netherlands, C1
Strengthening the role of convergence science in medicine
Harris Eyre, Malcolm Forbes, Cyrus Raji, Nicholas Cork, Steven Durning, Elizabeth Armstrong, Erica Wheeler, Arlen Meyers, Bernhard Baune, Michael Berk
(2015), Vol. 1, Convergement science physical oncology, Bristol, Eng., C1
Neuroprogression and Staging in Bipolar Disorder
F Kapczinski, E Vieta, P Magalhães, M Berk
(2015), Oxford, Eng., A7-1
Investigating the predictive validity of an emergency department mental health triage tool
N Sands, S Elsom, M Berk, J Hosking, R Prematunga, M Gerdtz
(2014), Vol. 16, pp. 11-18, Nursing and health sciences, Milton, Qld., C1
G Anderson, M Berk, M Maes
(2014), Vol. 129, pp. 83-97, Acta Psychiatrica Scandinavica, London, UK, C1
A O’Neil, M Berk, K Venugopal, S Kim, L Williams, F Jacka
(2014), Vol. 36, pp. 266-270, General Hospital Psychiatry, Amsterdam, The Netherlands, C1
G Anderson, M Berk, O Dean, S Moylan, M Maes
(2014), Vol. 28, CNS Drugs, Aukland, New Zealand, C1
A Walker, Y Kim, J Price, R Kale, J McGillivray, M Berk, S Tye
(2014), Vol. 5, Frontiers in psychiatry, Lausanne, Switzerland, C1-1
H Vargas, S Vargas Nunes, D Barbosa, M Vargas, A Cestari, S Dodd, K Venugopal, M Maes, M Berk
(2014), Vol. 102, pp. 65-71, Life sciences, Amsterdam, The Netherlands, C1
Prevalence of excessive daytime sleepiness in a sample of the Australian adult population
A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco
(2014), Vol. 15, pp. 348-354, Sleep medicine, Amsterdam, The Netherlands, C1
T Tran, W Luo, D Phung, R Harvey, M Berk, R Kennedy, S Venkatesh
(2014), Vol. 14, pp. 1-9, BMC psychiatry, London, Eng., C1
Systematic review of N-acetylcysteine in the treatment of addictions
E Asevedo, A Mendes, M Berk, E Brietzke
(2014), Vol. 36, pp. 168-175, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?
M Maes, G Anderson, M Kubera, M Berk
(2014), Vol. 18, pp. 495-512, Expert opinion on therapeutic targets, London, England, C1
M Berk, O Dean, S Cotton, S Jeavons, M Tanious, K Kohlmann, K Hewitt, K Moss, C Allwang, I Schapkaitz, J Robbins, H Cobb, F Ng, S Dodd, A Bush, G Malhi
(2014), Vol. 75, pp. 628-636, Journal of clinical psychiatry, Memphis, Tenn., C1
C Bortolasci, H Odebrecht Vargas, A Souza-Nogueira, D Barbosa, E Moreira, S Obedrecht Vargas Nunes, M Berk, S Dodd, M Maes
(2014), Vol. 159, pp. 23-30, Journal of affective disorders, Amsterdam, The Netherlands, C1
J Kulkarni, M Berk, W Wang, L Mu, E Scarr, T Van Rheenen, R Worsely, C Gurvich, E Gavrilidis, A de Castella, P Fitzgerald, S David
(2014), Vol. 43, pp. 52-61, Psychoneuroendocrinology, Oxford, England, C1
J Davis, S Moylan, B Harvey, M Maes, M Berk
(2014), Vol. 48, pp. 512-529, Australian and New Zealand journal of psychiatry, London, England, C1
Oxidative & nitrosative stress in depression: why so much stress?
S Moylan, M Berk, O Dean, Y Samuni, L Williams, A O'Neil, A Hayley, J Pasco, G Anderson, F Jacka, M Maes
(2014), Vol. 45, pp. 46-62, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
Predominant polarity as a course specifier for bipolar disorder: a systematic review
A Carvalho, R McIntyre, D Dimelis, X Gonda, M Berk, P Nunes-Neto, D Cha, T Hyphantis, J Angst, K Fountoulakis
(2014), Vol. 163, pp. 56-64, Journal of affective disorders, Amsterdam, The Netherlands, C1
M Bauer, T Glenn, M Alda, O Andreasssen, E Angelopoulos, R Ardua, C Baethge, R Bauer, F Belliver, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagionlini, M Frye, K Fountoulaski, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsa, F Kapczinski, S Kliwicki, B Konig, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow
(2014), Vol. 167, pp. 104-111, Journal of affective disorders, Amsterdam, The Netherlands, C1
T Deckersbach, A Peters, L Sylvia, A Urdahl, P Magalhaes, M Otto, E Frank, D Miklowitz, M Berk, G Kinryn, A Nierenberg
(2014), Vol. 171, pp. 178-186, American journal of psychiatry, Arlington, VA, C1
Suicidal ideation and physical illness: Does the link lie with depression?
L Sanna, A Stuart, J Pasco, M Kotowicz, M Berk, P Girardi, L Williams
(2014), Vol. 152-154, pp. 422-426, Journal of affective disorders, Amsterdam, The Netherlands, C1
The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)
G Morris, M Berk, P Galacki, M Maes
(2014), Vol. 49, pp. 741-756, Molecular neurobiology, New York, N. Y., C1
S Kim, L Berk, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, G Amminger, M Berk
(2014), Vol. 166, pp. 243-248, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Lifestyle medicine for depression
J Sarris, A O'Neil, C Coulson, I Schwitzer, M Berk
(2014), Vol. 14, pp. 1-13, BMC Psychiatry, London, England, C1
Comparison of self-report and structured clinical interview in the identification of depression
A Stuart, J Pasco, F Jacka, S Brennan, M Berk, L Williams
(2014), Vol. 55, pp. 866-869, Comphrensive psychiatry, Amsterdam, The Netherlands, C1
Attributions of responsibility and recovery within a no-fault insurance compensation system
J Thompson, M Berk, M O'Donnell, L Stafford, T Nordfjaern
(2014), Vol. 59, pp. 247-255, Rehabilitation psychology, Washington DC, C1
G Malhi, D Bargh, C Coulston, P Das, M Berk
(2014), Vol. 16, pp. 455-470, Bipolar disorders, Copenhagen, Denmark, C1
O Dean, A Turner, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, Y Samuni, M Tanious, N Dowling, A Waterdrinker, D Smith, M Berk
(2014), Vol. 0, pp. 1-10, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1
Assessing regional cerebral blood flow in depression using 320-slice computed tomography
Y Wang, H Zhang, S Tang, X Liu, A O'Neil, A Turner, F Chai, F Chen, M Berk
(2014), Vol. 9, pp. 1-10, PLoS One, San Francisco, Cal., C1
Adipokines as emerging depression biomarkers: a systematic review and meta-analysis
A Carvalho, D Rocha, R McIntyre, L Mesquita, C Köhler, T Hyphantis, P Sales, R Machado-Vieira, M Berk
(2014), Vol. 59, pp. 28-37, Journal of psychiatric research, Oxford, England, C1
Relationship between diet and mental health in children and adolescents: a systematic review
A O'Neil, S Quirk, S Housden, S Brennan, L Williams, J Pasco, M Berk, F Jacka
(2014), Vol. 104, pp. e31-e42, American journal of public health, Washington, DC, C1
C Bortolasci, M Maes, H Vargas, A Souza-Nogueira, E Moreira, S Nunes, M Berk, S Dodd, D Barbosa
(2014), Vol. 581, pp. 46-51, Neuroscience letters, Shannon, Ireland, C1
The impact of insight in a first-episode mania with psychosis population on outcome at 18 months
L Smith, C Shelton, M Berk, M Hasty, S Cotton, L Henry, R Daglas, E Gentle, P McGorry, C Macneil, P Conus
(2014), Vol. 167, pp. 74-79, Journal of affective disorders, Amsterdam, The Netherlands, C1
S Kim, M Schäfer, C Klier, M Berk, S Rice, K Allott, C Bartholomeusz, S Whittle, E Pilioussis, C Pantelis, P McGorry, G Amminger
(2014), Vol. 158, pp. 39-44, Schizophrenia Research, Amsterdam, The Netherlands, C1
S Dodd, M Berk, K Kelin, Q Zhang, E Eriksson, W Deberdt, J Craig Nelson
(2014), Vol. 168, pp. 284-293, Journal of affective disorders, Amsterdam, The Netherlands, C1
M Berk, L Williams, A Andreazza, J Pasco, S Dodd, F Jacka, S Moylan, E Reiner, P Magalhaes
(2014), Vol. 4, pp. 1-9, BMJ Open, London, England, C1
A Ghanizadeh, Z Rezaee, S Dehbozorgi, M Berk, S Akhondzadeh
(2014), Vol. 219, pp. 431-435, Psychiatry Research, Ireland, C1
Data Integration Protocol In Ten-steps (DIPIT) : a new standard for medical researchers
J Dipnall, M Berk, F Jacka, L Williams, S Dodd, J Pasco
(2014), Vol. 69, pp. 237-246, Methods, Amsterdam, The Netherlands, C1
M Pizzo de Castro, M Maes, R Guembarovski, C Ariza, E Reiche, H Vargas, M Vargas, L de Melo, S Dodd, M Berk, M Watanabe, S Nunes
(2014), Vol. 15, pp. 1-9, BMC Genetics, London, England, C1
Quality of life in bipolar and schizoaffective disorder - a naturalistic approach.
M Martin-Subero, L Berk, S Dodd, V Kamalesh, M Maes, J Kulkarni, A De Castella, P Fitzgerald, M Berk
(2014), Vol. 55, pp. 1540-1545, Comprehensive Psychiatry, Malden, Mass., C1
Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.
M Debnath, M Berk
(2014), Vol. 40, pp. 1412-1421, Schizophrenia Bulletin, Oxford , England, C1
S Odebrecht Vargas Nunes, M Pizzo de Castro, M Ehara Watanabe, R Losi Guembarovski, H Odebrecht Vargas, E Reiche, H Kaminami Morimoto, S Dodd, M Berk
(2014), Vol. 24, pp. 87-93, Psychiatric genetics, Philadelphia, PA, C1
Stage managing bipolar disorder.
M Berk, L Berk, S Dodd, S Cotton, C Macneil, R Daglas, P Conus, A Bechdolf, S Moylan, G Malhi
(2014), Vol. 16, pp. 471-477, Bipolar Disorders, Malden, Mass., C1
A Carvalho, M Berk, T Hyphantis, R McIntyre
(2014), Vol. 83, pp. 70-88, Psychotherapy and psychosomatics, Basel, Switzerland, C1
A Ghanizadeh, A Sahraeizadeh, M Berk
(2014), Vol. 45, pp. 185-192, Child Psychiatry & Human Development, New York, NY, C1
A Bechdolf, A Rateesh, S Cotton, B Nelson, A Chanen, J Betts, T Bingmann, A Yung, M Berk, P McGorry
(2014), Vol. 16, pp. 493-504, Bipolar Disorders: an international journal of psychiatry and neurosciences, London, Eng., C1
Atypical antipsychotic agents; peas in a pod or chalk and cheese?
A Singh, A Nierenberg, L Yatham, M Berk
(2014), Vol. 12, pp. 1-4, BMC Medicine, London, England, C1
F Kapczinski, P Magalhães, V Balanzá-Martinez, V Dias, S Frangou, C Gama, A Gonzalez-Pinto, I Grande, K Ha, M Kauer-Sant'Anna, M Kunz, R Kupka, M Leboyer, C Lopez-Jaramillo, R Post, J Rybakowski, J Scott, S Strejilevitch, M Tohen, G Vazquez, L Yatham, E Vieta, M Berk
(2014), Vol. 130, pp. 354-363, Acta Psychiatrica Scandinavica, Malden, United States, C1
The Glutathione System: a new drug target in neuroimmune disorders
G Morris, G Anderson, O Dean, M Berk, P Galecki, M Martin-Subero, M Maes
(2014), Vol. 50, pp. 1059-1084, Molecular neurobiology, New York, N. Y., C1
Excessive daytime sleepiness and body composition: a population-based study of adults
A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco
(2014), Vol. 9, pp. 1-8, PLoS One, San Francisco, CA, C1
J Thompson, M O'Donnell, L Stafford, T Nordfjaern, M Berk
(2014), Vol. 59, pp. 376-385, Rehabilitation Psychology, Washington, D.C., United States, C1
S Sarró, M Madre, P Fernández-Corcuera, M Valentí, J Goikolea, E Pomarol-Clotet, M Berk, B Amann
(2014), Vol. 172, pp. 110-115, Journal of Affective Disorders, Amsterdam , Netherlands, C1
A Peters, L Sylvia, P Da Silva Magalhães, D Miklowitz, E Frank, M Otto, N Hansen, D Dougherty, M Berk, A Nierenberg, T Deckersbach
(2014), Vol. 44, pp. 3455-3467, Psychological medicine, Cambridge, Eng., C1
Affective and content analysis of online depression communities
T Nguyen, D Phung, B Dao, S Venkatesh, M Berk
(2014), Vol. 5, pp. 217-226, IEEE Transactions on Affective Computing, Piscataway, N.J, C1
Association between alcohol consumption and self-reported depression among elderly Australian men
C Coulson, L Williams, M Berk, D Lubman, S Quirk, J Pasco
(2014), Vol. 2, pp. 3-8, Geriatric Mental Health Care, Amsterdam, The Netherlands, C1
Biomarkers and clinical staging in psychiatry
P McGorry, M Keshavan, S Goldstone, P Amminger, K Allott, M Berk, S Lavoie, C Pantelis, A Yung, S Wood, I Hickie
(2014), Vol. 13, pp. 211-223, World psychiatry, Oxford, England, C1
C Bortolasci, H Vargas, A Souza-Nogueira, E Gastaldello Moreira, S Vargas Nunes, M Berk, S Dodd, D Barbosa, M Maes
(2014), Vol. 19, pp. 232-241, Redox report, Leeds, England, C1
C Davey, A Chanen, S Cotton, S Hetrick, M Kerr, M Berk, O Dean, K Yuen, M Phelan, A Ratheesh, M Schäfer, G Amminger, A Parker, D Piskulic, S Harrigan, A Mackinnon, B Harrison, P McGorry
(2014), Vol. 15, pp. 1-9, Trials, London, Eng., C1
R Daglas, P Conus, S Cotton, C Macneil, M Hasty, L Kader, M Berk, K Hallam
(2014), Vol. 48, pp. 1017-1024, Australian and New Zealand journal of psychiatry, London, Eng., C1-1
N Leitan, E Michalak, L Berk, M Berk, G Murray
(2014), pp. 1-13, Bipolar Disorders, Malden, United States, C1
Ö Aydemir, Z Çubukçuoğlu, S Erdin, C Taş, E Onur, M Berk
(2014), Vol. 36, pp. 293-297, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1-1
Statin use and risk of depression: a Swedish national cohort study
C Redlich, M Berk, L Williams, J Sundquist, K Sundquist, X Li
(2014), Vol. 14, pp. 1-9, BMC Psychiatry, London, Eng., C1
Y Wang, H Zhang, F Chai, X Liu, M Berk
(2014), Vol. 14, pp. 1-7, BMC Psychiatry, London, England, C1
Cognitive dysfunction in depression - pathophysiology and novel targets
A Carvalho, K Miskowiak, T Hyphantis, C Kohler, G Alves, B Bortolato, P Sales, R Machado-Vieira, M Berk, R McIntyre
(2014), Vol. 13, pp. 1-17, CNS & Neurological Disorders - Drug Targets, Bussum, Netherlands, C1
S Vargas Nunes, M Pizzo de Castro, E Moreira, R Guembarovski, D Barbosa, H Vargas, L Piccoli de Melo, C Bortolasci, M Watanabe, S Dodd, M Berk, M Maes
(2014), Vol. 585C, pp. 132-137, Neuroscience letters, Shannon, Ireland, C1
M Maes, J Leunis, M Geffard, M Berk
(2014), Vol. 35, pp. 445-453, Neuroendocrinology Letters, Sweden, C1
The association between dietary patterns, diabetes and depression.
J Dipnall, J Pasco, D Meyer, M Berk, L Williams, S Dodd, F Jacka
(2014), Vol. 174, pp. 215-224, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
Treatment implications of predominant polarity and the polarity index: a comprehensive review.
A Carvalho, J Quevedo, R McIntyre, M Soeiro-de-Souza, K Fountoulakis, M Berk, T Hyphantis, E Vieta
(2014), Vol. 18, International Journal of Neuropsychopharmacology, England, C1
e-Mental health for mood and anxiety disorders in general practice
J Orman, B O'Dea, F Shand, M Berk, J Proudfoot, H Christensen
(2014), Vol. 43, pp. 832-837, Australian family physician, Melbourne, Vic., C1
Construct validity of the Experiences of Therapy Questionnaire (ETQ)
G Parker, A Paterson, K Fletcher, G McClure, M Berk
(2014), Vol. 14, pp. 1-6, BMC psychiatry, London, England, C1-1
O Dean, M Maes, M Ashton, L Berk, B Kanchanatawan, A Sughondhabirom, S Tangwongchai, C Ng, N Dowling, G Malhi, M Berk
(2014), Vol. 12, pp. 180-188, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1
M Hosain, A Kouzani, S Tye, O Abulseoud, A Amiet, A Galehdar, A Kaynak, M Berk
(2014), Vol. 2, pp. 1-13, IEEE journal of translational engineering in health and medicine, Piscataway, N.J., C1
The Association Between Use of Antidepressants and Bone Quality Using Quantitative Ultrasound.
Paivi Rauma, Julie Pasco, Michael Berk, Amanda Stuart, Risto Honkanen, Heli Koivumaa-Honkanen, Jason Hodge, Lana Williams
(2014), Vol. 29, pp. S462-S462, JOURNAL OF BONE AND MINERAL RESEARCH, Houston, TX, C1-1
Age of onset, course of illness, and response to psychotherapy for bipolar depression
A Peters, L Sylvia, P Magalhaes, D Miklowitz, E Frank, M Otto, M Berk, A Nierenberg, T Deckersbach
(2014), Vol. 16, pp. 44-44, ISBD 2014 : Proceedings of the 16th Annual Conference of the International Society for Bipolar Disorders, Seoul, South Korea, E1-1
High-impact child abuse may predict risk of elevated suicidality during antidepressant initiation
A Singh, C Bousman, C Ng, M Berk
(2014), Vol. 48, pp. 124-124, RANZCP 2014 : Evolving landscapes in mental health: interface & interaction : Proceedings of Congress 2014, Perth, W.A., E1-1
S Kim, M Schäfer, C Klier, M Berk, S Rice, K Allot, C Bartholomeusz, S Whittle, E Pilioussis, C Pantelis, P McGorry, G Amminger
(2014), Vol. 8, pp. 166-166, IEPA 2014 : To the new horizon : Proceedings of the 9th International Conference on Early Psychosis, Tokyo, Japan, E1-1
S Moylan, M Maes, N Wray, M Berk
(2013), Vol. 18, pp. 595-606, Molecular psychiatry, London, England, C1
Development of an online intervention for bipolar disorder. www.moodswings.net.au
S Lauder, A Chester, D Castle, S Dodd, L Berk, B Klein, D Austin, M Gilbert, J Chamberlain, G Murray, C White, L Piterman, M Berk
(2013), Vol. 18, pp. 155-165, Psychology, health and medicine, Oxon, England, C1
The sick role, illness cognitions and outcomes in bipolar disorder
M Berk, L Berk, S Dodd, P Fitzgerald, A de Castella, S Filia, K Filia, A Brnabic, K Kelin, W Montgomery, J Kulkarni, L Stafford
(2013), Vol. 146, pp. 146-149, Journal of affective disorders, Amsterdam, Netherlands, C1
S Nunes, M de Castro, H Vargasa, M Vargas, I de Batista Fonseca, S Dodd, M Berk
(2013), Vol. 12, pp. 158-165, Addictive disorders & their treatment, Philadelphia, PA, C1
Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women
F Jacka, J Pasco, L Williams, B Meyer, R Digger, M Berk
(2013), Vol. 109, pp. 2059-2066, British journal of nutrition, Cambridge, England, C1
A Ghanizadeh, M Berk, H Farrashbandi, A Alavi shoushtari, K Villagonzalo
(2013), Vol. 13, pp. 515-519, Mitochondrion, Amsterdam, The Netherlands, C1
Diet quality and mental health problems in adolescents from East London : a prospective study
F Jacka, C Rothon, S Taylor, M Berk, S Stansfeld
(2013), Vol. 48, pp. 1297-1306, Social psychiatry and psychiatric epidemiology, Heidelberg, Germany, C1
The nocebo effect : a clinicians guide
J Data-Franco, M Berk
(2013), Vol. 47, pp. 617-623, Australian and New Zealand journal of psychiatry, London, England, C1
L Williams, J Pasco, F Jacka, J Hodge, M Kotowicz, M Berk
(2013), Vol. 146, pp. 395-400, Journal of affective disorders, Amsterdam, The Netherlands, C1
Putative neuroprotective agents in neuropsychiatric disorders
S Dodd, M Maes, G Anderson, O Dean, S Moylan, M Berk
(2013), Vol. 42, pp. 135-145, Progress in neuro-psychopharmacology and biological psychiatry, United States, C1
Neurocognitive functioning in the prodrome of mania - an exploratory study
A Ratheesh, A Lin, B Nelson, S Wood, W Brewer, J Betts, M Berk, P McGorry, A Yung, A Bechdolf
(2013), Vol. 147, pp. 441-445, Journal of affective disorders, Amsterdam, The Netherlands, C1
J Hodge, Y Wang, M Berk, F Collier, T Fernandes, M Constable, J Pasco, S Dodd, G Nicholson, R Kennedy, L Williams
(2013), Vol. 74, pp. 32-39, Biological psychiatry, Amsterdam, The Netherlands, C1
G Anderson, M Maes, M Berk
(2013), Vol. 42, pp. 101-114, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1
M Moller, J Du Preez, F Viljoen, M Berk, R Emsley, B Harvey
(2013), Vol. 30, pp. 156-167, Brain, behavior, and immunity, Marylands Heights, Mo., C1
M Maes, M Kubera, I Mihaylova, M Geffard, P Galecki, J Leunis, M Berk
(2013), Vol. 149, pp. 23-29, Journal of affective disorders, Amsterdam, Netherlands, C1
G Parker, K Fletcher, M Berk, A Paterson
(2013), Vol. 206, pp. 293-301, Psychiatry research, Shannon, Ireland, C1-1
A Walker, S Burnett, K Hasebe, J McGillivray, L Gray, S McGee, K Walder, M Berk, S Tye
(2013), Vol. 242, pp. 76-83, Behavioural brain research, Amsterdam, The Netherlands, C1
A Ghanizadeh, R Freeman, M Berk
(2013), Vol. 8, pp. 2-8, Reviews on recent clinical trials, Bussum, The Netherlands, C1
The promise of N-acetylcysteine in neuropsychiatry
M Berk, G Malhi, L Gray, O Dean
(2013), Vol. 34, pp. 167-177, Trends in pharmacological sciences, Oxford, England, C1
P Das, M Tanious, K Fritz, S Dodd, O Dean, M Berk, G Malhi
(2013), Vol. 47, pp. 347-354, Australian and New Zealand journal of psychiatry, London, England, C1
B Frey, A Andreazza, J Houenou, S Jamain, B Goldstein, M Frye, M Leboyer, M Berk, G Malhi, C Lopez-Jaramillo, V Taylor, S Dodd, S Frangou, G Hall, B Fernandes, M Kauer-Sant'Anna, L Yatham, F Kapczinski, L Young
(2013), Vol. 47, pp. 321-332, Australian and New Zealand journal of psychiatry, London, England, C1-1
Lifestyle management of unipolar depression
M Berk, J Sarris, C Coulson, F Jacka
(2013), Vol. 127, pp. 38-54, Acta psychiatrica scandinavica, Malden, Mass., C1-1
A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania
P Vieira da Silva Magalhaes, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2013), Vol. 47, pp. 564-568, Australian and New Zealand journal of psychiatry, London, England, C1
Differences between first episode schizophrenia and schizoaffective disorder
S Cotton, M Lambert, B Schimmelmann, A MacKinnon, J Gleeson, M Berk, L Hides, A Chanen, J Scott, D Schottle, P McGorry, P Conus
(2013), Vol. 147, pp. 169-174, Schizophrenia research, Amsterdam, The Netherlands, C1
Pharmacological management of unipolar depression
G Malhi, R Hitching, M Berk, P Boyce, R Porter, K Fritz
(2013), Vol. 127, pp. 6-23, Acta psychiatrica scandinavica, Malden, Mass., C1
The relationship between excessive daytime sleepiness and depressive and anxiety disorders in women
A Hayley, L Williams, M Berk, G Kennedy, F Jacka, J Pasco
(2013), Vol. 47, pp. 772-778, Australian and New Zealand journal of psychiatry, London, England, C1
Physical comorbidities in men with mood and anxiety disorders: a population-based study
L Sanna, A Stuart, J Pasco, M Kotowicz, M Berk, P Girardi, S Brennan, L Williams
(2013), Vol. 11, pp. 1-9, BMC medicine, London, England, C1
J Strange, L Sylvia, P Vieira da Silva Magalhaes, D Miklowitz, M Otto, E Frank, M Berk, A Nierenberg, T Deckersbach
(2013), Vol. 74, pp. 249-255, Journal of clinical psychiatry, Memphis, Tenn., C1
Gender differences in first episode psychotic mania
S Cotton, M Lambert, M Berk, B Schimmelmann, F Butselaar, P McGorry, P Conus
(2013), Vol. 13, pp. 1-8, BMC psychiatry, London, England, C1
Aspirin : a review of its neurobiological properties and therapeutic potential for mental illness
M Berk, O Dean, H Drexhage, J McNeil, S Moylan, A O'Neil, C Davey, L Sanna, M Maes
(2013), Vol. 11, pp. 1-17, BMC medicine, London, England, C1
S Moylan, F Jacka, J Pasco, M Berk
(2013), Vol. 3, pp. 302-326, Brain and behavior, London, England, C1
Y Wang, X Liu, D Zhang, J Chen, S Liu, M Berk
(2013), Vol. 11, pp. 1-9, BMC medicine, London, England, C1
T Nordfjaern, O Bjerkeset, G Bratberg, S Moylan, M Berk, R Grawe
(2013), Vol. 68, pp. 107-116, Nordic journal of psychiatry, Oslo, Norway, C1
S Moylan, K Gustavson, E Karevold, S Overland, F Jacka, J Pasco, M Berk
(2013), Vol. 8, PLoS one, San Francisco, Calif., C1
Psychomotor depressive symptoms may differentially respond to venlafaxine
A Singh, C Bousman, C Ng, K Byron, M Berk
(2013), Vol. 28, pp. 121-126, International clinical psychopharmacology, Philadelphia, Pa., C1
S Moylan, H Eyre, M Maes, B Baune, F Jacka, M Berk
(2013), Vol. 37, pp. 573-584, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
Oxidative stress and inflammatory markers are associated with depression and nicotine dependence
H Vargas, S Nunes, M de Castro, M Vargas, D Barbosa, C Bortolasci, K Venugopal, S Dodd, M Berk
(2013), Vol. 544, pp. 136-140, Neuroscience letters, Amsterdam, The Netherlands, C1
A O'Neil, M Berk, C Itsiopoulos, D Castle, R Opie, J Pizzinga, L Brazionis, A Hodge, C Mihalopoulos, M Chatterton, O Dean, F Jacka
(2013), Vol. 13, pp. 1-7, BMC psychiatry, London, England, C1
Obesity and the relationship with positive and negative affect
J Pasco, L Williams, F Jacka, S Brennan, M Berk
(2013), Vol. 47, pp. 477-482, Australian & New Zealand journal of psychiatry, London, England, C1
S Smesny, B Milleit, U Hipler, C Milleit, M Schafer, C Klier, C Holub, I Holzer, G Berger, M Otto, I Nenadic, M Berk, P McGorry, H Sauer, G Amminger
(2013), Vol. 19, pp. 317-324, Molecular psychiatry, London, England, C1
F Jacka, N Reavley, A Jorm, J Toumbourou, A Lewis, M Berk
(2013), Vol. 47, pp. 920-929, Australian & New Zealand journal of psychiatry, London, England, C1
The association between diet quality, dietary patterns and depression in adults: a systematic review
S Quirk, L Williams, A O'Neil, J Pasco, F Jacka, S Housden, M Berk, S Brennan
(2013), Vol. 13, pp. 1-22, BMC psychiatry, London, England, C1
The chemistry and biological activities of N-acetylcysteine
Y Samuni, S Goldstein, O Dean, M Berk
(2013), Vol. 1830, pp. 4117-4129, Biochim biophys acta, Amsterdam, Netherlands, C1
S Brennan, L Williams, M Berk, J Pasco
(2013), Vol. 37, pp. 226-232, Australian and New Zealand journal of public health, Chichester, England, C1-1
Alcohol consumption and body composition in a population-based sample of elderly Australian men
C Coulson, L Williams, S Brennan, M Berk, M Kotowicz, D Lubman, J Pasco
(2013), Vol. 25, pp. 183-192, Aging clinical and experimental research, Cham, Switzerland, C1
H Vargas, S Vargas Nunes, M de Castro, C Bortolasci, D Barbosa, H Morimoto, K Venugopal, S Dodd, M Maes, M Berk
(2013), Vol. 150, pp. 923-930, Journal of affective disorders, Amsterdam, The Netherlands, C1
S Dodd, M Berk, K Kelin, M Mancini, A Schacht
(2013), Vol. 150, pp. 344-349, Journal of affective disorders, Amsterdam, The Netherlands, C1
L Sanna, A Stuart, M Berk, J Pasco, P Girardi, L Williams
(2013), Vol. 13, pp. 1-6, BMC psychiatry, London, England, C1
G Morris, G Anderson, P Galecki, M Berk, M Maes
(2013), Vol. 11, pp. 1-19, BMC medicine, London, England, C1-1
DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions
C Nemeroff, D Weinberger, M Rutter, H MacMillan, R Bryant, S Wessely, D Stein, C Pariante, F Seemuller, M Berk, G Malhi, M Preisig, M Brune, P Lysaker
(2013), Vol. 11, pp. 202-220, BMC medicine, London, England, C1
M Moller, J Du Preez, F Viljoen, M Berk, B Harvey
(2013), Vol. 28, pp. 687-696, Metabolic brain disease, New York, N. Y., C1
A Ghanizadeh, M Berk
(2013), Vol. 3, pp. 1-6, Medical gas research, London, England, C1
Clock face drawing test performance in children with ADHD
A Ghanizadeh, S Safavi, M Berk
(2013), Vol. 4, pp. 50-56, Basic and clinical neuroscience, Tehran, Iran, C1
T Nordfjaern, O Bjerkeset, S Moylan, M Berk, R Grawe
(2013), Vol. 38, pp. 2575-2580, Addictive behaviors, Amsterdam, The Netherlands, C1
Altered cardiac autonomic nervous function in depression
Y Wang, X Zhao, A O'Neil, A Turner, X Liu, M Berk
(2013), Vol. 13, pp. 1-7, BMC psychiatry, London, England, C1
Cardiac-self efficacy predicts adverse outcomes in coronary artery disease (CAD) patients
A O'Neil, M Berk, J Davis, L Stafford
(2013), Vol. 5, pp. 6-14, Health, London, England, C1
R McIntyre, M Tohen, M Berk, J Zhao, E Weiller
(2013), Vol. 150, pp. 378-383, Journal of affective disorders, Amsterdam, The Netherlands, C1
S Nunes, H Vargas, E Prado, D Barbosa, L Picoli de Melo, S Moylan, S Dodd, M Berk
(2013), Vol. 37, pp. 1336-1345, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
A low power micro deep brain stimulation device for murine preclinical research
A Kouzani, O Abulseoud, S Tye, M Hosain, M Berk
(2013), Vol. 1, pp. 1-9, IEEE journal of translational engineering in health and medicine, Piscataway, N.J., C1
I Pacchiarotti, D Bond, R Baldessarini, W Nolen, H Grunze, R Licht, R Post, M Berk, G Goodwin, G Sachs, L Tondo, R Findling, E Youngstrom, M Tohen, J Undurraga, A Gonzalez-Pinto, J Goldberg, A Yildiz, L Altshuler, J Calabrese, P Mitchell, M Thase, A Koukopoulos, F Colom, M Frye, G Malhi, K Fountoulaskis, G Vazquez, R Perlis, T Ketter, F Cassidy, H Akiskal, J Azorin, M Valenti, D Mazzei, B Lafer, T Kato, L Mazzarini, A Martinez-Aran, G Parker, D Souery, A Ozerdem, S McElroy, P Girardi, M Bauer, L Yatham, C Zarate, A Nierenberg, B Birmaher, S Kanba, R El-Mallakh, A Serretti, Z Rihmer, A Young, G Kotzalidis, G MacQueen, C Bowden, S Ghaemi, C Lopez-Jaramillo, J Rybakowski, H Kyooseob, G Perugi, S Kasper, J Amsterdam, R Hirschfeld, F Kapczinski, E Vieta
(2013), Vol. 170, pp. 1-14, American journal of psychiatry, Arlington, Virginia, C1
F Jacka, E Ystrom, A Brantsaeter, E Karevold, C Roth, M Haugen, H Meltzer, S Schjolberg, M Berk
(2013), Vol. 52, pp. 1038-1047, Journal of the American academy of child & pdolescent psychiatry, Amsterdam, The Netherlands, C1
Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs
F Giorlando, J Teister, S Dodd, M Udina, M Berk
(2013), Vol. 8, pp. 175-180, Current drug safety, Bussum, The Netherlands, C1
Emerging pharmacotherapy for cancer patients with cognitive dysfunction
J Davis, F Ahlberg, M Berk, D Ashley, M Khasraw
(2013), Vol. 13, BMC neurology, London, England, C1
A Ghanizadeh, N Derakhshan, M Berk
(2013), Vol. 12, pp. 1-6, Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, Bussum, Netherlands, C1
Antidepressant pharmacogenetics
A Singh, C Bousman, C Ng, M Berk
(2013), Vol. 27, pp. 43-51, Current Opinion in Psychiatry, Philadelphia, PA, C1
So depression is an inflammatory disease, but where does the inflammation come from?
M Berk, L Williams, F Jacka, A O'Neil, J Pasco, S Moylan, N Allen, A Stuart, A Hayley, M Byne, M Maes
(2013), Vol. 11, pp. 1-16, BMC medicine, London, UK, C1-1
Atopic disorders and depression: Findings from a large, population-based study
L Sanna, A Stuart, J Pasco, F Jacka, M Berk, M Maes, A O'Neil, P Girardi, L Williams
(2013), Vol. 155, pp. 261-265, Journal of Affective Disorders, Amsterdam, Netherlands, C1
Depression following fracture in women: a study of age-matched cohorts
L Williams, M Berk, M Henry, A Stuart, S Brennan, F Jacka, J Pasco
(2013), Vol. 4, BMJ open, London, England, C1
M Bauer, A Pfennig, E Severus, P Whybrow, J Angst, H Moller, M Berk
(2013), Vol. 14, pp. 334-385, World journal of biological psychiatry, London, England, C1-1
Potential mechanisms of action of lithium in bipolar disorder : current understanding
G Malhi, M Tanious, P Das, C Coulston, M Berk
(2013), Vol. 27, pp. 135-153, CNS drugs, Auckland, New Zealand, C1-1
L Berk, M Berk, S Dodd, C Kelly, S Cvetkovski, A Jorm
(2013), Vol. 11, pp. 1-13, BMC medicine, London, Eng., C1-1
To a broader concept of remission: rating the health-related quality of life in bipolar disorder
M Subero, L Berk, S Dodd, J Kulkarni, A De Castella, P Fitzgerald, M Berk
(2013), Vol. 150, pp. 673-676, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
High impact child abuse may predict risk of elevated suicidality during antidepressant initiation
A Singh, C Bousman, C Ng, M Berk
(2013), Vol. 47, pp. 1191-1195, Australian & New Zealand journal of psychiatry, London, Eng., C1-1
J Nelson, Q Zhang, K Kelin, E Eriksson, W Deberdt, M Berk
(2013), Vol. 29, pp. 827-833, Current medical research and opinion, London, Eng., C1-1
G Anderson, M Kubera, W Duda, W Lasoñz, M Berk, M Maes
(2013), Vol. 65, pp. 1647-1654, Pharmacological Reports, Switzerland, C1-1
D Castle, L Piterman, M Berk
(2013), Vol. 199, pp. S4-S5, The medical journal of australia, Australia, C1-1
Tobacco smoking predicts depression and poorer quality of life in heart disease
L Stafford, M Berk, H Jackson
(2013), Vol. 13, pp. 1-10, BMC cardiovascular disorders, London, Eng., C1-1
Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder
J Stange, L Sylvia, P Magalhães, E Frank, M Otto, D Miklowitz, M Berk, A Nierenberg, T Deckersbach
(2013), Vol. 47, pp. 1329-1336, Journal of psychiatric research, Amsterdam, The Netherlands, C1-1
G Morris, G Anderson, M Berk, M Maes
(2013), Vol. 48, pp. 883-903, Molecular neurobiology, New York, N.Y., C1-1
Safe and effective use of lithium
G Malhi, M Tanious, D Bargh, P Das, M Berk
(2013), Vol. 36, pp. 18-21, Australian prescriber, Surry Hills, N.S.W., C1-1
Pharmacological management of unipolar depression
G Malhi, R Hitching, M Berk, P Boyce, R Porter, K Fritz
(2013), Vol. 127, pp. 6-23, Acta psychiatrica Scandinavica, London, Eng., C1-1
Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies
A Young, J Calabrese, U Gustafsson, M Berk, S McElroy, M Thase, T Suppes, W Earley
(2013), Vol. 1, pp. 1-12, International journal of bipolar disorders, London, Eng., C1-1
H Grunze, E Vieta, G Goodwin, C Bowden, R Licht, H-J Möller, S Kasper, M Berk
(2013), Vol. 14, pp. 154-219, World journal of biological psychiatry, Abingdon, Eng., C1-1
Edoxaban versus warfarin in patients with atrial fibrillation
R Giugliano, C Ruff, E Braunwald, S Murphy, S Wiviott, J Halperin, A Waldo, M Ezekowitz, J Weitz, J Špinar, W Ruzyllo, M Ruda, Y Koretsune, J Betcher, M Shi, L Grip, S Patel, I Patel, J Hanyok, M Mercuri, E Antman, L Peruzzotti-Jametti, Y Malynovsky, S Morin, E Hoffman, N Deenadayalu, H Lanz, V Curt, A Duggal, J Davé, D Morgan, Y Choi, J Jin, J Xie, W Crerand, J Kappelhof, W Maxwell, M Skinner, G Selicato, C Otto, C Reissner, K Smith, J Ostroske, A Ron, S Connolly, J Camm, E Paolasso, P Aylward, H Heidbuchel, J Nicolau, A Goudev, D Roy, R Corbalán, Y Yang, R Botero, M Bergovec, P Grande, C Hassager, J Voitk, H Huikuri, M Nieminen, J Blanc, J LeHeuzey, V Mitrovic, D Alexopoulos, G Sotomora, R Kiss, B SomaRaju, B Lewis, P Merlini, M Metra, T Yamashita, A García-Castillo, T Ophuis, H White, D Atar, M Horna, N Babilonia, J Morais, M Dorobantu, M Ostojic, T Duris, A Dalby, N Chung, J Zamorano, S Juul-Möller, T Moccetti, S Chen, P Sritara, A Oto, A Parkhomenko, R Senior, F Verheugt, A Skene, J Anderson, K Bauer, J Easton, S Goto, C Lowe
(2013), Vol. 369, pp. 2093-2104, New England Journal of Medicine, United States, C1-1
Design and analysis of an antenna for wireless energy harvesting in head-mountable DBS device
M Hosain, A Kouzani, S Tye, O Abulseoud, M Berk
(2013), pp. 3078-3081, EMBC 2013 : Proceedings of the 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Osaka, Japan, E1-1
Online social capital : mood, topical and psycholinguistic analysis
T Nguyen, B Dao, D Phung, S Venkatesh, M Berk
(2013), pp. 449-456, ICWSM 2013 : Proceedings of the 7th AAAI International Conference on Weblogs and Social Media, Cambridge, Massachusetts, E1
An integrated framework for suicide risk prediction
T Tran, Q Phung, W Luo, R Harvey, M Berk, S Venkatesh
(2013), pp. 1410-1418, KDD'13: Proceedings of the 19th ACM SIGKDD international conference on Knowledge discovery and data mining, Chicago, Ill., E1-1
H Kalra, O Dean, S Dodd, M Berk
(2012), pp. 95-107, Antidepressants and Major Depressive Disorder, B1-1
M Berk, L Berk, S Dodd, F Jacka, P Fitzgerald, A de Castella, S Filia, K Filia, J Kulkarni, H Jackson, L Stafford
(2012), Vol. 18, pp. 360-364, Journal of evaluation of clinical practice, Oxford, England, C1-1
Dietary selenium intake and major depressive disorder: a nested case-control study
J Pasco, F Jacka, L Williams, M Evans-Cleverdon, S Brennan, M Kotowicz, G Nicholson, M Ball, M Berk
(2012), Vol. 20, pp. 119-123, Complementary therapies in medicine, Kidlington, England, C1
O Bjerkeset, L Williams, U Romild, M Berk
(2012), British journal of psychiatry, London, England, C1
Nutrient intakes and the common mental disorders in women
F Jacka, M Maes, J Pasco, L Williams, M Berk
(2012), Vol. 141, pp. 79-85, Journal of affective disorders, Amsterdam, The Netherlands, C1
A comparison of inflammatory markers in depressed and nondepressed smokers.
S Nunes, H Vargas, J Brum, E Prado, M Vargas, M de Castro, S Dodd, M Berk
(2012), Vol. 14, pp. 540-546, Nicotine and tobacco research, Oxford , England, C1-1
A O'Neil, E Williams, C Stevenson, B Oldenburg, M Berk, K Sanderson
(2012), Vol. 47, pp. 1145-1151, Social psychiatry and psychiatric epidemiology, Heidelberg , Germany, C1
The role of alprazolam for the treatment of panic disorder in Australia
S Moylan, F Giorlando, T Nordfjaern, M Berk
(2012), Vol. 46, pp. 212-224, Australian and New Zealand Journal of Psychiatry, Melbourne, Vic., C1
M Maes, M Kubera, J Leunis, M Berk
(2012), Vol. 141, pp. 55-62, Journal of affective disorders, Amsterdam, Netherlands, C1
J Sarris, D Camfield, M Berk
(2012), Vol. 138, pp. 213-221, Journal of affective disorders, Amsterdam, Netherlands, C1
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder
A Bechdolf, A Ratheesh, S Wood, T Tecic, P Conus, B Nelson, S Cotton, A Chanen, G Amminger, S Ruhrmann, F Schultze-Lutter, J Kosterkotter, P Fusar Poli, A Yung, M Berk, P McGorry
(2012), Vol. 18, pp. 358-375, Current pharmaceutical design, Bussum, The Netherlands, C1-1
G Malhi, D Bargh, R McIntyre, M Gitlin, M Frye, M Bauer, M Berk
(2012), Vol. 14, pp. 1-21, Bipolar disorders supplement, Malden, Mass., C1
Impact of sunlight on the age of onset of bipolar disorder
M Bauer, T Glenn, M Alda, O Andreassen, R Ardau, F Bellivier, M Berk, T Bjella, L Bossini, M Del Zompo, S Dodd, A Fagiolini, M Frye, A Gonzalex-Pinto, C Henry, F Kapczinski, S Kliwicki, B Konig, M Kunz, B Lafer, C Lopez-Jaramillo, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, R Morken, R Munoz, C O'Donovan, F Nery, A Pfennig, D Quiroz, N Rasgon, A Reif, J Rybakowski, K Sagduyu, C Simhandi, C Torrent, E Vieta, M Zetin, P Whybrow
(2012), Vol. [early view], pp. 1-10, Bipolar disorders, Malden, Mass., C1
R Anderson, M Frye, O Abulseound, K Lee, J McGillivray, M Berk, S Tye
(2012), Vol. 36, pp. 1920-1933, Neuroscience and biobehavioral reviews, Oxford, England, C1
Pain and the relationship with mood and anxiety disorders and psychological symptoms
L Williams, J Pasco, F Jacka, S Dodd, M Berk
(2012), Vol. 72, pp. 452-456, Journal of psychosomatic research, Philadelphia, Pa., C1
G Anderson, M Maes, M Berk
(2012), Vol. 78, pp. 752-756, Medical hypotheses, Kidlington, England, C1
The use of hormonal contraceptive agents and mood disorders in women
G Svendal, M Berk, J Pasco, F Jacka, A Lund, L Williams
(2012), Vol. 140, pp. 92-96, Journal of affective disorders, Amsterdam, Netherlands, C1
Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization
G Anderson, M Maes, M Berk
(2012), Vol. 88, pp. 27-48, Advances in protein chemistry and structural biology, Maryland Heights, Miss., C1
M Berk, L Berk, M Udina, S Moylan, L Stafford, K Hallam, S Goldstone, P McGorry
(2012), Vol. 46, pp. 92-99, Australian and New Zealand journal of psychiatry, London, England, C1
C Macneil, M Hasty, S Cotton, M Berk, K Hallam, L Kader, P McGorry, P Conus
(2012), Vol. 6, pp. 380-388, Early intervention in psychiatry, Richmond, Vic., C1-1
Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder
P Magalhaes, O Dean, A Bush, D Copolov, D Weisinger, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2012), Vol. 37, pp. 132-135, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1
P Magalhaes, F Kapczinski, A Nierenberg, T Deckersbach, D Weisinger, S Dodd, M Berk
(2012), Vol. 125, pp. 303-308, Acta psychiatrica scandinavica, Malden, Mass., C1
Minocycline : therapeutic potential in psychiatry
O Dean, J Data-Franco, F Giorlando, M Berk
(2012), Vol. 26, pp. 391-401, CNS Drugs, Auckland, New Zealand, C1
A Bechdolf, S Wood, B Nelson, D Velakoulis, M Yucel, T Takahashi, A Yung, M Berk, M Wong, C Pantelis, P McGorry
(2012), Vol. 201, pp. 34-39, Psychiatry research : neuroimaging, County Clare, Ireland, C1-1
Depressive symptoms in first episode schizophrenia spectrum disorder
S Cotton, M Lambert, B Schimmelmann, A Mackinnon, J Gleeson, M Berk, L Hides, A Chanen, P McGorry, P Conus
(2012), Vol. 134, pp. 20-26, Schizophrenia research, Amsterdam, Netherlands, C1
M Maes, Z Fisar, M Medina, G Scapagnini, G Nowak, M Berk
(2012), Vol. 20, pp. 127-150, Inflammopharmacology, Basel, Switzerland, C1-1
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
M Maes, M Berk, L Goehler, C Song, G Anderson, P Galecki, B Leonard
(2012), Vol. 10, pp. 1-19, BMC medicine, London, England, C1-1
M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, A Bush, S Dodd, G Malhi
(2012), Vol. 10, pp. 1-11, BMC medicine, London, England, C1
M Maes, K Ringel, M Kubera, M Berk, J Rybakowski
(2012), Vol. 136, pp. 386-392, Journal of affective disorders, Amsterdam, The Netherlands, C1
S Moylan, F Jacka, J Pasco, M Berk
(2012), Vol. 10, pp. 1-14, BMC medicine, London, England, C1
F Jacka, M Berk
(2012), Vol. Open 1, pp. 21-23, Medical journal of Australia, Strawberry Hills, N.S.W., C1
J Sarris, S Moylan, D Camfield, M Pase, D Mischoulon, M Berk, F Jacka, I Schweitzer
(2012), Vol. 2012, pp. 1-20, Evidence based complementary and alternative medicine, New York, N.Y., C1
Using lithium as a neuroprotective agent in patients with cancer
M Khasraw, D Ashley, G Wheeler, M Berk
(2012), Vol. 10, pp. 1-7, BMC Medicine, London, England, C1
A Ghanizadeh, M Berk
(2012), Vol. 67, pp. 122-124, European journal of clinical nutrition, London, England, C1
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
A Singh, C Bousman, C Ng, K Byron, M Berk
(2012), Vol. 2, pp. 1-6, Translational psychiatry, London, England, C1
Moving towards a population health approach to the primary prevention of common mental disorders
F Jacka, A Mykletun, M Berk
(2012), Vol. 10, pp. 1-6, BMC medicine, London, England, C1
G Svendal, O Fasmer, A Engeland, M Berk, A Lund
(2012), Vol. 10, pp. 1-6, BMC medicine, England, London, C1
Adjunctive antioxidants for bipolar disorder
P Magalhaes, O Dean, A Andreazza, M Berk, F Kapczinski
(2012), pp. 1-11, The Cochrane collaboration, Oxford, England, C1-1
L Yatham, S Kennedy, S Parikh, A Schaffer, S Beaulieu, M Alda, C O'Donovan, G MacQueen, R McIntyre, V Sharma, A Ravindran, L Young, R Milev, D Bond, B Frey, B Goldstein, B Lafer, B Birmaher, K Ha, W Nolen, M Berk
(2012), Vol. 15, pp. 1-44, Bipolar Disorders, Malden, Mass., C1
State-related alterations of gene expression in bipolar disorder : a systematic review
K Munkholm, M Vinberg, M Berk, L Kessing
(2012), Vol. 14, pp. 684-696, Bipolar disorders, Malden, Mass., C1
The science and practice of lithium therapy
G Malhi, M Tanious, P Das, M Berk
(2012), Vol. 46, pp. 192-211, Australian and New Zealand journal of psychiatry, London, England, C1
J Kulkarni, S Filia, L Berk, K Filia, S Dodd, A de Castella, A Brnabic, A Lowry, K Kelin, W Montgomery, P Fitzgerald, M Berk
(2012), Vol. 12, pp. 1-11, BMC psychiatry, London, England, C1
P Magalhaes, S Dodd, A Nierenberg, M Berk
(2012), Vol. 46, pp. 1058-1067, Australian and New Zealand journal of psychiatry, London, England, C1
Mania : diagnosis and treatment recommendations
G Malhi, M Tanious, M Berk
(2012), Vol. 14, pp. 676-686, Current psychiatry reports, Philadelphia, Pa., C1
Effects of N-acetyl cysteine on cognitive function in bipolar disorder
O Dean, A Bush, D Copolov, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2012), Vol. 66, pp. 514-517, Psychiatry and clinical neurosciences, Richmond, Vic., C1
M Maes, M Kubera, J Leunis, M Berk, M Geffard, E Bosmans
(2012), Vol. 127, pp. 344-354, Acta psychiatrica scandinavica, Malden, Mass., C1
The impact of statins on psychological wellbeing : a systematic review and meta-analysis
A O'Neil, L Sanna, C Redlich, K Sanderson, F Jacka, L Williams, J Pasco, M Berk
(2012), Vol. 10, pp. 1-9, BMC medicine, London, England, C1
Pathways to new drug discovery in neuropsychiatry
M Berk
(2012), Vol. 10, pp. 1-4, BMC medicine, London, England, C1
J Pasco, L Williams, F Jacka, M Henry, C Coulson, S Brennan, E Leslie, G Nicholson, M Kotowicz, M Berk
(2011), Vol. 23, pp. 292-298, International psychogeriatrics, Cambridge, England, C1
Lower levels of physical activity in childhood associated with adult depression
F Jacka, J Pasco, L Williams, E Leslie, S Dodd, G Nicholson, M Kotowicz, M Berk
(2011), Vol. 14, pp. 222-226, Journal of science and medicine in sport, Chatswood, N.S.W., C1
Diet quality in bipolar disorder in a population-based sample of women
F Jacka, J Pasco, A Mykietun, L Williams, G Nicholson, M Kotowicz, M Berk
(2011), Vol. 129, pp. 332-337, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Annual high-dose vitamin D3 and mental well-being: randomised controlled trial
K Sanders, A Stuart, E Wiliamson, F Jacka, S Dodd, G Nicholson, M Berk
(2011), Vol. 198, pp. 357-364, British journal of psychiatry, London, England, C1-1
M Berk, A Munib, O Dean, G Malhi, K Kohlmann, I Schapkaitz, S Jeavons, F Katz, M Anderson-Hunt, P Conus, B Hanna, R Otmar, F Ng, D Copolov, A Bush
(2011), Vol. 72, pp. 909-913, Journal of clinical psychiatry, [Memphis, Tenn.], C1-1
N-acetylcysteine in psychiatry - current therapeutic evidence and potential mechanisms of action
O Dean, F Giorlando, M Berk
(2011), Vol. 36, pp. 78-86, Journal of psychiatry and neuroscience, Ottowa, Canada, C1-1
O Dean, M van den Buuse, M Berk, D Copolov, C Mavros, A Bush
(2011), Vol. 499, pp. 149-153, Neuroscience letters, Clare, Ireland, C1-1
Antioxidant treatments for schizophrenia
P Magalhaes, A Andreazza, M Berk, F Kapczinski, O Dean
(2011), pp. 1-13, Cochrane database of systematic reviews, Oxford, U. K., C1-1
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 129, pp. 317-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder.
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 23, pp. 87-88, Acta neuropsychiatrica, Oxford, England, C1-1
M Berk, A Brnabic, S Dodd, K Kelin, M Tohen, G Malhi, L Berk, P Conus, P McGorry
(2011), Vol. 13, pp. 87-98, Bipolar disorders, Malden, Mass, C1
M Berk, F Kapczinski, A Andreazza, O Dean, F Giorlando, M Maes, M Yücel, C Gama, S Dodd, B Dean, P Magalhães, P Amminger, P McGorry, G Malhi
(2011), Vol. 35, pp. 804-817, Neuroscience & biobehavioral reviews, Oxford, England, C1-1
K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk
(2011), Vol. 52, pp. 562-566, Comprehensive psychiatry, Maryland Heights, MO, C1-1
Bipolar disorder and adiposity : a study using whole body dual energy X-ray absorptiometry scans
L Williams, J Pasco, F Jacka, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk
(2011), Vol. 23, pp. 219-223, Acta neuropsychiatrica, Malden, Mass, C1
Paracetamol (acetaminophen) use, fracture and bone mineral density
L Williams, J Pasco, M Henry, K Sanders, G Nicholson, M Kotowicz, M Berk
(2011), Vol. 48, pp. 1277-1281, Bone, New York, N. Y., C1
L Williams, O Bjerkeset, A Langhammer, M Berk, J Pasco, M Henry, B Schei, S Forsmo
(2011), Vol. 131, pp. 164-171, Journal of affective disorders, Amsterdam , The Netherlands, C1
L Williams, S Brennan, M Henry, M Berk, F Jacka, G Nicholson, M Kotowicz, J Pasco
(2011), Vol. 69, pp. 173-178, Maturitas, Shannon, Ireland, C1
Glutamate cysteine ligase (GCL) and self reported depression : an association study from the HUNT
M Berk, S Johansson, N Wray, L Williams, C Olsson, J Haavik, O Bjerkeset
(2011), Vol. 131, pp. 207-213, Journal of affective disorders, Amsterdam, The Netherlands, C1
P Badcock, E Moore, E Williamson, M Berk, L Williams, O Bjerkeset, H Nordahl, G Patton, C Olsson
(2011), Vol. 63, pp. 18-25, Australian journal of psychology, Oxford, England, C1-1
A prospective study of diet quality and mental health in adolescents
F Jacka, P Kremer, M Berk, A de Silva-Sanigorski, M Moodie, E Leslie, J Pasco, B Swinburn
(2011), Vol. 6, pp. 1-7, PLos one, San Francisco, Calif., C1
Don't worry, be active : positive affect and habitual physical activity
J Pasco, F Jacka, L Williams, S Brennan, E Leslie, M Berk
(2011), Vol. 45, pp. 1047-1052, Australian & New Zealand journal of psychiatry, London, England, C1
F Jacka, A Mykletun, M Berk, I Bjelland, G Tell
(2011), Vol. 73, pp. 483-490, Psychosomatic medicine, New York, N. Y., C1-1
D Camfield, J Sarris, M Berk
(2011), Vol. 35, pp. 887-895, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1
M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, C Allwang, H Cobb, A Bush, I Schapkaitz, S Dodd, G Malhi
(2011), Vol. 135, pp. 389-394, Journal of affective disorders, Amsterdam, Netherlands, C1
A consensus statement for safety monitoring guidelines of treatments for major depressive disorder
S Dodd, G Malhi, J Tiller, I Schweitzer, I Hickie, J Khoo, D Bassett, B Lyndon, P Mitchell, G Parker, P Fitzgerald, M Udina, A Singh, S Moylan, F Giorlando, C Doughty, C Davey, M Theodoros, M Berk
(2011), Vol. 45, pp. 712-725, Australian and New Zealand journal of psychiatry, London, England, C1
Y Wang, Z Xiao, X Liu, M Berk
(2011), Vol. 26, pp. 95-101, Human psychopharmacology : clinial and experimental, West Sussex, England, C1
L Berk, A Jorm, C Kelly, S Dodd, M Berk
(2011), Vol. 13, pp. 556-570, Bipolar disorders, Malden Mass., C1
Meta-analytic review of neurocognition in bipolar II disorder
E Bora, M Yucel, C Pantelis, M Berk
(2011), Vol. 123, pp. 165-174, Acta psychiatrica scandinavica, Malden Mass., C1
Who's left? Symptoms of schizophrenia that predict clinical trial dropout
J Thompson, M Berk, O Dean, K Kohlmann, S Jeavons, A Bush, D Copolov
(2011), Vol. 26, pp. 609-613, Human psychopharmacology, West Sussex, England, C1-1
N-acetylcysteine for major depressive episodes in bipolar disorder
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 33, pp. 374-378, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1
S Moylan, J Staples, S Ward, J Rogerson, D Stein, M Berk
(2011), Vol. 31, pp. 647-652, Journal of clinical psychopharmacology, Philadelphia, Pa., C1
L Stafford, M Berk
(2011), Vol. 72, pp. 1229-1235, Journal of clinical psychiatry, Memphis, Tenn., C1-1
C Macneil, M Hasty, M Berk, L Henry, M Evans, C Redlich, R Daglas, P McGorry, P Conus
(2011), Vol. 5, pp. 100-107, Early intervention in psychiatry, Richmond, Vic., C1-1
M Maes, P Ruckoanich, Y Chang, N Mahanonda, M Berk
(2011), Vol. 35, pp. 769-783, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1-1
M Maes, P Galecki, Y Chang, M Berk
(2011), Vol. 35, pp. 676-692, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1-1
T Callaly, T Trauer, M Hyland, T Coombs, M Berk
(2011), Vol. 19, pp. 221-225, Australasian Psychiatry, England, C1-1
Association of western and traditional diets with depression and anxiety in women
F Jacka, J Pasco, A Mykletun, L Williams, A Hodge, S O'Reilly, G Nicholson, M Katowice, M Berk
(2010), Vol. 167, pp. 305-311, American journal of psychiatry, Arlington, Va., C1-1
F Jacka, P Kremer, E Leslie, M Berk, G Patton, J Toumbourou, J Williams
(2010), Vol. 44, pp. 435-442, Australian & New Zealand journal of psychiatry, London, England, C1
Mental health services for young people - the challenge of integrating services
T Callaly, K Von Treuer, S Dodd, M Berk
(2010), Vol. 22, pp. 158-160, Acta neuropsychiatrica, Oxford, England, C1
Readmission to an acute psychiatric unit within 28 days of discharge : identifying those at risk
T Callaly, M Hyland, T Trauer, S Dodd, M Berk
(2010), Vol. 34, pp. 282-285, Australian health review, Melbourne, Vic., C1
S Dodd, T Callaly, A Thampi, S McConnell, P Hantz, D Goodman, K Kohlmann, P Vieira da Silva Magalhaes, M Berk
(2010), Vol. 8, pp. 105-110, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1
Obesity is associated with previous suicide attempts in bipolar disorder
F Gomes, M Kauer-Sant'Anna, P Magalhães, F Jacka, S Dodd, C Gama, Â Cunha, M Berk, F Kaczinski
(2010), Vol. 22, pp. 63-67, Acta neuropsychiatrica, Oxford, England, C1-1
A Mykletun, F Jacka, L Williams, J Pasco, M Henry, G Nicholson, M Kotowicz, M Berk
(2010), Vol. 10, pp. 1-9, BMC gastroenterology, London, England, C1-1
J Pasco, F Jacka, L Williams, M Henry, G Nicholson, M Kotowicz, M Berk
(2010), Vol. 79, pp. 323-325, Psychotherapy and psychosomatics, New York, N. Y., C1-1
Association of high-sensitivity C-reactive protein with de novo major depression
J Pasco, G Nicholson, L Williams, F Jacka, M Henry, M Kotowicz, H Schneider, B Leonard, M Berk
(2010), Vol. 197, pp. 372-377, British journal of psychiatry, London, England, C1-1
The prevalence of mood and anxiety disorders in Australian women
L Williams, F Jacka, J Pasco, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk
(2010), Vol. 18, pp. 250-255, Australasian psychiatry, London, England, C1-1
Termination of therapy: what can clinicians do to maximise gains?
C Macneil, M Hasty, P Conus, M Berk
(2010), Vol. 22, pp. 43-45, Acta neuropsychiatrica, Malden, Mass., C1-1
Enhancing medication adherence in patients with bipolar disorder
L Berk, K Hallam, F Colom, E Vieta, M Hasty, C Macneil, M Berk
(2010), Vol. 25, pp. 1-16, Human psychopharmacology : clinical and experimental, West Sussex, England, C1-1
K Choy, O Dean, M Berk, A Bush, M van den Buuse
(2010), Vol. 649, pp. 224-228, European journal of pharmacology, Amsterdam, The Netherlands, C1-1
O Dean, A Bush, M Berk, D Copolov, M van den Buuse
(2010), Vol. 97, pp. 293-300, Pharmacology, biochemistry and behavior, Philadelphia, Pa., C1-1
Oxidative pathways as a drug target for the treatment of autism
K Villagonzalo, S Dodd, O Dean, K Gray, B Tonge, M Berk
(2010), Vol. 14, pp. 1301-1310, Expert opinion on therapeutic targets, London, England, C1-1
Restless leg syndrome caused by olanzapine: a case series
S Aggarwal, S Dodd, M Berk
(2010), Vol. 5, pp. 129-131, Current drug safety, San Francisco, Ca., C1-1
From neuroprogression to neuroprotection : implications for clinical care
M Berk, P Conus, F Kapczinski, A Andreazza, M Yücel, S Wood, C Pantelis, G Malhi, S Dodd, A Bechdolf, G Amminger, I Hickie, P McGorry
(2010), Vol. 193, pp. 36-40, Medical journal of australia, Strawberry Hills, N.S.W., C1-1
M Berk, S Dodd, O Dean, K Kohlmann, L Berk, G Malhi
(2010), Vol. 22, pp. 237-242, Acta neuropsychiatrica, Oxford, England, C1-1
Evidence and implications for early intervention in bipolar disorder
M Berk, K Hallam, G Mahli, L Henry, M Hasty, C Macneil, M Yucel, C Pantelis, B Murphy, E Vieta, S Dodd, P McGorry
(2010), Vol. 19, pp. 113-126, Journal of mental health, Abingdon, England, C1-1
M Berk, F Ng, S Dodd, J Goldberg, G Malhi
(2010), Vol. 64, pp. 367-371, Psychiatry and clinical neurosciences, Richmond, Vic., C1-1
A qualitative evaluation of a regional early psychosis service 3 years after its commencement
T Callaly, C Ackerly, M Hyland, S Dodd, M O'Shea, M Berk
(2010), Vol. 34, pp. 382-385, Australian health review, Melbourne, Vic., C1-1
A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder
S Dodd, A Brnabic, L Berk, P Fitzgerald, A de Castella, S Filia, K Filia, K Kelin, M Smith, W Montgomery, J Kulkarni, M Berk
(2010), Vol. 51, pp. 504-509, Comprehensive psychiatry, Maryland Heights, MO, C1-1
S Dodd, J Kulkarni, L Berk, F Ng, P Fitzgerald, A de Castella, S Filia, K Filia, W Montgomery, K Kelin, M Smith, A Brnabic, M Berk
(2010), Vol. 124, pp. 22-28, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
J Kulkarni, C Gurvich, S Lee, H Gilbert, E Gavrilidis, A de Castella, M Berk, S Dodd, P Fitzgerald, S Davis
(2010), Vol. 35, pp. 1142-1147, Psychoneuroendocrinology, Oxford, England, C1-1
The role of psychotherapy in bipolar disorder
S Lauder, M Berk, D Castle, S Dodd, L Berk
(2010), Vol. 193, pp. 31-35, Medical journal of australia, Sydney, N.S.W., C1-1
K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk
(2010), Vol. 14, pp. 150-153, International journal of psychiatry in clinical practice, London, England, C1-1
C Coulson, L Williams, M Henry, M Berk, D Lubman, S Brennan, G Nicholson, M Kotowicz, S Korn, J Pasco
(2010), Vol. 44, pp. 946-951, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1
A Bechdolf, B Nelson, S Cotton, A Chanen, A Thompson, J Kettle, P Conus, G Amminger, A Yung, M Berk, P McGorry
(2010), Vol. 127, pp. 316-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Group-based psychosocial intervention for bipolar disorder : randomised controlled trial
D Castle, C White, J Chamberlain, M Berk, L Berk, S Lauder, G Murray, I Schweitzer, L Piterman, M Gilbert
(2010), Vol. 196, pp. 383-388, British journal of psychiatry, London, Eng., C1-1
P Conus, J Ward, N Lucas, S Cotton, A Yung, M Berk, P McGorry
(2010), Vol. 124, pp. 341-345, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
M Berk, L Henry, K Elkins, S Harrigan, M Harris, H Herrman, H Jackson, P McGorry
(2010), Vol. 6, pp. 212-234, Journal of dual diagnosis, Philadelphia, Pa., C1-1
P Conus, S Cotton, B Schimmelmann, M Berk, R Daglas, P McGorry, M Lambert
(2010), Vol. 12, pp. 244-252, Bipolar disorders, Hoboken, N.J., C1-1
P Conus, A Abdel-Baki, S Harrigan, M Lambert, P McGorry, M Berk
(2010), Vol. 126, pp. 88-95, Journal of affective disorders, Amsterdam, Netherlands, C1-1
Assessing oxidative pathway genes as risk factors for bipolar disorder
J Fullerton, Y Tiwari, G Agahi, A Heath, M Berk, P Mitchell, P Schofield
(2010), Vol. 12, pp. 550-556, Bipolar disorders, Hoboken, N.J., C1-1
K Kelin, M Berk, M Spann, D Sagman, J Raskin, D Walker, D Perahia
(2010), Vol. 64, pp. 719-726, International journal of clinical practice, Chichester, Eng., C1-1
H Grunze, E Vieta, G Goodwin, C Bowden, R Licht, H-J Möller, S Kasper, M Berk, WFSBP Task Force On Treatment Guidelines For Bipol
(2010), Vol. 11, pp. 81-109, World journal of biological psychiatry, Abingdon, Eng., C1-1
Bipolar disorder in young people: a psychological intervention manual
C Macneil, M Hasty, P Conus, M Berk, J Scott
(2009), A1-1
Craig Macneil, Melissa Hasty, Philippe Conus, Michael Berk, Jan Scott
(2009), pp. 55-64, Bipolar disorder in young people: a psychological intervention manual, Cambridge, Eng., B1-1
Cognitive behavioral therapy interventions
Craig Macneil, Melissa Hasty, Philippe Conus, Michael Berk, Jan Scott
(2009), pp. 65-97, Bipolar disorder in young people: a psychological intervention manual, Cambridge, Eng., B1-1
Craig Macneil, Melissa Hasty, Philippe Conus, Michael Berk, Jan Scott
(2009), pp. 21-35, Bipolar disorder in young people: a psychological intervention manual, Cambridge, Eng., B1-1
Craig Macneil, Melissa Hasty, Philippe Conus, Michael Berk, Jan Scott
(2009), pp. 98-104, Bipolar disorder in young people: a psychological intervention manual, Cambridge, Eng., B1-1
Description and qualitative evaluation of Jigsaw, an integrated young persons' mental health program
T Callaly, S Dodd, C Ackerly, P Hantz, M O'Shea, M Berk
(2009), Vol. 17, pp. 480-483, Australasian Psychiatry, London, England, C1-1
Suicidality - the challenge for public mental health services
T Callaly, M Berk, S Dodd
(2009), Vol. 21, pp. 41-43, Acta neuropsychiatrica, Oxford, England, C1-1
Vitamin D: is it relevant to psychiatry?
M Berk, S Dodd, L Williams, F Jacka, J Pasco
(2009), Vol. 21, pp. 205-206, Acta neuropsychiatrica, Oxford, England, C1-1
S Dodd, L Williams, F Jacka, J Pasco, O Bjerkeset, M Berk
(2009), Vol. 43, pp. 526-530, Australian and New Zealand journal of psychiatry, Melbourne, Vic., C1-1
F Jacka, S Overland, R Stewart, G Tell, I Bjelland, A Mykletun
(2009), Vol. 43, pp. 45-52, Australian & New Zealand journal of psychiatry, Melbourne, Vic., C1-1
Depression and bone metabolism : a review
L Williams, J Pasco, F Jacka, M Henry, S Dodd, M Berk
(2009), Vol. 78, pp. 16-25, Psychotherapy and psychosomatics, New York, N. Y., C1-1
Lifetime psychiatric disorders and body composition : a population-based study
L Williams, J Pasco, M Henry, F Jacka, S Dodd, G Nicholson, M Kotowicz, M Berk
(2009), Vol. 118, pp. 173-179, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting
M Berk, S Jeavons, O Dean, S Dodd, K Moss, C Gama, G Malhi
(2009), Vol. 14, pp. 357-360, CNS spectrums, New York, N.Y., C1-1
Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice
O Dean, A Bush, M Berk, D Copolov, M van den Buuse
(2009), Vol. 198, pp. 258-262, Behavioural brain research, Amsterdam, The Netherlands, C1-1
O Dean, M van den Buuse, A Bush, D Copolov, F Ng, S Dodd, M Berk
(2009), Vol. 16, pp. 2965-2976, Current medicinal chemistry, Schiphol, The Netherlands, C1-1
M Berk, C Gama, S Sundram, H Hustig, L Koopowitz, R D'Souza, H Malloy, C Rowland, A Monkhouse, A Monkhouse, F Bole, S Sathiyamoorthy, D Piskulic, S Dodd
(2009), Vol. 24, pp. 233-238, Human psychopharmacology : clinical and experimental, West Sussex, England, C1-1
Early intervention in bipolar disorders : clinical, biochemical and neuroimaging imperatives
M Berk, G Malhi, K Hallam, C Gama, S Dodd, A Andreazza, B Frey, F Kapczinski
(2009), Vol. 114, pp. 1-13, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
M Bernardo, S Dodd, C Gama, D Copolov, O Dean, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush, M Berk
(2009), Vol. 21, pp. 239-245, Acta neuropsychiatrica, Oxford, England, C1-1
The impact of age at onset of bipolar I disorder on functioning and clinical presentation
F Biffin, S Tahtalian, K Filia, P Fitzgerald, A De Castella, S Filia, M Berk, S Dodd, P Callaly, L Berk, K Kelin, M Smith, W Montgomery, J Kulkarni
(2009), Vol. 21, pp. 191-196, Acta neuropsychiatrica, Oxford, England, C1-1
Client-reported reasons for non-engagement in drug and alcohol treatment
C Coulson, F Ng, M Geertsema, S Dodd, M Berk
(2009), Vol. 28, pp. 372-378, Drug and alcohol review, Oxford, England, C1-1
'Mind and body' : a lifestyle programme for people on antipsychotic medication
A Jones, A Benson, S Griffiths, M Berk, S Dodd
(2009), Vol. 15, pp. 276-280, Journal of evaluation of clinical practice, Oxford, England, C1-1
D De Lucena, B Fernandes, M Berk, S Dodd, D Medeiros, M Pedrini, M Kunz, F Gomes, L Giglio, M Lobato, P Belmonte-de-Abreu, C Gama
(2009), Vol. 70, pp. 1416-1423, Journal of clinical psychiatry, Memphis, Tenn., C1-1
G Malhi, D Adams, C Cahill, S Dodd, M Berk
(2009), Vol. 69, pp. 2063-2101, Drugs, London, England, C1-1
Clinical practice recommendations for depression
G Malhi, D Adams, R Porter, A Wignall, L Lampe, N O'Connor, M Paton, L Newton, G Walter, A Taylor, M Berk, R Mulder
(2009), Vol. 119, pp. 8-26, Acta psychiatrica Scandinavica, London, Eng., C1-1
L Stafford, M Berk, H Jackson
(2009), Vol. 66, pp. 211-220, Journal of psychosomatic research, Amsterdam, The Netherlands, C1-1
Medial temporal lobe glutathione concentration in first episode psychosis : a 1H-MRS investigation
S Wood, G Berger, R Wellard, T Proffitt, M McConchie, M Berk, P McGorry, C Pantelis
(2009), Vol. 33, pp. 354-357, Neurobiology of disease, Amsterdam, The Netherlands, C1-1
Is lithium in a class of its own? A brief profile of its clinical use
G Malhi, D Adams, M Berk
(2009), Vol. 43, pp. 1096-1104, Australian and New Zealand journal of psychiatry, London, Eng., C1-1
Medicating mood with maintenance in mind : bipolar depression pharmacotherapy
G Malhi, D Adams, M Berk
(2009), Vol. 11, pp. 55-76, Bipolar disorders, London, Eng., C1-1
M Tohen, E Frank, C Bowden, F Colom, S Ghaemi, L Yatham, G Malhi, J Calabrese, W Nolen, E Vieta, F Kapczinski, G Goodwin, T Suppes, G Sachs, K Chengappa, H Grunze, P Mitchell, S Kanba, M Berk
(2009), Vol. 11, pp. 453-473, Bipolar disorders, London, Eng., C1-1
Clinical practice recommendations for bipolar disorder
G Malhi, D Adams, L Lampe, M Paton, N O'Connor, L Newton, G Walter, A Taylor, R Porter, R Mulder, M Berk
(2009), Vol. 119, pp. 27-46, Acta psychiatrica Scandinavica, London, Eng., C1-1
The potential use of biomarkers as an adjunctive tool for staging bipolar disorder
F Kapczinski, V Dias, M Kauer-Sant'Anna, E Brietzke, G Vazquez, E Vieta, M Berk
(2009), Vol. 33, pp. 1366-1371, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1-1
Neuroprogression: pathways to progressive brain changes in bipolar disorder
M Berk
(2009), Vol. 12, pp. 441-445, International journal of neuropsychopharmacology, Cambridge, Eng., C1-1
Clinical implications of a staging model for bipolar disorders
F Kapczinski, V Dias, M Kauer-Sant'Anna, B Frey, R Grassi-Oliveira, F Colom, M Berk
(2009), Vol. 9, pp. 957-966, Expert review of neurotherapeutics, London, Eng., C1-1
Intervention in individuals at ultra-high risk for psychosis: a review and future directions
P McGorry, B Nelson, G Amminger, A Bechdolf, S Francey, G Berger, A Riecher-Rössler, J Klosterkötter, S Ruhrmann, F Schultze-Lutter, M Nordentoft, I Hickie, P McGuire, M Berk, E Chen, M Keshavan, A Yung
(2009), Vol. 70, pp. 1206-1212, Journal of clinical psychiatry, Memphis, Tenn., C1-1
L Stafford, H Jackson, M Berk
(2009), Vol. 71, pp. 63-69, Psychosomatic medicine, Philadelphia, Pa., C1-1
M Juruena, C Gama, M Berk, P Belmonte-de-Abreu
(2009), Vol. 23, pp. 985-987, Journal of psychopharmacology, Thousand Oaks, Calif., C1-1
F Ng, O Mammen, I Wilting, G Sachs, I Ferrier, F Cassidy, S Beaulieu, L Yatham, M Berk
(2009), Vol. 11, pp. 559-595, Bipolar disorders, London, Eng., C1-1
The elephant on the couch: side-effects of psychotherapy
M Berk, G Parker
(2009), Vol. 43, pp. 787-794, Australian and New Zealand journal of psychiatry, London, Eng., C1-1
S Boer, M Berk, B Dean
(2009), Vol. 466, pp. 27-29, Neuroscience letters, Shannon, Ireland, C1-1
F Benazzi, M Berk, M Frye, W Wang, A Barraco, M Tohen
(2009), Vol. 70, pp. 1424-1431, Journal of clinical psychiatry, Memphis, Tenn., C1-1
K Hallam, D Smith, M Berk
(2009), Vol. 112, pp. 212-218, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
E Vieta, M Berk, W Wang, F Colom, M Tohen, R Baldessarini
(2009), Vol. 119, pp. 22-27, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
A critical update on psychological interventions for bipolar disorders
E Vieta, I Pacchiarotti, M Valentí, M Berk, J Scott, F Colom
(2009), Vol. 11, pp. 494-502, Current psychiatry reports, [Philadelphia, Pa.], C1-1
J Asarnow, M Berk, L Baraff
(2009), Vol. 40, pp. 118-125, Professional psychology: research and practice, [Washington, D.C.], C1-1
Clinical practice recommendations for depression
G Malhi, D Adams, R Porter, A Wignall, L Lampe, N O'Connor, M Paton, L Newton, G Walter, A Taylor, M Berk, R Mulder
(2009), Vol. 119, pp. 8-26, Acta psychiatrica Scandinavica, Chichester, Eng., C1-1
Heinz Grunze, Eduard Vieta, Guy Goodwin, Charles Bowden, Rasmus Licht, Hans-Jurgen Moller, Siegfried Kasper, H Akiskal, J Ayuso-Gutierrez, M Bauer, P Bech, Michael Berk, I Bitter, G Burrows, J Calabrese, G Cassano, M Cetkovich-Bakmas, J Cookson, I Ferrier, W Gattaz, F Goodwin, G Heinze, T Higuchi, R Hirschfeld, C Hoeschl, E Holsboer-Trachsler, K Redfield Jamison, C Katona, M Keller, E Kostukova, H Kruger, P Kulhara, Y Lecruibier, V Larach
(2009), Vol. 10, pp. 85-116, World journal of biological psychiatry, Abingdon, Eng., C1-1
Bipolar Disorder in Young People: A Psychological Intervention Manual
C Macneil, M Hasty, P Conus, M Berk, J Scott
(2009), Cambridge, Eng., A7-1
L Yatham, S Kennedy, A Schaffer, S Parikh, S Beaulieu, C O'Donovan, G MacQueen, R McIntyre, V Sharma, A Ravindran, L Young, A Young, M Alda, R Milev, E Vieta, J Calabrese, M Berk, K Ha, F Kapczinski
(2009), Vol. 11, pp. 225-255, Bipolar disorders, London, Eng., E1-1
The importance of the treatment alliance in bipolar disorder
L Berk, C Macneil, D Castle, M Berk
(2008), pp. 167-182, Psychotherapies for the psychoses: theoretical, cultural and clinical integration, Abingdon, Eng., B1-1
A descriptive interview with 64 patients discharged from an acute-psyciatric-inpatient service
T Callaly, S Dodd, D Goodman, Y Asgari, M Berk
(2008), Vol. 14, pp. 990-995, Journal of evaluation in clinical practice, Oxford, England, C1-1
Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample
M Berk, F Jacka, L Williams, F Ng, S Dodd, J Pasco
(2008), Vol. 42, pp. 874-878, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1
Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet
L Guimarães, F Jacka, C Gama, M Berk, C Leitão-Azevedo, M Belmonte de Abreu, M Lobato, A Andreazza, K Ceresér, F Kapczinski, P Belmonte-de-Abreu
(2008), Vol. 32, pp. 1595-1598, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1-1
F Jacka, C Gama, M Berk
(2008), Vol. 20, pp. 223-225, Acta neuropsychiatrica, Oxford, England, C1-1
Leptin in depressed women : Cross-sectional and longitudinal data from an epidemiologic study
J Pasco, F Jacka, L Williams, M Henry, G Nicholson, M Kotowicz, M Berk
(2008), Vol. 107, pp. 221-225, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Tobacco smoking as a risk factor for major depressive disorder : a population-based study
J Pasco, L Williams, F Jacka, F Ng, M Henry, G Nicholson, M Kotowicz, M Berk
(2008), Vol. 193, pp. 322-326, British journal of psychiatry, London, England, C1-1
L Williams, M Henry, M Berk, S Dodd, F Jacka, M Kotowicz, G Nicholson, J Pasco
(2008), Vol. 23, pp. 84-87, International clinical psychopharmacology, Philadelphia, Pa., C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush
(2008), Vol. 64, pp. 468-475, Biological psychiatry, Philadelphia, Pa., C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush
(2008), Vol. 64, pp. 361-368, Biological psychiatry, Philadelphia, Pa., C1-1
Glutathione : a novel treatment target in psychiatry
M Berk, F Ng, O Dean, S Dodd, A Bush
(2008), Vol. 29, pp. 346-351, Trends in pharmacological sciences, London, England, C1-1
Oxidative stress in psychiatric disorders : evidence base and therapeutic implications
F Ng, M Berk, O Dean, A Bush
(2008), Vol. 11, pp. 851-876, International journal of neuropsychopharmacology, Cambridge, England, C1-1
N-acetylcysteine for antioxidant therapy : pharmacology and clinical utility
S Dodd, O Dean, D Copolov, G Malhi, M Berk
(2008), Vol. 8, pp. 1955-1962, Expert opinion on biological therapy, London, England, C1-1
M Berk, S Dodd, K Hallam, L Berk, J Gleeson, M Henry
(2008), Vol. 6, pp. 22-25, Sleep and biological rhythms, Wiley-Blackwell Publishing Asia, C1-1
M Berk, F Ng, S Dodd, T Callaly, S Campbell, M Bernardo, T Trauer
(2008), Vol. 14, pp. 979-983, Journal of evaluation of clinical practice, Oxford, England, C1-1
Going up in smoke : tobacco smoking is associated with worse treatment outcomes in mania
M Berk, F Ng, W Wang, M Tohen, D Lubman, E Vieta, S Dodd
(2008), Vol. 110, pp. 126-134, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
S Dodd, M Berk
(2008), Vol. 8, pp. 1299-1306, Expert review of neurotherapeutics, London, England, C1-1
Duloxetine for major depression
S Dodd, M Berk
(2008), Vol. 9, pp. 65-66, Medicine today, Neutral Bay, N.S.W., C1-1
The bipolar comprehensive outcomes study (BCOS) : baseline findings of an Australian cohort study
J Kulkarni, M Berk, P Fitzgerald, A de Castella, W Montgomery, K Kelin, A Brnabic, R Granger, S Dodd
(2008), Vol. 107, pp. 135-144, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Depressive disorders and bone mineral density in a community based sample of premenopausal women
L Williams, J Pasco, F Jacka, S Dodd, G Nicholson, M Berk
(2008), Vol. 107, pp. 96-97, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Illness beliefs about heart disease and adherence to secondary prevention regimens
L Stafford, H Jackson, M Berk
(2008), Vol. 70, pp. 942-948, Psychosomatic Medicine, Philadelphia, Pa., C1-1
E Bora, M Yucel, A Fornito, M Berk, C Pantelis
(2008), Vol. 118, pp. 172-187, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1
Decreased serum neurotrophin 3 in chronically medicated schizophrenic males
H Vargas, C Gama, A Andreazza, D Medeiros, L Stertz, G Fries, J Palha, K Cereser, M Berk, F Kapczinski, P Belmonte-de-Abreu
(2008), Vol. 440, pp. 197-201, Neuroscience Letters, Shannon, Clare Ireland, C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush
(2008), Vol. 64, pp. 361-368, Biological Psychiatry, Philadelphia, Pa., C1-1
The empirical redefinition of the psychometric criteria for remission in bipolar disorder
M Berk, F Ng, W Wang, J Calabrese, P Mitchell, G Malhi, M Tohen
(2008), Vol. 106, pp. 153-158, Journal of Affective Disorders, Amsterdam, The Netherlands, C1-1
Pure and mixed manic subtypes: A review of diagnostic classification and validation
F Cassidy, L Yatham, M Berk, P Grof
(2008), Vol. 10, pp. 131-143, Bipolar Disorders, Denmark, C1-1
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression
G Malhi, F Ng, M Berk
(2008), Vol. 42, pp. 346-349, Australian & New Zealand Journal of Psychiatry, London, Eng., C1-1
M Kunz, C Gama, A Andreazza, M Salvador, K Ceresér, F Gomes, P Belmonte-de-Abreu, M Berk, F Kapczinski
(2008), Vol. 32, pp. 1677-1681, Progress in Neuro-Psychopharmacology & Biological Psychiatry, Philadelphia, Pa., C1-1
C Gama, M Berk, A Andreazza, F Kapczinski, P Belmonte-de-Abreu
(2008), Vol. 30, pp. 337-340, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1-1
B Harvey, C Joubert, J du Preez, M Berk
(2008), Vol. 33, pp. 508-517, Neurochemical Research, New York, N.Y., C1-1
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients
S Lavoie, M Murray, P Deppen, M Knyazeva, M Berk, O Boulat, P Bovet, A Bush, P Conus, D Copolov, E Fornari, R Meuli, A Solida, P Vianin, M Cuénod, T Buclin, K Do
(2008), Vol. 33, pp. 2187-2199, Neuropsychopharmacology, London, Eng., C1-1
Tobacco smoking as a risk factor for major depressive disorder: population-based study
J Pasco, L Williams, F Jacka, F Ng, M Henry, G Nicholson, M Kotowicz, M Berk
(2008), Vol. 193, pp. 322-326, British Journal of Psychiatry, London, Eng., C1-1
Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males
C Gama, M Salvador, A Andreazza, M Lobato, M Berk, F Kapczinski, P Belmonte-de-Abreu
(2008), Vol. 433, pp. 270-273, Neuroscience Letters, Shannon, Clare Ireland, C1-1
The proximal prodrome to first episode mania--a new target for early intervention
P Conus, J Ward, K Hallam, N Lucas, C Macneil, P McGorry, M Berk
(2008), Vol. 10, pp. 555-565, Bipolar Disorders, Hoboken, N.J., C1-1
A functional MRI study of Theory of Mind in euthymic bipolar disorder patients
G Malhi, J Lagopoulos, P Das, K Moss, M Berk, C Coulston
(2008), Vol. 10, pp. 943-956, Bipolar Disorders, Hoboken, N.J., C1-1
Effects of a walking program in the psychiatric in-patient treatment setting: a cohort study.
F Ng, S Dodd, F Jacka, E Leslie, M Berk
(2007), Vol. 18, pp. 39-42, Health promotion journal of Australia, West Perth, W.A., C1
The bipolar depression rating scale (BDRS) : its development, validation and utility
M Berk, G Malhi, C Cahill, A Carman, D Hadzi-Pavlovic, M Hawkins, M Tohen, P Mitchell
(2007), Vol. 9, pp. 571-579, Bipolar disorders, Copenhagen, Denmark, C1-1
Vitamin D deficiency may play a role in depression
M Berk, K Sanders, J Pasco, F Jacka, L Williams, A Hayles, S Dodd
(2007), Vol. 69, pp. 1316-1319, Medical hypotheses, Amsterdam, The Netherlands, C1-1
Depression and bone mineral density in a community sample of men : Geelong Osteoporosis Study
F Jacka, J Pasco, M Henry, S Korn, L Williams, M Kotowicz, G Nicholson, M Berk
(2007), Vol. 4, pp. 292-297, Journal of men's health & gender, Amsterdam, The Netherlands, C1-1
Self-reported depression and cardiovascular risk factors in a community sample of women
F Jacka, J Pasco, S McConnell, L Williams, M Kotowicz, G Nicholson, M Berk
(2007), Vol. 48, pp. 54-59, Psychosomatics, Amsterdam, The Netherlands, C1-1
F Jacka, M Berk
(2007), Vol. 19, pp. 321-323, Acta neuropsychiatrica, Oxford, England, C1-1
Setting the stage : from prodrome to treatment resistance in bipolar disorder
M Berk, P Conus, N Lucas, K Hallam, G Malhi, S Dodd, L Yatham, A Yung, P McGorry
(2007), Vol. 9, pp. 671-678, Bipolar disorders, Copenhagen, Denmark, C1-1
History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder
M Berk, S Dodd, P Callaly, L Berk, P Fitzgerald, A de Castella, S Filia, K Filia, S Tahtalian, F Biffin, K Kelin, M Smith, W Montgomery, J Kulkarni
(2007), Vol. 103, pp. 181-186, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Dopamine dysregulation syndrome : implications for a dopamine hypothesis of bipolar disorder
M Berk, S Dodd, M Kauer-Sant'Anna, G Malhi, M Bourin, F Kapczinski, T Norman
(2007), Vol. 116, pp. 41-49, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1
Monitoring the safe use of Clozapine : a consensus view from Victoria, Australia
M Berk, J Fitzsimons, T Lambert, C Pantelis, J Kulkarni, D Castle, E Ryan, S Jespersen, P McGorry, G Berger, B Kuluris, T Callaly, S Dodd
(2007), Vol. 21, pp. 117-127, CNS drugs, London, England, C1-1
A survey of combination antidepressant use in Australia
D Horgan, S Dodd, M Berk
(2007), Vol. 15, pp. 26-29, Australasian psychiatry, London, England, C1-1
Atypical antipsychotics for bipolar disorder : overblown or blown over?
F Ng, S Dodd, M Berk
(2007), Vol. 5, pp. 53-64, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1-1
The effects of physical activity in the acute treatment of bipolar disorder : a pilot study
F Ng, S Dodd, M Berk
(2007), Vol. 101, pp. 259-262, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
The benefits of physical activity in the management of bipolar disorder
F Ng, S Dodd, M Berk
(2007), Vol. 9, pp. 83-83, Bipolar disorders, Copenhagen, Denmark, C1-1
F Ng, T Trauer, S Dodd, T Callaly, S Campbell, M Berk
(2007), Vol. 19, pp. 304-310, Acta neuropsychiatrica, Oxford, England, C1-1
L Stafford, M Berk, H Jackson
(2007), Vol. 29, pp. 417-424, General Hospital Psychiatry, United States, C1-1
The role of lamotrigine in the management of bipolar disorder.
F Ng, K Hallam, N Lucas, M Berk
(2007), Vol. 3, pp. 463-474, Neuropsychiatric Disease and Treatment, New Zealand, C1-1
CNS 14-3-3zeta: changes with sex but not psychiatric diagnoses or psychotropic drug treatment.
B Dean, S Boer, A Mackinnon, M Berk
(2007), Vol. 93, pp. 51-57, Schizophrenia Research, Netherlands, C1-1
Pilot of group intervention for bipolar disorder
D Castle, M Berk, L Berk, S Lauder, J Chamberlain, M Gilbert
(2007), Vol. 11, pp. 279-284, International Journal of Psychiatry in Clinical Practice, Abingdon, Eng., C1-1
Should we be targeting exercise as a routine mental health intervention?
M Berk
(2007), Vol. 19, pp. 217-218, Acta Neuropsychiatrica, C1-1
The potential utility of a staging model as a course specifier: a bipolar disorder perspective.
M Berk, K Hallam, P McGorry
(2007), Vol. 100, pp. 279-281, Journal of Affective Disorders, Netherlands, C1-1
Neuroprotection in emerging psychotic disorders
G Berger, M Dell'Olio, P Amminger, B Cornblatt, L Phillips, A Yung, Y Yan, M Berk, P McGorry
(2007), Vol. 1, pp. 114-127, Early Intervention in Psychiatry, Richmond, Vic., C1-1
C Gama, A Andreazza, M Kunz, M Berk, P Belmonte-de-Abreu, F Kapczinski
(2007), Vol. 420, pp. 45-48, Neuroscience Letters, Ireland, C1-1
Net-effect? Online psychological interventions
S Lauder, A Chester, M Berk
(2007), Vol. 19, pp. 386-388, Acta Neuropsychiatrica, C1-1
DNA damage in rats after treatment with methylphenidate.
A Andreazza, B Frey, S Valvassori, C Zanotto, K Gomes, C Comim, C Cassini, L Stertz, L Ribeiro, J Quevedo, F Kapczinski, M Berk, C Gonçalves
(2007), Vol. 31, pp. 1282-1288, Progress in Neuro-Psychopharmacology & Biological Psychiatry, England, C1-1
Does dopamine dysfunction drive depression?
G Malhi, M Berk
(2007), Vol. 115, pp. 116-124, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1
Does dopamine dysfunction drive depression?
G Malhi, M Berk
(2007), Beyond DSM, Beyond Neurotransmitters : 2006 Conference on Melancholia, Copenhagen, Denmark, E1-1
Pharmacological treatment of anxiety and depression in pregnancy and lactation
S Dodd, J Opie, M Berk
(2006), pp. 163-184, Mood and anxiety disorders in women, Cambridge, England, B1-1
Depression and pain : an overview
L Williams, F Jacka, J Pasco, S Dodd, M Berk
(2006), Vol. 18, pp. 79-87, Acta neuropsychiatrica, Oxford, England, C1-1
Diagnosing bipolar disorder : how can we do it better?
M Berk, L Berk, S Dodd, K Moss, G Malhi
(2006), Vol. 184, pp. 459-462, Medical journal of Australia, Strawberry Hills, N. S. W., C1-1
M Berk, S Dodd, M Henry
(2006), Vol. 27, pp. 151-155, Bioelectromagnetics, New York, N.Y., C1-1
It's the economy : the effect of macroeconomic variables of the rate of suicide
M Berk, S Dodd, M Henry
(2006), Vol. 36, pp. 181-189, Psychological medicine, Cambridge, England, C1-1
Health-related quality of life and functioning in bipolar disorder : the impact of pharmacotherapy
M Berk, K Hallam, N Lucas, L Kader, C MacNeil, M Hasty, S Dodd, G Malhi, P Conus
(2006), Vol. 6, pp. 509-523, Expert review of pharmacoeconomics and outcomes research, London, England, C1-1
The safety of medications for the treatment of bipolar disorder during pregnancy and the peurperium
S Dodd, M Berk
(2006), Vol. 1, pp. 25-33, Current drug safety, Bussum, The Netherlands, C1-1
Combination pharmacotherapy in unipolar depression
F Ng, S Dodd, M Berk
(2006), Vol. 6, pp. 1049-1060, Expert review of neurotherapeutics, London, England, C1-1
Seasonal influences on first-episode admission in affective and non-affective psychosis
K Hallam, M Berk, L Kader, P Conus, N Lucas, M Hasty, C Macneil, P McGorry
(2006), Vol. 18, pp. 154-161, Acta neuropsychiatrica, Cambridge, Eng., C1-1
Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?
P Conus, M Berk, P McGorry
(2006), Vol. 40, pp. 199-207, Australian and New Zealand Journal of Psychiatry, Australia, C1-1
P Conus, S Cotton, A Abdel-Baki, M Lambert, M Berk, P McGorry
(2006), Vol. 8, pp. 221-231, Bipolar disorders, Chichester, Eng., C1-1
The orygen first episode mania study. A randomised trial of olanzapine compared to chlorpromazine
M Berk
(2006), Vol. 9, pp. S44-S44, International Journal of Neuropsychopharmacology, Chicago, IL, E1-1
F Jacka, J Pasco, M Henry, M Kotowicz, S Dodd, G Nicholson, M Berk
(2005), Vol. 12, pp. 88-91, Menopause, New York, N. Y., C1-1
The relationship between depression and cardiovascular disease
S McConnell, F Jacka, L Williams, S Dodd, M Berk
(2005), Vol. 9, pp. 157-167, International journal of psychiatry in clinical practice, London, England, C1-1
M Berk, S Dodd
(2005), Vol. 65, pp. 39-43, Medical hypotheses, Amsterdam , Netherlands, C1-1
Bipolar II disorder : a review
M Berk, S Dodd
(2005), Vol. 7, pp. 11-21, Bipolar disorders, Malden, Mass, C1-1
Efficacy of atypical antipsychotics in bipolar disorder
M Berk, S Dodd
(2005), Vol. 65, pp. 257-269, Drugs, Auckland, New Zealand, C1-1
The management of bipolar disorder in primary care : a review of existing and emerging therapies
M Berk, S Dodd, L Berk
(2005), Vol. 59, pp. 229-239, Psychiatry and clinical neurosciences, Richmond, Vic., C1-1
Diagnosis and management of patients with bipolar disorder in primary care
M Berk, S Dodd, L Berk, J Opie
(2005), Vol. 55, pp. 662-664, British journal of general practice, London, Eng., C1-1
Bipolar missed states : the diagnosis and clinical salience of bipolar mixed states
M Berk, S Dodd, G Mahli
(2005), Vol. 39, pp. 215-221, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1
To combine or not to combine? A literature review of antidepressant combination therapy
S Dodd, D Horgan, G Mahli, M Berk
(2005), Vol. 89, pp. 1-3, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Clinical characteristics and management of bipolar disorder in women across the life span
S Dodd, S Katsenos, J Tiller, M Berk
(2005), Vol. 1, pp. 421-428, Women's health, London, England, C1-1
J Fitzsimons, M Berk, T Lambert, M Bourin, S Dodd
(2005), Vol. 4, pp. 731-744, Expert opinion on drug safety, London, England, C1-1
Atypical mood stabilizers : a 'typical' role for atypical antipsychotics
G Malhi, M Berk, M Bourin, B Ivanovski, S Dodd, J Lagopoulos, P Mitchell
(2005), Vol. 111, pp. 29-38, Acta psychiatrica Scandinavica, Malden, Ma., C1-1
Australasian commentary on CANMAT guidelines for treatment of bipolar disorder
M Berk, I Shah, C Andrade, P Joyce, L Tiebang, K-S Ha
(2005), Vol. 7, pp. 83-86, Bipolar disorders, Copenhagen, Denmark, C1-1
Executive functioning and theory of mind in euthymic bipolar disorder
A Olley, G Malhi, J Bachelor, C Cahill, P Mitchell, M Berk
(2005), Vol. 7, pp. 43-52, Bipolar disorders, Copenhagen, Denmark, C1-1
Scale matters : the need for a Bipolar Depression Rating Scale (BDRS)
M Berk, G Malhi, P Mitchell, C Cahill, A Carman, D Hadzi-Pavlovic, M Hawkins, M Tohen
(2004), Vol. 110, pp. 39-45, Acta Psychiatrica Scandinavia, Oxford, England, C1-1
Dietary omega-3 fatty acids and depression in a community sample
F Jacka, J Pasco, M Henry, M Kotowicz, G Nicholson, M Berk
(2004), Vol. 7, pp. 101-106, Nutritional neuroscience, London, England, C1-1
The pharmacology of bipolar disorder during pregnancy and breastfeeding
S Dodd, M Berk
(2004), Vol. 3, pp. 221-229, Expert opinion on drug safety, London, England, C1-1
Predictors of antidepressant response : a selective review
S Dodd, M Berk
(2004), Vol. 8, pp. 91-100, International journal of psychiatry in clinical practice, London, England, C1-1
A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use
S Jespersen, M Berk, C Van Wyk, O Dean, S Dodd, C Szabo, C Maud
(2004), Vol. 19, pp. 161-164, International clinical psychopharmacology, Philadelphia, Pa., C1-1
R Lewis, E Musella, M Berk, S Dodd, H McKenzie, M Hyland
(2004), Vol. 10, pp. 549-552, Journal of evaluation of clinical practice, Oxford, England, C1-1
H Grunze, S Kasper, G Goodwin, C Bowden, H-J Möller, M Berk, WFSBP Task Force on Treatment Guidelines for Bipol
(2004), Vol. 5, pp. 120-135, World journal of biological psychiatry, Abingdon, Eng., C1-1
Recent developments in the treatment of bipolar disorders
M Berk, S Dodd
(2003), Vol. 12, pp. 1621-1632, Expert opinion on investigational drugs, London, England, C1-1
The evolution of clinical audit as a tool for quality improvement.
M Berk, T Callaly, M Hyland
(2003), Vol. 9, pp. 251-257, Journal of Evaluation in Clinical Practice, England, C1-1
D Wynchank, M Berk
(2003), Vol. 18, pp. 271-275, Human Psychopharmacology, England, C1-1
M Vangu, J Esser, I Boyd, M Berk
(2003), Vol. 27, pp. 15-19, Progess in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1-1
Serological observations in patients suffering from acute manic episodes
A Wadee, R Kuschke, L Wood, M Berk, L Ichim, M Maes
(2002), Vol. 17, pp. 175-179, Human psychopharmacology, Chichester, Eng., C1-1
Barriers to treatment among members of a mental health advocacy group in South Africa
S Seedat, D Stein, M Berk, Z Wilson
(2002), Vol. 37, pp. 483-487, Social psychiatry and psychiatric epidemiology, Berlin, Germany, C1-1
Emerging options in the treatment of bipolar disorders
M Berk, J Segal, L Janet, M Vorster
(2001), Vol. 61, pp. 1407-1414, Drugs, Berlin, Germany, C1-1
G Schutz, M Berk
(2001), Vol. 16, pp. 275-278, International Clinical Psychopharmacology, England, C1-1
Platelet glutamate receptor supersensitivity in major depressive disorder.
M Berk, H Plein, D Ferreira
(2001), Vol. 24, pp. 129-132, Clinical Neuropharmacology, United States, C1-1
The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression.
W Verbeeck, M Berk, J Paiker, B Jersky
(2001), Vol. 11, pp. 215-220, European Neuropsychopharmacology, Netherlands, C1-1
M Berk, C Ichim, S Brook
(2001), Vol. 16, pp. 87-92, International Clinical Psychopharmacology, England, C1-1
The platelet as a peripheral marker in psychiatric illness
H Plein, M Berk
(2001), Vol. 16, pp. 229-236, Human Psychopharmacology - Clinical and Experimental, C1-1
Personality factors, stress and immunity
A Wadee, R Kuschke, S Kometz, M Berk
(2001), Vol. 17, pp. 25-40, Stress and health, Chichester, Eng., C1-1
M Berk, H Plein
(2000), Vol. 23, pp. 182-185, Clinical Neuropharmacology, UNITED STATES, C1-1
M Berk, D Stein, A Potgieter, C Maud, C Els, M Janet, E Viljoen
(2000), Vol. 15, pp. 291-295, International clinical psychopharmacology, Philadelphia, Pa., C1-1
Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial.
L Ichim, M Berk, S Brook
(2000), Vol. 12, pp. 5-10, Annals of Clinical Psychiatry, United States, C1-1
The specificity of platelet glutamate receptor supersensitivity in psychotic disorders.
M Berk, H Plein, B Belsham
(2000), Vol. 66, pp. 2427-2432, Life Sciences, England, C1-1
H Plein, M Berk, S Eppel, N Butkow
(2000), Vol. 66, pp. 425-431, Life Sciences, ENGLAND, C1-1
H Plein, M Berk
(2000), Vol. 15, pp. 93-98, International Clinical Psychopharmacology, England, C1-1
Pharmacotherapy of mania: a review
J Segal, S Walton, H Clark, M Berk
(2000), Vol. 4, pp. 171-193, International journal of psychiatry in clinical practice, Abingdon, Eng., C1-1
M Berk, S Brook, F Nur
(2000), Vol. 4, pp. 139-142, International journal of psychiatry in clinical practice, Abingdon, Eng., C1-1
Relationship between serotonin and the temperament and character inventory
A Peirson, J Heuchert, L Thomala, M Berk, H Plein, C Cloninger
(1999), Vol. 89, pp. 29-37, Psychiatry Research, Shannon, Clare Ireland, C1-1
M Berk, S Brook, A Trandafir
(1999), Vol. 14, pp. 177-180, International clinical psychopharmacology, London, Eng., C1-1
Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia.
M Berk, H Plein, T Csizmadia
(1999), Vol. 14, pp. 119-122, International Clinical Psychopharmacology, ENGLAND, C1-1
H Plein, M Berk
(1999), Vol. 9, pp. 107-110, European Neuropsychopharmacology, NETHERLANDS, C1-1
D Stein, M Berk, C Els, R Emsley, L Gittelson, D Wilson, R Oakes, B Hunter
(1999), Vol. 89, pp. 402-406, South African Medical Journal, Claremont, South Africa, C1-1
D Wynchank, M Berk
(1998), Vol. 8, pp. 21-23, Depression and Anxiety, UNITED STATES, C1-1
The platelet intracellular calcium response to serotonin in subsyndromal depression
M Berk, V Mitchell, H Plein
(1998), Vol. 13, pp. 107-110, International clinical psychopharmacology, London, Eng., C1-1
S Saffer, M Berk
(1998), Vol. 14, pp. 89-93, The Journal of Electroconvulsive Therapy, UNITED STATES, C1-1
J Segal, M Berk, S Brook
(1998), Vol. 21, pp. 176-180, Clinical Neuropharmacology, United States, C1-1
M Berk, B Jacobson
(1998), Vol. 10, pp. 441-446, CNS Drugs, C1-1
D Mattson, M Berk, M Lucas
(1997), Vol. 158, pp. 487-494, The Journal of Genetic Psychology: Research and Theory on Human Development, United States, C1-1
Acute phase proteins in major depression
M Berk, A Wadee, R Kuschke, A O'Neill-Kerr
(1997), Vol. 43, pp. 529-534, Journal of psychosomatic research, Amsterdam, The Netherlands, C1-1
M Berk, K Kessa, C Szabo, N Butkow
(1997), Vol. 22, pp. 57-63, International journal of eating disorders, Chichester, Eng., C1-1
M Berk, A du Plessis, M Birkett, D Richardt, Lilly Duloxetine Depression Study Group
(1997), Vol. 12, pp. 137-140, International Clinical Psychopharmacology, Philadelphia, Pa., C1-1
H Clark, M Berk, S Brook
(1997), Vol. 12, pp. 325-328, Human psychopharmacology, Chichester, Eng., C1-1
Lithium blocks 45Ca2+ uptake into platelets in bipolar affective disorder and controls.
M Berk, N Kirchmann, N Butkow
(1996), Vol. 19, pp. 48-51, Clinical Neuropharmacology, United States, C1-1
M Berk, W Bodemer, T Van Oudenhove, N Butkow
(1995), Vol. 10, pp. 189-193, Human psychopharmacology: clinical and experimental, Chichester, Eng., C1-1
Spontaneous abortions in repeat diabetic pregnancies: a relationship with glycemic control
M MIODOVNIK, F MIMOUNI, T SIDDIQI, J KHOURY, M BERK
(1990), Vol. 75, pp. 75-78, Obstetrics & gynecology, New York, N.Y., C1-1
F Camus-Bablon, R Cohen, M Berk, G Perisutti, K Hunter, L Frohman
(1990), Vol. 71, pp. 46-52, Journal of clinical endocrinology and metabolism, Oxford, Eng., C1-1
M Miodovnik, F Mimouni, M Berk, K Clark
(1989), Vol. 160, pp. 1239-1244, American journal of obstetrics & gynecology, St. Louis, Mo., C1-1
Macrosomia in infants of insulin-dependent diabetic mothers
M Berk, F Mimouni, M Miodovnik, V Hertzberg, J Valuck
(1989), Vol. 83, pp. 1029-1034, Pediatrics, Evanston, Ill., C1-1
M MIODOVNIK, F MIMOUNI, P DIGNAN, M BERK, J BALLARD, T SIDDIQI, J KHOURY, R TSANG
(1988), Vol. 11, pp. 713-718, Diabetes care, Alexandria, Va., C1-1
F Mimouni, M Miodovnik, T Siddiqi, M Berk, C Wittekind, R Tsang
(1988), Vol. 72, pp. 175-180, Obstetrics & gynecology, New York, N.Y., C1-1
Impact of pregnancy on complications of insulin-dependent diabetes mellitus
M Berk, M Miodovnik, F Mimouni
(1988), Vol. 5, pp. 359-367, American journal of perinatology, New York, N.Y., C1-1
T Williams, M Berelowitz, M Berk, L Frohman
(1987), Vol. 10, pp. 278-285, Diabetes care, Alexandria, Va., C1-1
S ROSEN, M BERK, D POPP, P SERUSCLAT, E SMITH, S SHAH, A GINSBERG, W CLUTTER, P CRYER
(1984), Vol. 58, pp. 1068-1076, Journal of clinical endocrinology and metabolism, Oxford, Eng., C1-1
Funded Projects at Deakin
Australian Competitive Grants
Providing evidence for the primary prevention of the high-prevalence mental disorders in men: the role of diet in the aetiology of depression, anxiety, and psychological distress
Prof Felice Jacka, Prof Michael Berk, Prof Julie Pasco, Prof Lana Williams
NHMRC Project Grant
- 2014: $13,687
- 2013: $142,302
- 2012: $144,871
Diet as a therapeutic target in depression: A randomised controlled trial
Prof Felice Jacka, Prof Michael Berk, Prof David Castle, Dr Laima Brazionis, A/Prof Catherine Itsiopoulos, Dr Adrienne O'Neil
NHMRC Project Grant
- 2015: $9,996
- 2014: $114,611
- 2013: $227,006
- 2012: $65,002
Inflammatory cytokines as risk factors for the development of both depression and osteoporosis in men
Prof Michael Berk, Prof Julie Pasco, Prof Lana Williams, Prof Felice Jacka, Dr Margaret Henry
NHMRC Project Grant
- 2014: $92,771
- 2013: $129,413
- 2012: $158,906
The Efficacy of N-acetylcysteine as an Adjunctive Treatment in Bipolar Depression: A Double-blind, Randomised, Placebo-controlled Trial
Prof Michael Berk, A/Prof Olivia Dean, A/Prof Susan Cotton, Dr Seetal Dodd, Prof Gin Malhi, A/Prof Chee Ng
NHMRC Project Grant
- 2015: $69,545
- 2014: $169,437
- 2013: $74,883
- 2012: $197,858
Developing evidence for the primary prevention of depressive disorders: The role of diet and physical activity
Prof Michael Berk, Prof Julie Pasco, A/Prof Evie Leslie, Prof Colin Bell, Prof Felice Jacka
NHMRC Project Grant
- 2012: $196,827
- 2011: $71,971
The Efficacy of N-acetylcysteine as an adjunctive treatment in unipolar depression
Prof Michael Berk, Prof Gin Malhi, Dr Seetal Dodd, A/Prof Olivia Dean
NHMRC Project Grant
- 2012: $32,725
- 2011: $48,924
Proof of principle of the inflammatory and oxidative theory of depression: A treatment study
Prof Michael Berk, Dr Andrew Chanen, Ms Susan Harrigan, Christopher Davey, Dr Sarah Hetrick, A/Prof Olivia Dean, Dr Seetal Dodd
NHMRC Project Grant
- 2018: $20,933
- 2017: $102,975
- 2016: $152,181
- 2015: $110,745
- 2014: $111,704
- 2013: $105,227
- 2012: $26,547
Novel therapies, risk pathways and prevention of mood disorders - Senior Principal Research Fellow (SPRF)
Prof Michael Berk
NHMRC - Research Fellowship
- 2018: $177,653
- 2017: $175,200
- 2016: $172,781
- 2015: $170,395
- 2014: $167,382
Diet and nutritional status of people with major depression
Prof Felice Jacka, Dr Ewa Szymlek-Gay, Prof Michael Berk
MLA Grant - Research - Meat & Livestock Australia Limited
- 2015: $84,485
- 2013: $84,300
Gene Expression Signature Technology to Repurpose Drugs for Bipolar Disorder
Prof Ken Walder, Prof Michael Berk, Prof Marion Leboyer, Prof Brian Dean
NHMRC Project Grant
- 2017: $157,493
- 2016: $207,762
- 2015: $117,544
The efficacy of adjunctive Garcinia mangostana Linn. pericarp for bipolar depression: A 24-week double-blind, randomized, placebo-controlled trial.
A/Prof Olivia Dean, Prof Michael Berk, Prof Chee Ng, Dr Seetal Dodd, Prof Malcolm Hopwood, Dr Alyna Turner, Prof Felice Jacka
NHMRC Project Grant
- 2020: $76,202
- 2019: $264,142
- 2018: $342,644
- 2017: $209,758
ARC Research Hub for Digital Enhanced Living
Prof Kon Mouzakis, Prof Svetha Venkatesh, Prof Anthony Maeder, Prof Alison Hutchinson, Prof Michael Berk, Prof Ralph Maddison, Prof Abbas Kouzani, Prof Rajesh Vasa, Prof Helen Christensen, Prof Patricia Williams, Prof John Yearwood, Prof Susan Gordon, Prof David Powers, A/Prof Niranjan Bidargaddi, A/Prof Santu Rana, A/Prof Truyen Tran, Prof Sunil Gupta, Dr Wei Luo, A/Prof Mohamed Abdelrazek, Dr Felix Tan, Prof Henning Langberg, A/Prof Lars Kayser, Prof Finn Kensing, Prof Freimut Bodendorf, Prof James Warren, Dr Roopak Sinha, Prof A Smeaton, Mr Fonda Voukelatos, Mr John Fouyaxis, Dr Kit Huckvale, Prof John Grundy, David Varley, Dr Leonard Hoon, Nicole Cockayne, Dr Tanya Petrovich, Dr Anju Kissoon Curumsing, Matthew Macfarlane, Prof Deborah Parker, Dr Scott Barnett, Ms Sharon Grocott, Dr Tom McClean, Prof Jean-Guy Schneider, A/Prof Carsten Rudolph, Prof Nilmini Wickramasinghe, Dr Jessica Rivera Villicana, Mr Fernando Escorcia, Dr Gnana Bharathy
ARC Industrial Transformation Research Hubs
- 2021: $388,477
- 2020: $385,381
- 2019: $399,716
- 2018: $449,083
- 2017: $601,698
Novel therapies for psychiatric disorders
Prof Michael Berk
NHMRC - Research Fellowship
- 2023: $63,543
- 2022: $187,442
- 2021: $185,403
- 2020: $182,843
- 2019: $180,318
CREDIT: The CRE for the Development of Innovative Therapies for Psychiatric Disorders
Prof Michael Berk, Prof John McGrath, Prof Patrick McGorry, Prof John McNeil, Prof Gin Malhi, Prof Felice Jacka, A/Prof Susan Cotton, Prof Ken Walder, A/Prof Olivia Dean, Prof Lana Williams
NHMRC - Centres of Research Excellence
- 2023: $124,785
- 2022: $498,725
- 2021: $563,659
- 2020: $576,585
- 2019: $510,344
The Candesartan Adjunctive bipolar DEpression Trial - CADET
Prof Michael Berk, Prof Gin Malhi, Prof Chee Ng, Prof Malcolm Hopwood, Ms Brisa Simoes Fernandes, Dr Stella Gwini, Dr John Amerena, Dr Mary Lou Chatterton, Prof Trisha Suppes, Prof Lana Williams
MRFF (NHMRC) Clinical Trials Activity: Rare Cancers, Rare Diseases and Unmet Need Grant
- 2022: $27,927
- 2021: $28,492
- 2020: $30,666
- 2019: $2,103,202
Protecting the mental health of small-medium enterprise owners: Evaluating real-world approaches to mental health first aid and client-relationship building training for small business advisers
Prof Andrew Noblet, Prof George Tanewski, Prof Michael Berk, A/Prof Arlene Walker, Prof Tony LaMontagne, Dr Nicola Reavley, Prof Karina Nielsen
NHMRC - Partnership Project
- 2023: $44,286
- 2022: $142,076
- 2021: $217,420
- 2020: $150,174
The Candesartan Adjunctive Major Depression Trial - CADET: A double-blind, randomised, placebo-controlled trial
Prof Michael Berk, Prof Gin Malhi, Prof Chee Ng, Prof Malcolm Hopwood, Ms Brisa Simoes Fernandes, Dr Stella Gwini, Dr John Amerena, Dr Mary Lou Chatterton, Prof Lana Williams
NHMRC - Clinical Trials and Cohort Studies Grant
- 2023: $77,366
- 2022: $187,240
- 2021: $228,701
- 2020: $201,835
Using 'omics to unravel the pathophysiology and repurpose drugs to treat ME/CFS
Prof Ken Walder, Prof Michael Berk, Dr Chiara Bortolasci, Prof Sean Mcgee, Prof Clinton Bruce, Dr Wolf Marx
NHMRC Targeted Call for Research into Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) Grant Opportunity
- 2023: $93,853
- 2022: $164,314
- 2021: $152,361
- 2020: $25,320
Mental Health Australia General Clinical Trial Network (MAGNET)
Prof Michael Berk, Prof Susan Rossell, Dr Paul Fitzgerald, Prof Adrienne O'Neil, Dr Alyna Turner, Prof undefined Rodgers, Prof Cathy Mihalopoulos, Prof Chee Ng, Dr Christopher Davey, Prof Cherrie Galletly, Prof Anthony Harris, Prof Christos Pantelis, Prof Colleen Loo, Prof Daniel Lubman, Prof Dan Siskind, Prof David Forbes, Prof Denise Meyer, Prof Felice Jacka, A/Prof Frances Kay-Lambkin, Prof Gin Malhi, Prof Greg Murray, Prof Helen Christensen, Prof Jayashri Kulkarni, Prof Jerome Sarris, Prof Jim Lagopoulos, Prof John McGrath, Dr Kate Hoy, Prof Katherine Mills, Prof Mark Nelson, Prof Meaghan O'Donnell, Prof Jane Gunn, Dr Michael Millard, Prof Michael Kyrios, Prof Murat Yucel, Prof Nicholas Glozier, Prof Nicholas Martin, A/Prof Olivia Dean, Prof Osvaldo Almeida, A/Prof Philip Batterham, A/Prof Rebecca McKetin, Prof Richard Bryan, Prof Richard Osborne, Dr Samuel Harvey, Prof Sean Hood, Prof Stephen Touyz, Prof Suresh Sundram, Prof Vasso Apostolopoulos, A/Prof Sophia Zoungas, Prof Svetha Venkatesh, Sarah Russell
MRFF Million Minds Mission Grant Opportunity
- 2022: $1,936,399
- 2021: $1,478,704
Development of a bench to bedside platform for novel therapy development for psychiatric disorders
Prof Michael Berk
NHMRC - Investigator Grant
- 2023: $169,500
Evaluating the efficacy of psilocybin-assisted psychotherapy in treatment resistant depression
Dr Paul Fitzgerald, Dr Kate Hoy, Prof Jayashri Kulkarni, Prof Michael Berk, Dr Neil Bailey, A/Prof Stephane Heritier, Dr Jeggan Tiego, Prof Nicholas Glozier
MRFF (NHMRC) - Innovative Therapies for Mental Illness Grant Opportunity
- 2023: $12,530
Other Public Sector Funding
MoodSwings: an online intervention for bipolar affective disorder
Prof Michael Berk, Ms Sue Lauder, Prof David Castle, Ms Monica Gilbert, Prof L Pitterman, A/Prof B Klein, Prof David Austin, Dr G Murray, A/Prof A Chester, Dr Seetal Dodd, Ms C Holdsworth, Dr J Chamberlain, Ms L Berk
bbVCoE Centre - Centres of Excellence - beyondblue Victoria
- 2011: $14,831
Using Lithium as a neuroprotectant in patients undergoing prophylactic cranial irradiation for small cell lung cancer - A feasibility study.
Prof David Ashley, Dr Greg Wheeler, Dr Mustafa Khasraw, Prof Michael Berk, A/Prof Robert Ramsay
DH VIC VCA Palliative and Supportive Care Capacity Building Grant - Department of Health - Victorian Cancer Agency
- 2012: $80,000
NHMRC Equipment Grant 2011 - Barwon Psychiatric Research Centre
Prof Michael Berk
NHMRC - Equipment Grant (pre 2017)
- 2011: $10,000
Personality disorders in the community
Prof Michael Berk, Miss Shae Quirk
NHMRC Scholarship
- 2015: $14,549
- 2014: $27,642
Eppendorf Refrigerated Centrifuge 5702R
Prof Michael Berk
NHMRC - Equipment Grant (pre 2017)
- 2014: $8,100
Refrigerated Centrifuge and Vortex
Prof Michael Berk, A/Prof Olivia Dean
NHMRC - Equipment Grant (pre 2017)
- 2015: $8,187
NHMRC Equipment Grant 2016
Prof Michael Berk, Prof Ken Walder
NHMRC - Equipment Grant (pre 2017)
- 2016: $17,691
Development of MyMAPS, an innovative blended face-to-face and mobile application psychosocial intervention for bipolar disorder
Prof Michael Berk, Dr Lesley Berk, Prof David Castle, Prof Malcolm Hopwood, Dr Mohammadreza Mohebbi, Prof Greg Murray, Prof John Grundy, Dr Mary Lou Chatterton, Dr Sue Lauder, Dr Emma Gliddon
DHHS - Victorian Medical Research Acceleration Fund
- 2018: $99,872
Protecting the mental health of small-medium enterprise owners: Evaluating real-world approaches to mental health first aid and client-relationship building training for small business advisers
Prof Andrew Noblet, Prof George Tanewski, Prof Michael Berk, A/Prof Arlene Walker, Prof Tony LaMontagne, Dr Nicola Reavley, Prof Karina Nielsen
Victorian Workcover Authority (WorkSafe Vic) - Partnership
- 2022: $30,000
- 2021: $30,000
- 2020: $30,000
An evaluation of the first two years of implementation of the Australian Mental Health Leaders Fellowship (AMHLF).
A/Prof Sandeep Reddy, A/Prof Grant Phelps, Mr John Rasa, Mr Imran Muhammad, A/Prof Martin Hensher, A/Prof Melissa O'Shea, Prof Michael Berk
National Mental Health Commission
- 2021: $25,652
- 2020: $51,305
Long term physical and psychological consequences of Covid-19 infection. A Comparitive Observational Study in Regional Victoria.
Prof Eugene Athan, Dr Darcie Cooper, Prof Peter Vuillermin, Dr Daniel O'Brien, Prof John Stambas, Prof Alister Ward, Prof Michael Berk, Prof Julie Pasco, A/Prof Alyssa Barry, Prof Soren Alexandersen
Department of Jobs, Precincts & Regions
- 2021: $228,000
Counting on U: Supporting SME advisors & owners towards better mental health
Prof Andrew Noblet, Prof George Tanewski, Prof Michael Berk, A/Prof Arlene Walker, Prof Tony LaMontagne
DISER - BusinessBalance ad hoc grant
- 2021: $2,238,000
The mental health data-sharing node: HeSANDA
Prof Alison Yung, Prof Peter Vuillermin, Prof Michael Berk, A/Prof Olivia Dean
ARDC Health Studies National Data Asset Program - Australian Research Data Commons
- 2023: $60,000
- 2022: $60,000
- 2021: $120,000
The ASPIRE program: ASsess, Predict, and InteRvEne: improving mental health outcomes following traumatic brain injury in victims of physical assault
Prof Karen Caeyenberghs, Prof Michael Berk, Prof Peter Enticott
VESKI Near-Miss Award Pilot
- 2023: $34,000
- 2022: $35,000
Industry and Other Funding
Efficacy of N-Acetyl Cysteine in Autism: A double blind, placebo-controlled randomised trial
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean, Dr Katherine Gray, Prof Bruce Tonge
Simons Foundation Autism Research Initiative
- 2013: $143,821
- 2012: $119,640
Assessing an Online Psychotherapy Program for Bipolar Disorder
Prof Michael Berk, Dr Emma Gliddon
Australian Rotary Health - Ian Parker Bipolar Fund Scholarship
- 2017: $3,500
- 2016: $8,500
- 2015: $17,000
- 2014: $17,000
- 2013: $17,000
The efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for the treatment of Schizophrenia: A double-blind, randomized, placebo controlled trial.
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean, Dr Alyna Turner, A/Prof Susan Cotton, Prof John McGrath, Dr Frances Dark
SMRI - Treatment Trials - Stanley Medical Research Institute
- 2021: $117,491
- 2019: $96,709
- 2018: $167,831
- 2017: $363,170
- 2016: $239,559
ARC Research Hub for Digital Enhanced Living
Prof Kon Mouzakis, Prof Svetha Venkatesh, Prof Anthony Maeder, Prof Alison Hutchinson, Prof Michael Berk, Prof Ralph Maddison, Prof Abbas Kouzani, Prof Rajesh Vasa, Prof Helen Christensen, Prof Patricia Williams, Prof John Yearwood, Prof Susan Gordon, Prof David Powers, A/Prof Niranjan Bidargaddi, A/Prof Santu Rana, A/Prof Truyen Tran, Prof Sunil Gupta, Dr Wei Luo, A/Prof Mohamed Abdelrazek, Dr Felix Tan, Prof Henning Langberg, A/Prof Lars Kayser, Prof Finn Kensing, Prof Freimut Bodendorf, Prof James Warren, Dr Roopak Sinha, Prof A Smeaton, Mr Fonda Voukelatos, Mr John Fouyaxis, Dr Kit Huckvale, Prof John Grundy, David Varley, Dr Leonard Hoon, Nicole Cockayne, Dr Tanya Petrovich, Dr Anju Kissoon Curumsing, Matthew Macfarlane, Prof Deborah Parker, Dr Scott Barnett, Ms Sharon Grocott, Dr Tom McClean, Prof Jean-Guy Schneider, A/Prof Carsten Rudolph, Prof Nilmini Wickramasinghe, Dr Jessica Rivera Villicana, Mr Fernando Escorcia, Dr Gnana Bharathy
Cancer Council Victoria Grant - Research, Black Dog Institute, Uniting NSW.ACT, Dementia Australia (Alzheimer's Australia) Vic Inc, Health Metrics, Interrelate Limited, NeoProducts Pty Ltd, Uniting AgeWell, goAct, Aged Care & Housing Group Inc, Unisono Pty Ltd
- 2022: $793,130
- 2020: $553,025
- 2019: $378,745
1/2 A Randomized Trial of Internet-Based Interventions for Bipolar Disorder
Prof Trisha Suppes, Prof Michael Berk
NIH Grant - Research - National Institutes of Health
- 2017: $81,508
- 2016: $56,252
Development of MyMAPS, a novel integrative intervention for bipolar disorder
Prof Michael Berk, Dr Lesley Berk, Ms Frances Quirk, Prof David Castle, Dr Steve Moylan, Mrs Janine Haigh, Prof Sheri Johnson, Dr Tim Denton, A/Prof Thilo Deckersbach
Avant Mutual Group Limited
- 2017: $9,090
The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial
A/Prof Olivia Dean, Prof Michael Berk, Dr Melanie Ashton
Australian Rotary Health - Ian Parker Bipolar Fund Scholarship
- 2019: $15,750
- 2018: $17,000
- 2017: $13,136
- 2016: $3,863
Can we reduce tobacco smoking using N-acetylcysteine as a cessation treatment?
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean
Harry Windsor Research Grant
- 2018: $25,000
- 2017: $25,000
MACH-3 Exploratory Depression Diagnostic Performance: An Abbreviated Investigational Device Exemption Study
Prof Michael Berk
Medibio
- 2017: $170,500
Development of MyMAPS, an innovative blended face-to-face and mobile application psychosocial intervention for bipolar disorder
Prof Michael Berk, Dr Lesley Berk, Prof David Castle, Prof Malcolm Hopwood, Dr Mohammadreza Mohebbi, Prof Greg Murray, Prof John Grundy, Dr Mary Lou Chatterton, Dr Sue Lauder, Dr Emma Gliddon
Healthscope Operations Pty Ltd
- 2018: $100,000
Protecting the mental health of small-medium enterprise owners: Evaluating real-world approaches to mental health first aid and client-relationship building training for small business advisers
Prof Andrew Noblet, Prof George Tanewski, Prof Michael Berk, A/Prof Arlene Walker, Prof Tony LaMontagne, Dr Nicola Reavley, Prof Karina Nielsen
Beyondblue Grant - Research, Institute of Public Accountants, Mental Health First Aid Australia
- 2022: $75,000
- 2021: $75,000
- 2020: $120,450
Beyond Blue Mentally Healthy learning Communities.
Dr Erin Hoare, Prof Felice Jacka, Prof Michael Berk
The Sax Institute
- 2019: $25,000
Depression Assist Partnership Project
Dr Lesley Berk, Prof Michael Berk
GMHBA
- 2022: $10,000
- 2021: $10,000
- 2020: $10,000
Repurposing drugs to treat bipolar depression using stem cell technology
Prof Ken Walder, Dr Chiara Bortolasci, Prof Michael Berk, Dr Amy Sinclair
Milken Institute and Baszucki Brain Research Fund - Bipoloar Disorder Grant
- 2022: $257,128
A Listening and Learning Healthcare System approach to improve outcomes for acute-care mental health consumers in the Barwon-Southwest Victoria Region.
Prof Anna Peeters, Prof Steven Allender, Prof Sharon Brennan-Olsen, Prof Michael Berk, A/Prof Olivia Dean, Prof Felice Jacka, Prof Adrienne O'Neil, A/Prof Melissa O'Shea, Prof Rajesh Vasa, A/Prof Michael Johnstone, A/Prof Martin Hensher, Dr Josh Hayward, Dr Elijah Marangu, Prof Alison Hutchinson, Dr Mary Lou Chatterton, Miss Sally Buchanan-Hagen
Western Alliance
- 2023: $59,284
- 2021: $118,568
Other Funding Sources
Deakin as a participant member of Mental Health CRC
Prof Michael Berk
Mental Health CRC
- 2018: $28,204
- 2017: $98,592
Neon Open System Electroporator
Prof Ken Walder, Prof Michael Berk
NHMRC - Equipment Grant - Not R&D income countable (2017-current)
- 2019: $11,347
Supervisions
Wing Hong Jason Yuen
Thesis entitled: A Novel Voltammetric Approach for Biomarker Identification and Deep Brain Stimulation for Cocaine Addiction
Doctor of Philosophy (Medicine), School of Medicine
Shilpa Aggarwal
Thesis entitled: The development of a psychosocial intervention for self-harm in youth
Doctor of Philosophy (Medicine), School of Medicine
Emma Gliddon
Thesis entitled: Discussion Forum Engagement in an Online Intervention for Bipolar Disorder
Doctor of Philosophy (Medicine), School of Medicine
Steven Edward John Moylan
Thesis entitled: Cigarette Smoking and Increased Anxiety Symptoms and Disorders
Doctor of Philosophy (Medicine), School of Medicine
Jason Hugh Thompson
Thesis entitled: Attributions of responsibility for motor vehicle accidents and post-injury outcomes
Doctor of Philosophy (Medicine), School of Medicine
Bruno Agustini
Thesis entitled: Effects of aspirin on the management of depression in older adults: data analyses of the ASPREE cohort
Doctor of Philosophy (Medicine), School of Medicine
Amelia McGuinness
Thesis entitled: The effect of bowel preparation for colonoscopy on depression symptomatology and gut microbiota composition
Doctor of Philosophy (Medicine), School of Medicine
Anna Lena Wrobel
Thesis entitled: The Role of Trauma in the Treatment of Bipolar Disorder
Doctor of Philosophy (Medicine), School of Medicine
Lauren Arancini
Thesis entitled: Predictors of Successful Tobacco Smoking Cessation
Doctor of Philosophy (Medicine), School of Medicine
Stephanie Cowdery
Thesis entitled: Investigating the association between mood disorders and incident cancer
Doctor of Philosophy (Medicine), School of Medicine
Andrew Leung
Thesis entitled: Investigation and isolation of Xanthones and bioactive compounds from mangosteen.
Doctor of Philosophy (Life & Env), School of Life and Environmental Sciences
Fathima Hajara Abdus Samad
Thesis entitled: Dairy Intake and Health: Exploring Mechanisms and Functions
Doctor of Philosophy (Medicine), School of Medicine
Claire Young
Thesis entitled: A Digital Dietary Intervention for Depression: Development, Optimisation and Feasibility
Doctor of Philosophy (Medicine), School of Medicine
Vinoomika Chandrasekaran
Thesis entitled: Bipolar Disorder, Associated Treatments and Bone Health
Doctor of Philosophy (Medicine), School of Medicine
Bianca Kavanagh
Thesis entitled: Impact of Personality Disorder on Health, Functioning, and Treatment Outcomes
Doctor of Philosophy (Medicine), School of Medicine
Joshua Blair Price
Thesis entitled: Investigating Mechanisms of Stress, Inflammation, and Bioenergetics in Treatment-resistant Depression
Doctor of Philosophy (Medicine), School of Medicine
Scott Adams
Thesis entitled: A neurochemical-based closed-loop deep brain stimulation system
Doctor of Philosophy (Engineering), School of Engineering
Melanie Ashton
Thesis entitled: Exploring factors that contribute to treatment response in bipolar depression
Doctor of Philosophy (Medicine), School of Medicine
Srisaiyini Kidnapillai
Thesis entitled: Molecular Mechanisms of Action of Drugs Used to Treat Bipolar Disorder
Doctor of Philosophy (Medicine), School of Medicine
Joanna Frith Dipnall
Thesis entitled: The Development of a Risk Index for Depression (RID)
Doctor of Philosophy (Medicine), School of Medicine
Rajas Kale
Thesis entitled: Developing Neurostimulation Techniques to Investigate Antidepressant and Mood Modulating Behaviors
Doctor of Philosophy (Engineering), School of Engineering
Kevin Elliott Bennet
Thesis entitled: Diamond-Based Electrode for Chronic Sensing in Deep Brain Stimulation
Doctor of Philosophy (Engineering), School of Engineering
Shae Elise Quirk
Thesis entitled: Personality Disorders in the community
Doctor of Philosophy (Medicine), School of Medicine